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Membrane Bound IL21 Promotes Natural Killer Cell Expansion Through miR 124-3p 
Mediated Regulation 
Anitha Somanchi, M.S. 
Advisory Professors: Eugenie Kleinerman, M.D. & Dean A. Lee, M.D., Ph.D. 
 
 Natural Killer (NK) cells are cells of the innate immune system that act as first line of 
defense against viral infections and participate in tumor immune surveillance. NK cells do not 
cause graft versus host disease (GvHD), or require prior antigen exposure to exert anti-tumor 
activity, hence are an attractive choice for immunotherapy applications. NK cells comprise a 
mere 1-32% (6% median) of peripheral blood cells, hence ex vivo expansion of NK cells is 
critical for adoptive immunotherapy; various expansion methods for NK cells have been 
explored over the decades. We developed a robust platform for expansion of human NK cells 
using K562 expressing membrane bound IL-21 (K562.mbIL21), and showed that 
K562.mbIL21 enables significantly higher expansion of functionally potent NK cells 
compared to K562.mbIL15. Both membrane bound IL15 (mbIL15) and membrane bound IL21 
(mbIL21) expanded NK cells are currently in several Phase I/II clinical trials. K562.mbIL21 
surpasses all other NK cell expansion methods in its rate of NK cell expansion, as well as 
cytokine secretion, cytotoxicity, telomere length and MTOC synapse formation, yielding 
highly activated non-senescent cells.  
 
 IL-15 and IL-21 signaling are essential for proliferation and activation of NK cells in 
vivo, yet mbIL21 far exceeds that of mbIL15 based expansion ex vivo. This could be due to 
promotion of telomerase activity and telomere length by Stat 3 due to IL-21 signaling, 
 however this may not be the only determining factor. The observed differences between these 
2 expansion systems could be caused by miRNAs, crucial regulators of post-transcriptional 
gene regulation. The role of miRNA in NK cell biology is an emerging area of interest and 
their effect on regulation of protein expression and function during expansion of NK cells 
remains unexplored. We hypothesize that activating and expanding human NK cells on 
membrane bound IL15 and membrane bound IL21 will lead to differential gene expression 
mediated by miRNAs and subsequent observed differential expansion potential in these cells. 
Thus, my project’s goal is to identify miRNA that regulate the superior proliferation and 
function of NK cells produced by IL-21 signaling as well as to delineate the pathways that 
enable IL-21 signaling in achieving this effect.  
 
 To accomplish this, we initiated an exploratory study and evaluated the global changes 
in differential gene, protein and miRNA between mbIL15 and mbIL21 expanded NK cells and 
identified BCL2L11, Bim and miR 124-3p to be the most differentially expressed factors, 
respectively (p < 0.01), with highest expression in mbIL15 NK cells. This indicated that miR 
124-3p and Bim downregulation might mediate a proliferative and anti-apoptotic advantage in 
mbIL21 NK cells, and consequently better expansion. MiR 124-3p is recently shown to be a 
tumor suppressor miRNA, with high expression in normal cells; downregulation of miR 124-
3p induces tumorigenesis, proliferation and suppression of apoptosis. We further correlated 
and validated the findings by knockdown of miR124-3p in NK cells, and showed its effect on 
BCL2L11, Bim and Stat3 expression. We discovered that knockdown of miR124-3p decreased 
BCL2L11 and Bim expression, and increased telomerase reverse transcriptase (TERT), Stat 3 
and Stat 3 phosphorylation and consequent increase in proliferation, decreased apoptosis and 
increased overall expansion of NK cells.  
  Thus, this study establishes additional mechanisms for the superior proliferation in 
mbIL21-expanded NK cells, provides a potential approach to increase expansion of NK cells 
on mbIL15 for adoptive immunotherapy applications, and provides insight into the 
mechanistic role of miR124-3p in regulating NK cells proliferation and apoptosis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table of Contents 
 
 
Approvals ……………………………………………………………………………………… i 
 
Title …………………………………………………………………………………………… ii 
 
Dedication ……………………………………………………………………………………. iii  
 
Acknowledgements …………………………………...……………………………………… iv  
 
Abstract …………………………………………………………………………………….... vii  
 
Table of Contents........................................................................................................................ x  
 
List of Figures ......................................................................................................................... xiii 
 
List of Tables ………………………………………………………………………………… xv 
 
 
CHAPTER 1: INTRODUCTION  
 
 
NK cell Discovery …………………………………………………………………………….. 1 
 
NK Cell Receptors ……………………………………………………………………………. 1 
 
NK Cell Complexity and Functions …………………………………………………………... 4 
 
NK Cell Adoptive Immunotherapy …………………………………………………………… 5 
 
Expansion of NK Cells for Adoptive Immunotherapy ……………………….……………….. 7 
 
IL-15 and IL-21 Signaling in NK Cells ……………………………………………………... 11 
 
miRNA: Discovery and Biogenesis …………………………………………………………. 17 
 
miRNA Mechanisms of Gene Regulation ……………………………………….……...…… 19 
 
miRNA in NK cells: Global Expression and Function ……………………………………… 21 
 
 
CHAPTER 2: OBJECTIVES AND STUDY DESIGN 
 
 
Overall Study Design ………………………………………………………………………... 24 
 
 CHAPTER 3: MATERIALS AND METHODS 
 
Cells and Cell Lines …………………………………….………………….…………...…… 25 
 
NK Cell Isolation and Expansion ………………………………….………....……………… 25 
 
NK Cell Phenotype by Flow Cytometry ………………………………….………….……… 28 
 
Assessment of Expansion ………………………………………………….………………… 30 
 
NK Cell Cytotoxicity ………………………………………………………...……………… 32 
 
Global Expression Analyses …………………………………………….………………….... 33 
 
mRNA Isolation ……………………………………………………………………………... 33 
 
Gene Expression Analysis ……………………………………...……….…………………… 33 
 
Protein Isolation ………………………………………………………………………...…… 36 
 
Protein Expression Array and Analysis ……………………………………………………... 36 
 
miRNA Isolation …………………………………………………………………………….. 37 
 
Nanostring Expression Assay …………………………………………….………………….. 37 
 
NK Cell miRNA Expression Analysis …………………………………………………….… 38 
 
miRNA Knockdown and Quantitative RT-PCR …………………………………………….. 41 
 
CFSE Proliferation Assay …………………………………………………………………… 42 
 
Apoptosis Assay …………………………………………………….………………….……. 42 
 
Gene Expression by qPCR ………………………………………………………………..…. 43 
 
Western Blot ………………………………………………………...……….………………. 44 
 
 
CHAPTER 4: RESULTS AND DISCUSSION 
 
 
mbIL15 and mbIL21 Lead to Differential Expansion of NK Cells …………...………... 46 
 
 
 NK Expansion on mbIL15 and mbIL21 Differentially Regulate Gene and Protein 
Expression …………………………………………………………………………….…….. 53 
 
 Gene Expression …………………………………………………………….……….. 54 
 
 RPPA Protein Expression ……………………………………………….…………… 66
  
 
Expansion Platforms Lead to Differences in miRNA Expression Profiles ……………... 76 
 
 miR 124-3p ………………………………………………………….……………….. 87 
 
Correlation of Key Findings ……………………………………………………………...... 88 
 
miR 124-3p Regulates Proliferation, Apoptosis and Senescence in NK Cells ….............. 90 
 
 miR 124-3p Knockdown Increases Overall Expansion ……………………………... 93 
 
 miR 124-3p Knockdown Increases Proliferation ……………………………………. 95 
 
 miR 124-3p Knockdown Decreases Apoptosis …………………………….………... 98 
 
 miR 124-3p Knockdown Regulates Expression of STAT 3, TERT And BCL2L11 
 (Bim) ……………………………………………………………………………….. 101 
 
 
CHAPTER 5: SUMMARY AND CONCLUSION ……………………………………… 107 
 
 
Impact of Work ………………………………………………………………………..…… 114 
 
 
CHAPTER 6: FUTURE DIRECTIONS ………………………………………………… 115 
Bibliography ………………………………………………………………………….……...118 
Vita …………………………………………………………………………………………. 149 
 
 
 
 
 
 
 
 
 
 List of Figures 
 
 
Figure 1: NK Cell Receptors and Secretory Granules ………………………………………... 3 
 
Figure 2: Comparison of Fold Expansion of Various NK Cell ex vivo Expansion 
Methodologies.………………………………………………………………………………... 9 
 
Figure 3: IL-15 and IL-21 Signaling in NK Cells …………………………………………….13  
 
Figure 4: miRNA Formation and Mechanism of Action …………………………….……… 20  
 
Figure 5: Schematic of NK Cell Expansion and Global Expression Analysis ……...……….. 27 
 
Figure 6: Phenotype of Day 0 NK Cells .................................................................................. 29  
 
Figure 7:  Verification of Geometric Density of mRNA Expression ....................................... 35 
 
Figure 8: Schematic for miRNA Data Analysis.  …………………………………….……… 40 
 
Figure 9: mbIL21 Expanded NK Cells Have Higher Cytotoxicity Potential ………………... 48 
 
Figure 10: NK Cells Expanded on mbIL15 And mbIL21 are Phenotypically Similar …..….. 49 
 
Figure 11: mbIL21 Expansion is More Robust and Superior Compared to mbIL15 ...…….... 52 
 
Figure 12: Volcano Plot of mRNA Gene Expression Analysis …………………...………… 56 
 
Figure 13: Differential Gene Expression Between mbIL15 and mbIL21 Expanded NK Cells 
………………………………………………………………………………………………... 57 
 
Figure 14: Interrogation of Differential Expressions of Specific Genes Between mbIL15 and 
mbIL21. ………………………………………………………………………………….…... 65 
 
Figure 15: Comparison of Apoptosis Between mbIL15 and mbIL21 NK Cells …….………. 66 
 
Figure 16: Protein Expression Overview in NK Cells, Before and After Expansion …..…… 68 
 
Figure 17: Comparison of Most Differentially Expressed Proteins by RPPA. …..……..…… 71 
 
Figure 18: Expression of Cell Cycle and Apoptotic Proteins in NK cells Before and After 
Expansion …………………………………………………………...……………………….. 73 
 
Figure 19: Differential miRNA Expression Between Fresh, mbIL15 and mbIL21 Expanded 
NK Cells …………………………………….…………….……………………..……...…… 78 
 
 Figure 20: Summary of Most Significantly Differential miRNA Between Fresh, mbIL15 and 
mbIL21 Expanded NK Cells ………………………………….…..……………………….… 83 
 
Figure 21: Schematic of Correlation of Key Findings miR 124-3p, BCL2L11 and Bim ...…. 89 
 
Figure 22: miR 124-3p Expression in NK Cells Following Knockdown by Electroporation  
………………………………………………………………………………………………... 91 
 
Figure 23: Knockdown of miR 124-3p Enhances Expansion of mbIL15 NK Cells ………… 94 
 
Figure 24: Knockdown of miR124-3p Enhances Proliferation in mbIL15 NK Cells ……….. 96 
 
Figure 25: Knockdown of miR124-3p Reduces Apoptosis in mbIL15 NK cells ………….... 99 
 
Figure 26: Knockdown of miR124-3p Increases STAT3 and TERT, and Decreases BCL2L11 
in NK Cells ……………………………………...……………………………..…………… 103 
 
Figure 27: Expansion of NK Cells with mbI15 After Knockdown of miR124-3p Increases 
STAT3 and TERT, and Decreases BCL2L11 in NK cells …………………………….…… 104 
 
Figure 28: Knockdown of miR 124-3p Increases Stat 3, p-Stat3 and Tert Protein Expression 
and Decreases Bim Protein Expression ………………………………...…………………... 106 
 
Figure 29: Schematic of Modified IL-15 Mediated Signaling in NK Cells ………………... 110 
 
Figure 30: Schematic of Modified IL-21 Mediated Signaling in NK cells ……………….... 111 
 
Figure 31: Schematic of the Effect of miR 124-3p Knockdown on Improving the Overall 
Expansion Potential of mbIL15 NK Cells …….………………………………………….… 113 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 List of Tables 
 
 
Table 1: Comparison of Features of NK Cells Expanded on mbIL15 And mbIL21 .………..16 
 
Table 2: NK Cell Fold Expansion Calculation ………………………………………………. 31 
 
Table 3A: Functional Correlation of Highly Expressed Genes in mbIL15 Expanded NK Cells 
………………………………………………………………………………………….…….. 58 
 
Table 3B: Functional Correlation of Highly Expressed Genes in mbIL21 Expanded NK Cells 
………………………………………………………………………………………….…….. 59 
 
Table 4: Most Highly Expressed Genes in mbIL15 and mbIL21 Expanded NK Cells and Their 
Broad Cellular Functions ……………………………………………………………………. 62 
 
Table 5: Correlation of Differentially Expressed miRNA to Their Known Regulatory 
Functions ………………………………………………….…………………………………. 85 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 1	
CHAPTER 1: INTRODUCTION 
NK cell Discovery 
 Natural killer (NK) cells are large granular lymphocytes of innate immune system that 
play a critical role in host defense against viral infection and surveillance against malignant 
transformation. NK cells were first identified in 1974 as a subset of lymphocytes that were 
capable of cell-mediated cytotoxicity against tumor cells, both in cancer patients and animal 
models. Even in these early experiments, NK cells were observed to cause a ‘natural’ or 
‘spontaneous’ killing of tumor cells without the need for prior sensitization (1). This 
phenomenon was later shown in human lymphocyte derived-cytotoxic lymphocytes against 
human cancer cell lines (2, 3). Later the same year, Heberman et al, isolated ‘unique lymphoid 
cells’ from mouse tumor capable of natural cytotoxicity and described them as “Null Cells” 
since these cells carried no known cell surface markers, and the mechanism of cytotoxicity 
was distinct from known methods such as antibody dependent cellular cytotoxicity (ADCC) at 
that time (4). The term “Natural Killer Cells” was coined in 1975 by Keissling et al, to identify 
a subset of mouse splenic-derived and enriched cells lacking T and B lymphocytes that caused 
cell mediated lysis against Moloney leukemia cells, and were concluded to be a subset of 
lymphocytes that were as yet unidentified (5), and later the same year West, et al, identified 
these cells in human samples (6).  
 
NK Cell Receptors 
 
 NK cells are now accepted to be complex in nature, with a large repertoire of activating 
and inhibitory receptors expressed on their cell surface that drive their intricate anti-tumor 
functions. It is in fact the expression of these activating and inhibitory receptors that determine 
	 2	
the mode of NK cell cytotoxicity; NK cells do not require priming (prior antigen exposure) 
and are not restricted by the expression of major histocompatibility complex (MHC) molecules 
on the target cells, rather the receptors engage a wide variety of molecules on target cell 
surface (7, 8). It is this feature that also distinguishes NK cells in their selectivity against target 
cells while sparing ‘self’ cells. Inhibitory receptors expressed on NK cell surface recognize 
MHC class I or lack thereof on target cells, thus effectively preventing cytolytic destruction of 
these cells (9). On the other hand, strong stimulatory signals from activating receptors that 
overcome inhibitory signals are required for NK cell functioning against the malignant cells. 
Under normal conditions, lack of stress signals including MHC and absence of stress ligands 
from infected or tumor cells prevent NK cell activation against ‘self’. Tumor and virally 
infected cells secrete stress ligands that are recognized by NK cells, and tilt the balance toward 
activation and cytolytic function. Thus maintenance of a critical balance of activation and 
inhibitory signals on NK cells drive their overall cytolytic potential. NK cells are identified by 
surface expression of CD56 and CD16, and absence of T cell receptor CD3 (CD56+CD16+ 
CD3-) (10, 11). Most peripheral blood NK cells are capable of cytotoxicity in response to 
simulation by malignant cells (12). Also characteristic of peripheral blood NK cells capable of 
tumor and viral target recognition and cytotoxicity have high expression of activating natural 
cytotoxicity receptors NKp46, NKp30 and NKp44 (NCR), with NKp46 expressed on majority  
of peripheral blood NK cells (13), NKG2D, DNAM1, as well as killer immunoglobulin-like 
receptors (KIRs) (14). NK cells also express a number of other activating receptors that 
recognize stress-induced ligands on the surface of the target cell such as NKG2D, NKG2C, 
CD226 and 2B4 (15). Additionally, other proteins such as CD11a/LFA-1 and TRAIL may play 
key roles in target cell engagement and enhancing cytotoxicity (Figure 1). 
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Figure 1: NK cell receptors and secretory granules. NK cells express several cell surface 
receptors that help maintain balance between the activation and inhibition state of the cells. 
The receptors shown here are grouped into activating (red), inhibitory (blue), adaptor 
molecules (purple), cytokine receptors (orange), adhesion factors (magenta), and chemokine 
receptors (green). Secretory factors such as interferon γ, pro-inflammatory cytokines, perforin 
and granzyme B are also indicated. This list of receptors, while not exhaustive lends insight 
into the complexity of NK cells. 
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NK Cell Complexity and Functions 
 
 NK cells are a subset of cytotoxic lymphocytes, and their primary function is in 
immune surveillance, recognition and killing of virally infected and malignantly transformed 
cells. These attributes of NK cells are mediated by cytokines as well as the signals generated 
by activating and inhibitory receptors (16). NK cells mediate their cytotoxic functions 
primarily through direct lysis of target cells by secretion of lytic granules containing perforin 
and granzyme, a proteolytic serine protease similar to trypsin (17-19), and by induction of 
apoptosis of target cells mediated by death receptor pathway proteins such as FAS ligand 
(FASL), TNF and TRAIL (8, 20). MHC class I molecules are often downregulated in 
malignant cells. NK cell activating receptors are also capable of recognizing and killing 
malignant cells’ stress induced signals due to cellular stress and DNA damage (21-23). 
Further, antibody-coated tumor cells or virally infected cells are recognized by FcϒRIII CD16 
receptors on NK cells, leading to NK cell activation and resultant release of cytolytic granules 
and apoptosis of target cells by a process called antibody dependent cellular cytotoxicity 
(ADCC) (24, 25). NK cells that are highly cytotoxic also secrete a variety of cytokines (26).  
 
 Alongside target cell lysis, NK cells also play a role in regulating immune responses of 
other lymphocytes through secretion of cytokines such as IFN-γ, TNF-α, IL10 and IL13 (27), 
and the subset of NK cells with cytokine secretory ability are more predominant in lymph 
nodes and secondary lymphoid organs (28-30). This cytokine secretion ensures the regulation 
of ADCC as well as activation of pre-existing inflammatory cells, and in recruitment of other 
immune cells including dendritic, T and B cells. Thus, both innate and adaptive immune 
responses are mediated by cytokines secreted by NK cells (31-35). Further, depending on 
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stimulation conditions, peripheral blood NK cell subsets within an individual could be 
heterogeneous with phenotypically distinct subsets and changes in expression of activating 
receptors, indicating plasticity and adaptability (36, 37). Additionally, NK cells have recently 
been shown to exhibit features of adaptive immunity, where they acquire antigen-specific 
immunological memory similar to T and B cells (38, 39). Further, during hematopoietic stem 
cell transplantation (HSCT), donor-derived NK cells in T-cell depleted haploidentical grafts 
were found to exert potent anti-leukemia effects without causing graft vs host disease (GvHD) 
(25, 40-42). These attributes of NK cells have made them an attractive candidate for exploring 
NK cell adoptive immunotherapy. 
 
NK Cell Adoptive Immunotherapy 
 
 Given the diversity of functions of NK cells in cytokine secretion, activation of other 
immune cell components, lack of ability to cause graft vs host disease, and propensity for 
cytotoxicity against tumor cells, NK cells have emerged as one of the most promising 
candidates for adoptive immunotherapy of cancer, and there is significant momentum to 
advancing NK cells in clinical setting. NK cell therapy is currently being tested against 
multiple cancers, and adoptive transfer of activated NK cells has been shown to be safe and 
potentially efficacious for treatment of cancer (24, 43, 44). The therapeutic potential of NK 
cells has led to several approaches in immunotherapy. Most of the early studies in adoptive 
therapy were focused on enhancing endogenous NK cells’ antitumor capabilities. 
 
 Some of the early trials included induction of autologous NK cells by systemic 
administration of IL-2 against breast cancer and lymphoma. However, lower doses did not 
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potentiate substantial activation and cytotoxic function, while higher doses caused an increase 
in systemic cytokines with toxicities associated with high dose IL-2 in patients (40, 45, 46). 
Similarly, activation of NK cells with other cytokines like IL-12, IL-15, IL-18, IL-21 and type 
I IFNs yielded moderate generation of NK cells, but not sufficient to cause clinical responses 
(47). In clinical setting, autologous NK cell therapy using IL-2 activated NK cells were found 
to be safe but less efficacious, and was attributed to lack of KIR mismatch with autologous 
tumor cells (48-52). In order to overcome this drawback, IL-2 activated allogeneic NK cells 
were used in AML patients, but with limited success (43). NK cells that are activated and 
expanded ex vivo prior to adoptive transfer using “cytokine cocktail” with soluble cytokines 
such as IL-2, IL-15 and IL-21 have also been tested in clinical trials with limited success (53-
57), partly due to the number of NK cells generated by these methods are much lower than an 
‘ideal’ number to cause a favorable clinical outcome.  
 
 Despite these significant advances in NK cell adoptive immunotherapy, the bottleneck 
for success has been finding methods of generating large number of NK cells with high purity 
and potency required for therapeutic benefit. Most cancer clinical trials require NK cells 
ranging from 5×106 to 5×107 per kilogram (43, 58-60), with recent studies using doses as high 
as 1×108 NK cells per kilogram per infusion. Given the small percentage of NK cells in 
peripheral blood (61, 62), the amount of NK cells required for infusion into patients become 
challenging. Several attempts have focused on finding robust methods of ex vivo expansion of 
NK cells. Expansion of NK cells from sources such as embryonic stem cells, cord blood, and 
buffy coats (peripheral blood monocytic cells, PBMCs) have opened up possibilities of 
increased expansion and a shift in NK cell adoptive immunotherapies. Some of the ex vivo 
expansion methods for NK cells are discussed in the section below. 
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Expansion of NK Cells for Adoptive Immunotherapy 
 
 One of the early methods for isolation of peripheral blood NK cells for immunotherapy 
was the traditional steady state leukopheresis (followed by T cell depletion and overnight 
activation with IL-2). This method is not only cumbersome but also yielded very low numbers 
of NK cells for patient infusions during clinical trials, due to the lower percent of NK cells in 
the peripheral blood. A typical leukopheresis isolation of NK cells yielded less than 2 X 107 
cells for a single infusion (63). Magnetic selection of NK cells followed by activation with 
high dose IL-2 and IL-15 yielded moderate expansion of CD56+CD16+CD3- NK cells, but did 
not eliminate CD56+CD16+CD3+ cells (52). Expansion platforms using bisphosphonate-coated 
dendrimers for selective expansion of NK cells from PBMCs (64), feeder cells derived from 
EBV-lymphoblastoid cell lines (LCL), achieving a mean 490-fold expansion in 21 days have 
also been reported. These cells were tested successfully against adult and pediatric leukemia in 
clinic (65-67). K562 expressing 4-1BBL and MIC-A, plus soluble IL-15 was shown to yield 
550-fold expansion of NK cells in 24 days (68). Overall, these methods enabled ex vivo 
expansion of NK cells from ~35 folds in (12 days) to 1625 folds (2 weeks) (69) (Figure 2).  
 
 Prominent amongst the various expansion platforms include K562-based feeder cells 
developed by transducing 4-1BBL (CD137L) and membrane-bound IL-15 (K562.mbIL15) 
(70, 71), and K562-based feeder cells transduced with CD64, CD86, CD137L, truncated CD19 
and membrane bound IL-21 (K562.mbIL21) developed in our lab (62, 69, 72). K562.mbIL21 
surpasses any other expansion to date not only in its rate of proliferation, but also cytokine 
secretion, cytotoxicity, telomere length and MTOC synapse formation, yielding highly 
activated non-senescent cells, with an average 67,000 fold expansion of pure NK cells in 21 
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days. Both K562.mbIL15 and K562.mbIL21 circumvent the high toxicities involved with 
soluble cytokines and cytokine cocktails by the use of membrane bound versions of IL-15 and 
IL-21, respectively. A comparative fold expansion of various methods published thus far 
ranging from 12 days to 21 days is represented in Figure 2. 
 
 NK cells expanded on K562.mbIL15 yields a mean expansion of 277 folds in 21 days, 
and although the cells are highly cytotoxic both in vitro and in vivo, their proliferation is 
limited due to senescence, attributed to telomere shortening (70). NK cells expanded on these 
platforms are currently used in several clinical trials (K562.mbIL15: NCT02123836, 
NCT03003728; K562.mbIL21: NCT02809092, NCT01787474, NCT02005289, 
NCT00514085). Additionally, our K562.mbIL21 expansion methodology is widely used to 
study several aspects of NK cells including NK cell biology (73, 74), expansion of NK cells 
form umbilical cord blood (75), human embryonic stem cells and inducible pluripotent stem 
cells (76, 77), preclinical evaluation of neuroblastoma (78, 79), as well as expansion from 
rhesus macaques and canine models  (80, 81).  
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Figure 2: Comparison of fold expansion of various NK cell ex vivo expansion 
methodologies. (A) Methods of NK expansion in this panel include high dose IL-2 cytokine 
stimulation, leukopheresis, dendrimer-based expansion platform, cytokine cocktails and 
membrane bound IL-21 from left to right. Of the expansion methods for 2 weeks included in 
this panel, only mbIL21 expansion yields highly pure NK cell product without contaminating 
CD3 positive cells, and circumvents toxicities associated with soluble cytokines. (B) This 
panel includes methodologies where NK cells were expanded for 21 days or longer. Methods 
include soluble cytokines IL-2, IL-15 in combination with other agents such as hydrocortisone, 
anti-CD3 antibody, OKT3, K562 cell line stimulation; EBV transformed LCL cell line, K562 
gene modified with membrane bound IL-15 and K562 gene modified with membrane bound 
IL-21. As shown, mbIL21 expansion surpasses other methods by several thousand folds, while 
making the NK cells highly potent and cytotoxic against a wide variety of tumors tested.  
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IL-15 and IL-21 Signaling in NK Cells 
 
 K562.mbIL15 and K562.mbIL121 platforms rely on IL-15 and IL-21 cytokine 
signaling respectively. Both cytokines’ signaling activation is via JAK-STAT pathway, 
however they differ in their specific pathway of action. IL-15 and IL-21 preferentially and 
predominantly activate through signal transducer and activator of transcription – STAT 5 and 
STAT 3, respectively (82). IL-15 and IL-21 belong to the class of common γ-chain cytokines, 
along with IL-2. IL-15 has long been recognized for its role in in vivo lymphocyte activation, 
maturation, proliferation and homeostasis, particularly in NK cells (83, 84). In vivo, IL-15 is 
considered a pivotal cytokine required for NK cell development and maintenance. Signaling is 
initiated when IL-15 binds to its cognate receptor IL-2/15Rβγ on NK cells, and activates 
Janus-associated kinase 3 (JAK3). This series of events preferentially activates 
phosphorylation of STAT5 via IL-2/15Rβγ heterodimer’s γ-chain (85), promotes translocation 
to the nucleus and binding to specific DNA elements causing activation of downstream 
signals, thus enhancing proliferation and cytotoxic effector functions (86-88) (Figure 3A). 
Similar to IL-15, activation of signaling by IL-21 is initiated when IL-21 binds to IL-2/21Rβγ 
receptor on NK cells, however it activates Janus-associated kinase 1 (JAK1) (89, 90). This in 
turn preferentially recruits and activates STAT3 phosphorylation and activates further 
downstream signaling leading to proliferation as well as enhancing cytotoxicity properties of 
NK cells by activation of granzyme B and perforin (Figure 3B). Interestingly, IL-21 is a 
pleiotropic cytokine and its function varies from one immune cell type to the other (91). IL-21 
signaling in NK cells in synergy with IL-15 and IL-18 has been shown to promote 
proliferation, maturation, increase interferon gamma (IFN-γ) production, and increase 
cytotoxicity of NK cells in vivo (92, 93). Additionally, whilst IL-21 signaling is highly 
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beneficial to the immune components like CD8 T cells, dendritic cells, macrophages, and 
particularly NK cells, as well as enhancing NK cell mediated ADCC, it has been shown to 
induce apoptosis in certain lymphomas and other malignancies (94-97). Based on these 
attributes of IL-21 signaling and advantages, we developed the K562 feeder cell based mbIL21 
platform for the expansion of NK cells.  
 
 In our studies, we have previously extensively compared the properties of NK cells 
expanded on K562.mbIL15 and K562.mbIL21 (mbIL15 and mbIL21, respectively), since both 
expansion platforms are based on feeder cells modified to express membrane bound cytokines 
(Table 1), we showed that there are certain similarities as well as differences between the NK 
cells expanded on mbIL15 and mbIL21. For instance, both mbIL15 and mbIL21 expanded NK 
cells had similar phenotypic expression of activating and inhibitory receptors, and their effect 
on cytotoxicity, with marginal differences in these attributes (62). In their original report of 
mbIL15 feeder cell expansion platform for NK cells, Fujisaki, et al demonstrated that mbIL15 
causes decrease in telomerase reverse transcriptase enzyme (hTERT), and consequently 
replicative senescence in NK cells. This effect was overcome by the addition of recombinant 
hTERT (70). On the other hand, STAT3 is a known activator of hTERT (98), and we reported 
that mbIL21 expanded NK cells indeed had significantly higher telomere length. The biggest 
observed difference however was in the fold expansion between mbIL15 and mbIL21, as 
shown in Figure 2 and Table 1. It is possible that mbIL21 expansion is significantly better due 
to the regulation of telomere length by promotion of telomerase activity, however this may not 
be the only determining factor.  
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Figure 3: IL-15 and IL-21 signaling in NK cells. (A) IL-15 binding to its cognate receptor 
IL-2/15Rβγ activates Janus Kinase (JAK) phosphorylation, which leads to recruitment, and 
preferential phosphorylation and activation of Stat5. The now activated Stat5 is translocated to 
the nucleus where it binds specific DNA elements causing activation of downstream signals, 
including PI3K, MAPK pathways thus enhancing proliferation and cytotoxic effector functions 
in NK cells. When NK cell stimulation occurs in vivo in response to cellular stress, IL-15 
mediated stimulation leads to active proliferation of NK cells by prevention of apoptotic 
signals. This, in addition to the well-established role of IL-15 in activation, proliferation and 
homeostasis in vivo, was the basis upon which mbIL15 expansion platform was developed. 
(B) Similar to IL-15, IL-21 binding to the IL-2/21Rβγ promotes preferential recruitment and 
phosphorylation of Stat3, which in turn is translocated to the nucleus, where it binds the DNA 
elements and causes activation of downstream signals including PI3K, MAPK, BCL-2 (anti-
apoptotic) and granzyme A, thus enhancing proliferation and cytotoxic effector functions in 
NK cells. IL-21 is a pleiotropic cytokine with varied functions in different immune cell types, 
and in vivo IL-21 mediated signaling in NK cells promotes proliferation, maturation, survival, 
increased interferon gamma (IFN-γ) production, and increased cytotoxicity. 
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Table 1: Comparison of features of NK cells expanded on mbIL15 and mbIL21. Based on 
our previous studies, we compared the properties of NK cells expanded on mbIL15 and 
mbIL21. Both expansion platforms are based on feeder cells modified to express membrane 
bound cytokines. As shown, phenotype and cytotoxicity were similar in our prior studies. The 
differences include activation signaling through Stat 5 and Stat 3 for IL-15 and IL-21, 
respectively. Additionally, mbIL21 expansion promoted maintenance of telomere length, 
whereas mbIL15 expansion diminished TERT expression, leading to senescent cells. The 
largest and the most significant difference between the expansion methods were in the fold 
expansion after 3 weeks, as shown. 
 
K562.mbIL15 K562.mbIL21
Phenotype High	Expression	of	
Activating	Receptors
High	Expression	of	
Activating	Receptors
Cytotoxicity High	Potency High	Potency	(greater	than	
mbIL15	expanded	NK	cells)
Clinical	Trials Yes Yes
Activation	
Signal
Preferentially	Through	
STAT	5
Preferentially	Through	
STAT	3
Telomere	
Length Low	-	Senescent	NK	cells
High	-	Non-senescent									
NK	cells
Expansion						
(3	weeks)
277	fold 67000	fold
Expansion	based	on	gene	modified	feeder	cells
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 Although a number of transcription factors and molecular mechanisms regulating 
various aspects of NK cells including their development, maturation, survival, and function 
have been identified, several of the regulatory aspects of NK cells are under active 
investigation. In this project, we sought to address the key differences in expansion between 
mbIL15 and mbIL21 and the mechanisms involved in causing their expansion outcome. We 
proposed that the robustness in mbIL21 expansion compared to mbIL15 could be due to an 
increased proliferation of NK cells with mbIL21, increased senescence and apoptosis in 
mbIL15 expansion or a combination of all these factors. We also proposed that genes and 
proteins involved in regulation of cellular proliferation, apoptosis and senescence could be 
differentially expressed in mbIL15 and mbIL21 expanded NK cells. Further, these differences 
could have basis in differential transcriptional and post-transcriptional regulation of gene 
expression, and could be mediated and regulated through the involvement of microRNA 
(miRNA).  
  
miRNA: Discovery and Biogenesis 
 
 MicroRNA (miRNAs) are a large class of small non-coding RNA molecules that are 
18-22 nucleotides long and are highly conserved across species. miRNAs were discovered in 
1993; they comprise 3-4% of human genome and are concentrated in and around tumor 
susceptibility loci (99, 100). miRNAs act as key regulators of post transcriptional gene 
expression, and regulate over 30% of known mammalian genes to date (101). More than 2500 
miRNAs have been discovered, and they control complex regulatory network of gene 
expression. miRNA mediated regulation has been observed in several signaling and cellular 
processes including tissue development, survival, cell differentiation, proliferation, neuronal 
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development, metabolism, stem cell maintenance, apoptosis and immune modulation (102-
110). Deregulation of miRNA expression is commonly found in cancers, and these changes are 
implicated in tumorigenesis, invasion, proliferation and increased metastasis (111); several 
miRNAs are currently used as diagnostic biomarkers. Modulation and restoration of miRNA 
expression levels using miRNA inhibitors and/or mimetics are being investigated as 
therapeutic intervention against several cancer models. (112-114).  
 
 The miRNA are formed from long non-coding RNAs through a series of enzymatic 
steps. The sequential processing of miRNA occurs fist in the nucleus followed by the 
cytoplasm, where they bind to genes and regulate gene expression by either suppression or 
activation of cognate mRNA. miRNA genes are transcribed in the nucleus as pri- and pre- 
double stranded miRNA; the pri-miRNA is processed in the nucleus by the RNAse enzyme 
Drosha into a 70 nucleotide-long hairpin-like precursor called pre-miRNA, which is exported 
to the cytoplasm by exportin 5-Ras GTPase complex. In the cytoplasm, pre-miRNA undergoes 
additional processing by another RNAse III enzyme Dicer, thus generating the double strand 
miRNA (115-117) (Figure 4).  
 
 The transcriptional regulation action of miRNA is mediated through base-pairing 
between the double strand miRNA – Argonaute protein complex (Ago-1 and Ago-2) and an 
imperfectly matched target site usually located at the 3′-end of a target mRNA. This process 
leads to unwinding and elimination of the passenger strand, leaving the mature miRNA to be 
incorporated into the RNA-inducing silencing complex (RISC), resulting in translational 
repression followed by deadenylation and degradation of the mRNA (Figure 4). Each miRNA 
has been shown to affect several of its target mRNA in a given cell, and the strength of 
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repression or activation is dependent on the binding affinity of the miRNA-mRNA-RISC 
complex (118, 119). 
 
miRNA Mechanisms of Gene Regulation 
 
 Although traditional roles of miRNA in gene regulation were considered to be 
translational repression, recent studies show evidence of overall gene regulation by repression 
as well as activation of protein expression (111). The miRNA-mediated downregulation has 
been shown to be reversible. Additionally, it has also been observed that miRNA upregulates 
certain proteins in specific cell types and conditions, in response to cellular stimuli (120-122).  
 
 The miRNA suppress gene expression by several means: shortening of poly A tail, 
cleavage and destruction of mRNA, destabilization of mRNA (partial cleavage), inhibition of 
translational initiation and/or elongation, as well as ribosomal obstruction of translation 
leading to lower output of target proteins (123, 124). In order to cause downregulation of gene 
expression, each miRNA pairs with the 3′ untranslated region (3’ UTR) of its mRNA target 
mediated by a 6–8-nucleotide seed sequence at the 5′ end of the miRNA, which in turn binds 
the 3’ UTR of mRNA promoter region (125). Some miRNAs have also been shown to target 
5’ UTR of mRNA, the coding regions of mRNA (120, 126) (Figure 4). 
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Figure 4: miRNA formation and mechanism of action. The formation of functionally active 
miRNA is an enzymatically regulated process that begins in the nucleus with miR gene 
transcribed into pri-miR, which by a series of steps involving Drosha and Dicer enzyme 
complexes leads to the formation of a mature ‘sense’ strand of miRNA in the cytoplasm. This 
sense strand forms a RNA-Induced Silencing Complex (RISC), and binds mature mRNA. The 
effector function of miRNA regulation is determined by binding of miRNA on specific 
translational activation or repression domains of mRNA. 3’ UTR mRNA-miRNA binding 
cause translational repression as shown, while incomplete binding causes poly A tail 
degradation, and thereby repression. Recent studies have shown 5’ UTR mRNA-miRNA 
binding specifically recruits TNF and Ago 2 proteins leading to translational activation. 
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 The mechanisms that drive upregulation of protein expression due to miRNA 
intervention are diverse as well. For example, a recent study showed that when Ago2-RISC 
complex binds to Fragile X mental retardation protein 1 (FXR1) protein, it leads to direct 
activation of eIF4E (elongation factor), and thereby translation (127). A similar mechanism 
was reported when miR 369-3 interacted with AU rich region of tumor necrosis factor (TNF) 
mRNA, and caused augmentation of protein expression during cell cycle arrest. Specifically, 
direct base pairing between the miR 369-3 and its target caused translational upregulation after 
cellular stress stimuli such as serum starvation (120, 128).  In the same study, miR let-7a was 
shown to switch the target genes from translational repression to activation during cell cycle 
arrest. miRNA binding to 5’ UTR region has been associated with enhancing ribosomal 
biogenesis, causing increased global protein synthesis and subsequent oncogenic 
transformation in NIH3T3 cells (129). Additionally, AGO2 has been shown to be involved in 
activation of gene expression when the target mRNA lacks poly(A) tail (130). Thus, miRNA 
regulation of gene expression is through diverse mechanisms of both translational repression 
and activation.   
  
miRNA in NK cells: Global Expression and Function 
 
 In literature, the role of miRNA is extensively studied in various cellular functions 
such as proliferation, apoptosis and migration in several cancers, immune cells such as T cells, 
and to a smaller extent in NK cells. Recent advances have highlighted the importance of 
miRNA-mediated post-transcriptional regulation in NK cell development, maturation, and 
function (131-133). Several studies on miRNA in NK cells are focused on global expression 
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and observational analyses of miRNAs. It is conceivable that the expression profiles of 
miRNA in NK cells would be determined by the source and mode of activation of NK cells. 
Thus, there are several studies that have explored miRNA expression in NK cells form mouse 
(132), cord blood (134), NK-92 cell line (135) and NK cells stimulated with cocktail of soluble 
IL-2, IL-15 and IL-21 cytokines (136). Whilst this is a growing field, there are however, 
currently no reports of comparison of miRNAs in membrane bound IL-15 and IL-21 expanded 
NK cells or the role of miRNA in promoting robust expansion of NK cells with IL-21. This 
aspect of the study is of high interest to us, particularly because this platform was developed in 
our group, it indeed is better than all other platforms for ex vivo expansion of NK cells 
developed thus far, and that NK cells expanded on mbIL21 are currently in several clinical 
trials. Hence we proposed that activating and expanding human NK cells on membrane bound 
IL15 and membrane bound IL21 will lead to differential gene expression mediated by miRNAs 
and subsequent observed differential expansion potential in these cells.  
 
 Further, there are currently several reports where the roles of specific miRNAs in NK 
cell function have been shown. Most of these studies focus on delineating the role of miRNA 
in modulating NK cell development, maturation and function (133, 137-141). There are 
currently no studies on the roles of specific miRNA in regulating cytokine-mediated 
proliferation and expansion of NK cells. Thus the overarching goal of this project was to 
identify the differential gene expression, and if stimulation of NK cells with mbIL15 and 
mbIL21 could differentially regulate miRNA profiles of these cells, and if so how these 
miRNA influence the observed difference in expansion of NK cells. It is worthwhile to note 
that while we have specifically focused on the role of miRNA in regulating expansion aspect 
of NK cells, we have also identified miRNA that has potential to modulate other aspects of NK 
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cells function including cytokine secretion, chemokines and chemokine receptor expression, 
expression of activating and inhibitory receptors and intracellular granzyme B and perforin 
expression, as well as NK cell development. These miRNAs are discussed in the future 
directions section of the thesis, with potential future studies including modulation of these 
miRNA either during expansion on mbIL21 or to study NK cell biology.  
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CHAPTER 2: OBJECTIVES AND STUDY DESIGN  
 
 Based on the rationale provided above, the overarching objectives for this study are to 
(1) understand the global miRNA, gene and protein expression profiles of NK cells that are 
isolated from peripheral blood, as well as NK cells that are expanded on K562.mbIL15 and 
K562.mbIL21 feeder cells, (2) to identify the differential expression of miRNA, gene and 
proteins in K562.mbIL15 and K562.mbIL21 expanded NK cells, (3) to correlate the 
differentially expressed miRNA, gene and proteins that play a role in determining the observed 
changes in expansion, and (4) to validate the identified miRNA targets in these NK cells by 
modulating their expression through transient knockdown/ upregulation by electroporation.  
 
Overall Study Design 
 
 The differential global expressions of miRNA, gene and protein were assessed, 
followed by statistical analyses and correlation of miRNA, gene and protein expressions. miR 
124-3p, BCL2L11 and Bim were identified to be the most significantly differentially expressed 
factors with highest expression in mbIL15 expanded and fresh NK cells. We further correlated 
miR 124-3p to BCL2L11 as well as other genes that are critical to the expansion outcome. In 
order to understand the role of miR 124-3p in expansion of NK cells, miR124-3p was knocked 
down in NK cells and evaluated for its effect on regulating proliferation, apoptosis and 
senescence as key functions that cause the overall observed differential expansion.  
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CHAPTER 3: MATERIALS AND METHODS 
 
Cells and Cell lines 
 
 Anonymized normal donor derived buffy coats were obtained form Gulf Coast 
Regional Blood Center (under IRB approved protocol) and the MDACC blood bank. 
Peripheral blood mononuclear cells (PBMCs) were isolated from these buffy coats by ficoll 
paque premium plus (GE Healthcare, USA) centrifugation as described previously (62, 69, 
72). NK cells were isolated from the separated PBMCs as described below.  
 
 CML cell line K562 was purchased from ATCC, AML cell line Molm 13 was a gift 
from Dr. Zweidler McKay’s lab, Division of Pediatrics, MDACC.  Both cell lines were 
maintained in RPMI 1640 containing 10% FBS, 1% L-Glutamine and 1% penicillin/ 
streptomycin.  The authenticity of the cell lines was confirmed by short tandem repeat DNA 
profiling analysis (Promega Powerplex 16HS Kit).  
 
NK Cell Isolation And Expansion 
 
 NK cells were isolated from PBMCs by negative selection with RosetteSep Human NK 
cell enrichment Cocktail (Stem Cell technologies, Ca), and the cells were maintained in 
complete RPMI 1640 (Cellgro, VA) containing 10% Fetal Bovine Serum (Invitrogen, CA), L-
glutamine (Gibco, CA), penicillin/streptomycin, sodium pyruvate and non-essential amino 
acids (Cellgro, VA) and freshly supplemented with 50 IU/ml recombinant human IL-2 
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(Proleukin, Novartis) [1, 3]. Freshly isolated NK cells were expanded by stimulation with 
gamma-irradiated (100 Gy) feeder cells K562.mbIL15 or K562.mbIL21 (for each donor) [3] 
for 2 weeks (14 days) by co-culture at 2:1 ratio in complete RPMI media. Half of the media 
was replaced every 2 days or as needed and supplemented with fresh IL-2 for the entire 
volume of media. At the end of 1 week of expansion (Stim 1), NK cells were again co-cultured 
with 1:1 ratio of gamma-irradiated feeder cells in complete RPMI media freshly supplemented 
with 50 U/ml IL-2 (stim 2); NK cells were collected at the end of 14 days (Figure 5). 
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Figure 5: Schematic of NK cell expansion and global expression analysis. NK cells from 4 
normal donors were isolated using Rosettesep NK cell cocktail, and miRNA, mRNA and 
protein were isolated from these cells as shown. 2 aliquots of these NK cells each were 
stimulated with either K562.mbIL15 or K562.mbIL21 for 2 weeks. NK cells were checked for 
purity after 2 weeks by flow cytometry, and miRNA, mRNA and proteins were isolated from 
these samples as before. As indicated, miRNA analysis was performed by Nanostring analysis, 
mRNA by Affymetrix HTA 2.0 and protein by RPPA. 
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NK Cell Phenotype By Flow Cytometry 
 
 Freshly isolated (unexpanded) NK cells were stained with anti-CD56, anti-CD16, anti-
CD3 and anti-NKp46 antibodies (BD Biosciences, USA) and assessed by flow cytometry 
using BD FACSCalibur. Data was analyzed with FlowJo Version 10 software (TreeStar Inc) 
and GraphPad Prism. NK cells that were >99.9 % CD3negCD56pos CD16pos NKp46pos were 
considered pure and used for further studies (Figure 6).  
 
 Phenotype of expanded NK cells was assessed based on the expression of a panel of 
surface markers. Fluorochrome conjugated antibodies were used to assess the expression of 
anti-CD56, Anti-CD16, anti-CD3, anti-NKp46, anti-NKp44, anti-NKp30, anti-NKG2D, anti-
CD244, anti-CD226, anti- CD11b, anti-CD27, antiCD11a, anti-TRAIL, anti-CD28, anti-CD2, 
anti-CD57, anti-CD62L, anti-CD69, anti-CD25 (BD Biosciences, USA), anti-CD160 
(Biolegend, USA), anti-KIR2DL1/DS1, anti-KIR 2 DL2/3, anti-KIR3DL1 (Miltenyi, USA), 
anti-KIR3DL1, anti-NKG2A and anti-KIR2D1 (R&D Biosystems, USA).  
 
 Briefly, a small aliquot of rosette sep purified NK cells (0.5E+05 cells) were 
resuspended in blocking medium (50% FBS in PBS) and incubated for 30 minutes at 4 °C. 
Following this, NK cells were stained with antibody cocktails of the cell surface markers 
described above (69), and assessed by flow cytometry using BD FACSCalibur and data was 
analyzed with FlowJo Version 10 software (TreeStar Inc). Student t-test, and one-way 
ANOVA were used to statistically analyze the combined data using Graphpad Prism Version 6 
and p < 0.05 was considered significant. 
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Figure 6: Phenotype of day 0 NK cells. NK cells were isolated from normal donor-derived 
buffy coats by rosette sep purification. Purity of NK cells was assessed by flow cytometry. NK 
cells were stained with anti-CD56 FITC, anti-CD16 PE, anti-CD 3 PeCy5 and anti-NKp46 
APC. In order to prevent expression analyses miRNA, gene and protein expression of 
contaminating T cells, only NK cells with < 1% of CD3 positive cells were considered for 
further experiments. However, if NK cells were only to be used for expansion purposes, 
presence of contaminating T cells in the culture would be eventually eliminated after 2 weeks 
of expansion. We have previously shown that pure population of NK cells is achievable even 
when we start the expansion cultures with PBMCs. Data shown here is representative from 1 
donor.  
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Assessment Of Expansion 
 
 The fold expansion of NK cells on mbIL15 and mbIL21 was calculated as shown in 
Table 2. Briefly, NK cell expansion was started with > 99.9% CD3negCD56posCD16pos 
NKp46pos cells, and the fold expansion was calculated based on this population. The overall 
fold expansion for each week was calculated using the formula: 
 
Inferred Total NK cells expanded/week X total number of cells in culture 
___________________________________________________________ 
NK cells carried forward for expansion each week. 
 
 When all NK cells are not carried forward for expansion, the data is presented as 
“Inferred fold expansion” calculated based on the formula:  
 
Inferred total NK cells after ‘x’ weeks of expansion 
___________________________________________ 
Inferred total NK cells after week 1 of expansion. 
 
where ‘x’ is the number of weeks (in this case 2 weeks). An example of fold expansion 
calculation is included in the table below. The differential fold expansion between mbIL15 and 
mbIL21 expanded NK cells was statistically analyzed by paired student t-test, using Graphpad 
Prism Version 6 and p < 0.05 were considered significant. Fold expansion of NK cells 
following knockdown of miR 124-3p was calculated in a similar manner.  
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Table 2: NK cell Fold Expansion Calculation. Rosette sep purified NK cells from 4 donors 
were expanded on K562.mbIL15 or K562.mbIL21 for the initial expression analysis studies. 
Cells were expanded for 2 weeks and fold expansion was calculated as shown. Data shown 
here is an example. For knockdown studies, unelectroprated control NK cells, scrambled 
negative control and miR 124-3p knocked down NK cells were expanded on mbIL15 or 
mbIL21 simultaneously, and fold expansion was calculated from 5 experiments.  
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NK Cell Cytotoxicity 
 
 Cytotoxicity mediated by expanded NK cells was assessed by calcein release assay as 
previously described (69, 142). Target cell lines K562 and Molm13 were stained with 2 µg/ml 
Calcein AM (Life Technologies, Carlsbad, CA) in complete RPMI media containing 1 mg/ml 
stock of calcein AM (staining media). 1x106/ml tumor cells were resuspended in staining 
media and incubated for 30 minutes at 37°C in 5% CO2 incubator with intermittent mixing, 
then washed and resuspended at 1x105 cells/ml. In the meantime, mbIL15 and mbIL21 
expanded NK cells were counted, and resuspended at 1x106 cells/ml. NK cells were then two 
fold serially diluted 5 times in a U-bottom 96 well plate. All experiments were set up in 
triplicates. The final NK cell numbers in each triplicate set were 1x105, 5x104, 2.5x104, 
1.25x104, 6.25x103 and 3.125x103 cells/well. Calcein-AM loaded target tumor cells were 
added to each of these wells at 1x104 cells/well in 100-µl volumes for final E:T ratios of 10:1, 
5:1. 2.5:1, 1.25:1, 0.625:1 and 0.3125:1. 1x104 calcein-AM loaded target tumor cells were set 
up in 6 replicates with 1% Triton X-100 and plain media for maximum and spontaneous 
release controls, respectively. The set up was incubated at 37°C in 5% CO2 for 4 hours, 
followed by measurement of fluorescence using BioTek Synergy 2 plate reader (Excitation: 
485 nm / Emission: 530 nm). The percent specific lysis was calculated using the formula: 
 
(Test release−Spontaneous release) 
_______________________________________    X 100 
(Maximum release−Spontaneous release) 
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Global Expression Analyses 
 
 The differential expression of mRNA in NK cells was studied with Nanostring n-
counter miRNA expression assay, gene expression was studied using Affymetrix 2.0 HTA 
gene expression array, and protein expression was assessed by reverse phase protein array 
(RPPA).  Normal donor derived and Rosettesep purified fresh NK cells, NK cells expanded to 
two weeks (14 days) on K562.mbIL15 and K562.mbIL21 were used for this part of the study 
(Figure 5). For all samples, NK cells from 4 donors were used to attain statistical significance. 
 
mRNA Isolation 
 
 mRNA was isolated from NK cells by RNeasy method (Qiagen, USA). Cells were 
collected and washed with PBS and denatured followed by ethanol phase separation. Samples 
were then processed on an RNeasy spin column and mRNA was eluted in ultrapure water and 
concentration measured using Nanodrop ND-1000 Spectrophotometer (ThermoScientific, 
USA); ratio of absorbance of ~ 2 was considered pure yield of mRNA and used for further 
analyses. For all other studies, mRNA was isolated as described after different experimental 
treatments of NK cells (knockdown of miRNA).   
 
Gene Expression Analysis 
 
 Gene expression analysis was performed using Affymetrix Gene Chip HTA micro 
array 2.0, according to manufacturer’s instructions, at the MDACC Proteomics core. The array 
analyzes the expression levels of over 47000 transcripts, including transcript variants of genes. 
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In order to identify differentially expressed genes between the groups, we analyzed the data in 
2 ways. We first analyzed the differential expression of genes between fresh and expanded NK 
cells. This data is not used further in this study, hence not included here. We then analyzed the 
gene expression differences between mbIL15 and mbIL21 expanded NK cells.   
 
 Data analysis and employed statistical algorithms were carried out following the 
manufacturer’s instructions and guidelines. The dataset analysis was performed as follows: 
robust multi array average (RMA) normalization was performed by background correction to 
eliminate noise, followed by quantile normalization in order to normalize probe intensities 
between the different arrays. Next we assessed the geometric density distribution of the 
samples by comparing the expression against density for the 4 donors, as well as the 3 groups, 
in order to ensure that there is ‘even’ distribution (Figure 7).  As a final step, we applied 
correction for multiple testing by false discovery rate (FDR) of < 0.025. We performed two 
sample t-tests to identify differentially expressed genes between the two groups at the 
transcript level. In reporting the most significantly differentially expressed genes between the 
2 groups, our parameters included mean fold difference of ≥ 2.0 fold change, and p < 0.05. 
 
 Volcano plot was generated using the background corrected data, and highest 
differentially expressed genes in both groups were assessed from this data. Heatmap was 
generated by euclidean hierarchical clustering and Pearson Correlation method. Individual 
probing of dataset was performed using the normalized data from above. 
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Figure 7:  Verification of geometric density of mRNA Expression. Gene expression 
analysis was performed after data normalization and background correction. Geometric density 
distribution of the samples was assessed by comparison of expression against density for the 4 
donors used in the study, as well as the 3 groups (fresh NK cells, mbIL15 expanded NK cells 
and mbIL21 expanded NK cells), an essential step to ensure that the expression analysis was 
performed after normalization and correction for sample loading.  
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Protein Isolation  
 
 As detailed for mRNA isolation, protein was isolated from the same 4 normal donor-
derived fresh, mbIL15 and mbIL21 expanded NK cells based on MDACC proteomics core 
protocol for protein submission for RPPA analysis. Briefly, NK cells were treated with lysis 
buffer (1% Triton X‐100, 50mM HEPES, 150mM NaCl, 1.5mM MgCl2, 1mM EGTA, 100mM 
NaF, 10mM sodium pyrophosphate, 1mM sodium orthovanadate and 10% glycerol), freshly 
added with protease and phosphatase inhibitors (Roche Applied Science). Cells were incubated 
on ice for 20 minutes with intermittent shaking followed by centrifugation at 14,000 rpm for 
10 minutes at 4 °C. Supernatant (cell lysate) was collected and protein concentration was 
assessed by Pierce BCA protein assay kit (Thermofisher, USA). Cell lysate was mixed with 
4X SDS sample buffer (40% Glycerol, 8% SDS, 0.25M Tris-HCL, pH 6.8, freshly 
supplemented with 1/10th volume of β-mercaptoethanol), boiled for 5 minutes and submitted to 
the core facility to perform RPPA. Protein for western blots was isolated and prepared in a 
similar manner and stored in -80 °C until use. 
 
Protein Expression Array and Analysis 
 
 Protein expression array was performed at the RPPA core as follows: 287 unique 
antibodies and 4 secondary antibodies as negative controls were coated on array slides. NK 
cell samples were run on these slides, followed by data analysis. Quality control (QC) was 
performed after data background correction and normalization for protein loading.  A QC 
Score > 0.8 was considered good antibody staining, only data that scored above this range was 
included for further analyses.  Mouse specific antibodies in the panel were eliminated from 
	 37	
consideration. Individual normalized values were transformed to linear values and average of 
the normalized linear values are represented in comparative bar graphs in the results section. 
To generate the heatmaps, normalized linear value was transformed to log2 values and used 
for hierarchical cluster analysis using Pearson Correlation and a center metric. All protein 
expression data from RPPA were statistically analyzed by paired student t-test method using 
Graphpad prism 6.0 software and p < 0.05 were considered significant. 
 
miRNA Isolation 
 
 For global expression analysis, miRNA was isolated from the same 4 normal donor-
derived fresh and expanded NK cells using phenol:chloroform based miRNeasy kit (Qiagen, 
USA). Briefly, NK cells were collected, washed with PBS and homogenized in Qiazol Lysis 
Reagent and chloroform, followed by centrifugation at >8000g for 15 minutes at 4°C. The 
upper aqueous phase containing the miRNA was carefully extracted and ethanol (molecular 
grade, Sigma Aldrich, USA) was added to bind RNA. The sample was then processed on an 
RNeasy spin column and miRNA eluted in ultrapure water. Concentration was measured using 
Nanodrop ND-1000 Spectrophotometer (Thermo Scientific, USA) and a ratio of absorbance of 
~ 2 was considered pure yield of miRNA and used for further analyses. For all other studies, 
miRNA was isolated as described following different experimental treatments of NK cells.   
 
Nanostring Expression Assay 
 
 miRNA expression was analyzed by Nanostring n-Counter expression assay (143) in 
collaboration with Dr. Laurence Cooper’s laboratory, Pediatrics, MDACC. n-Counter is a 
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multiplexed, direct digital detection technique that utilizes DNA-RNA hybrid capture. A total 
of 8 negative controls, 6 positive controls and 6 housekeeping genes are in built in to the probe 
set. n-Counter measures the expression of 800 miRNAs in a single step reaction without 
amplification by counting the actual numbers of transcripts that are captured and hybridized by 
a biotinylated capture probe and a fluorescently-barcoded probe juxtapositioned with each 
other (144). miRNA expression is represented by the number of unique sequences bound to the 
fluorescent probes and translated into number of counts per target. Fluorescent probe sets for 
n-Counter are represented as Codeset RLF File (table of reporter library file), and each 
fluorescent barcode corresponds to specific miRNA. The final output data for miRNA n-
Counter expression is represented as Reporter Code File (RCC), and are automatically sorted 
based on the correct RLF file for further analysis. 
 
NK Cell miRNA Expression Analysis  
 
 Expression data from n-Counter digital analyzer was analyzed using the accompanying 
n-Solver software. RCC data for miRNA expression was analyzed as follows: Quality Control 
(QC) was performed on raw data by background correction and subtracting negative controls 
from experimental counts to ensure correctness of inter-sample variability of hybridization 
efficiency, followed by normalization with positive controls (Figure 8). As a final step, the 
dataset was normalized to housekeeping genes. For this analysis, QC stringency was set at 
99%. No sample normalization ‘flags’ was found, indicating that there were no issues with 
hybridization efficiency or total counts of RNA. Differential miRNA expression was analyzed 
in 2 ways: comparison of miRNA between primary NK cells versus expanded NK cells (both 
mbIL15 and mbIL21), and comparison of miRNA between mbIL15 and mbIL21 expanded NK 
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cells. Fold difference in expression was calculated for each sample based on the normalized 
counts per target values, and data was analyzed on GraphPad Prism 6 using student's t test for 
pair-wise comparisons.  
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Figure 8: Schematic for miRNA data analysis. The flowchart illustrates n-Solver based 
miRNA analysis in NK cells. A total of 800 miRNAs were subject to normalization with 
positive, negative controls and housekeeping genes, followed by assessment of linearity to 
ensure stringent correction for sample loading and normalization. Data analysis parameters 
were set at high stringency as shown, with p < 0.01, and a threshold difference in log 
expression of miRNA between the groups to be > 4 (8 fold difference in expansion or more). 
Only miRNA that fit these criteria, and were expressed at least 8 fold or more different 
between mbIL15 and mbIL21 were considered for further evaluation. 
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miRNA Knockdown and Quantitative RT-PCR 
 
 Freshly isolated and rosette sep purified NK cells were transfected with anti-miR 124-
3p, and negative controls using miRIDIAN microRNA Human hsa-miR-124-3p inhibitor and 
miRIDIAN microRNA Hairpin Inhibitor Negative Control (GE Healthcare Dharmacon RNA 
Technologies; 20 µM stock solution), respectively. NK cells were centrifuged in serum-free 
media at 100g for 10 minutes and resuspended in 99 µl of nucleofector solution (Nucleofector 
solution for human NK cells, Lonza Technologies, USA) containing 1 µl of inhibitor or 
negative control (final concentration: 200 nM). The nucleofection reaction was performed 
using Amaxa Nucleofector Device (Lonza, USA) on program X-01. The cells were maintained 
in serum-free media for 2 hours, followed by addition of complete media containing 2X FBS, 
and freshly supplemented with 50 U/ml IL-2. NK cells were collected at various time points 
for subsequent experimentation.  
 
 The knockdown efficiency of miR 124-3p in NK cells was measured by qRT-PCR 
assessment of miR 124-3p using Taqman miRNA reverse transcription kit, following 
manufacturer’s protocol. cDNA was synthesized with the TaqMan MicroRNA Reverse 
Transcription Kit (Applied Biosystems, CA) using primer/probe sets for miR-124-3p (Applied 
Biosystems, CA), and the data was normalized to RNU6 which was used as housekeeping 
control. Data were analyzed according to the comparative CT method, and ΔΔCt values from 
triplicate counts was calculated and represented as comparative bar graphs. The data was 
further analyzed for significance using graphpad prism and p < 0.05 was considered 
significant.  
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CFSE Proliferation Assay 
 
 Fresh NK cells were electroporated with anti-miR 124-3p or negative control, and 
assessed for cellular proliferation using CellTrace CFSE Proliferation kit (ThermoFisher, 
USA) by flow cytometry. Live NK cells were labeled with the bright fluorescent CFSE, a 
DNA-binding dye that reduces its intensity with every cell cycle, and can be measured as 
different peaks by flow cytometry, based on the number of cell cycle occurrences in a given 
population. For the study here, fresh unelectroporated NK cells, NK cells electroporated with 
anti-miR 124-3p and negative control were loaded with 5 µM solution of CFSE dye, according 
to manufacturer’s protocol. The CFSE loaded NK cells were then expanded on either mbIL15 
or mbIL21 for 7 days. The final samples included mbIL15 and mbIL21 expansions from each 
of the following groups: unelectroporated NK cells, anti-miR 124-3p NK cells and negative 
control NK cells. Samples were collected from each of the groups after 1, 2, 3, 4 and 7 days of 
expansion and CFSE dilution measured by flow cytometry. The corresponding proliferation in 
each group was calculated based on the number of peaks, and data combined for all 4 donors, 
and represented as comparative bar graphs and flow cytometry histograms, to show the actual 
proliferative peaks. Paired student t test was performed on graphpad prism to assess 
significance, p < 0.05 was considered significant change in proliferation.   
 
Apoptosis Assay 
 
 Similar to proliferation assay, apoptosis in NK cells following knockdown of miR 124-
3p by electroporation was measured using annexin V and propidium iodide (PI) staining, and 
flow cytometry. Unelectroporated NK cells were expanded on mbIL15 and mbIL21 for 7 days, 
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and stained with AnnexinV and PI, to evaluate baseline rate of apoptosis induced due to IL-15 
and IL-21 signaling. Fresh NK cells from the same donors were also electroporated with either 
anti-miR 124-3p or negative control, and apoptosis measured in these cells in a similar 
manner. Percentage apoptotic, live and dead cells form the 3 donor NK cells tested were 
combined, student t test was performed using graphpad prism, and data represented as 
comparative bar graphs as well as flow plots.  
  
Gene Expression by qPCR 
 
 The knockdown effect of miR 124-3p on gene expression in NK cells was assessed by 
quantitative RT-PCR. Fresh NK cells were electroporated with anti-miR 124-3p and negative 
control; unelectroporated cells were used as baseline. mRNA was isolated from 
unelectroporated, miR 124-3 knockdown and negative control NK cells at time points 1, 2, 3 
day, by the method described above. Gene expression was analyzed by the 2 step RT-PCR 
reaction using SYBR Green RT-PCR Master Mix (Applied Biosystems, USA) as follows: 
first, cDNA was prepared from 500 ng of mRNA as template from all the samples using a 
mixture of random hexamers, deoxy NTPs and reverse transcriptase enzyme in a thermal 
cycler, according to manufacturer’s protocol. Next, PCR was performed using the forward and 
reverse primers / probe set (forward and reverse primer sets are given below), and SYBR 
Green PCR Master Mix, and the reaction was performed on Roche LightCycler 480, according 
to manufacturer’s protocol. The data was normalized to GAPDH expression, and analyzed by 
comparative CT method, ΔΔCt values from triplicate counts was calculated and represented as 
comparative bar graphs. 
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 To measure the effect of IL-15 and IL-21 signaling, NK cells were electroporated with 
miR 124-3p, negative controls and unelectroporated cells followed by expansion with mbIL15 
or mbIL21 for 7 days, and CD56+NKp46+ NK cells were sorted by Fluorescence Activated 
Cell Sorting (FACS) at the MDACC flow core. mRNA was isolated and qRT-PCR was 
performed on these samples as before. 
 
Primer sets used:  
 
BCL2L11: FOR 5’ TGGCAAAGCAACCTTCTGATG 3’,  
  REV 5’ GCAGGCTGCAATTGTCTACCT 3’ 
STAT 3: FOR 5’ ATCACGCCTTCACAGACTGC 3’; 
  REV 5’ CATCCTGGAGATTCTCTACCACT 3’ 
HTERT: FOR 5’ CGGAAGAGTGTCTGGAGCAA 3’;  
  REV 5’ TGACCTCCGTGAGCCTGTC 3’ 
GAPDH: FOR 5’ CGTGAGGTCCGTTAGGAAAA 3’;  
  REV 5’ ATAGTGGGATGCGAGTCCAG 3’ 
  
Western Blot 
 
 5 normal donor-derived and rosette sep purified NK cells were electroporated with 
anti-miR 124-3p and negative controls as before; unelectroporated samples were used as 
baseline. Protein was isolated and quantitated from all these samples by the method described 
previously. Western blot analysis was performed for assessment of Stat 3, phospho Stat3, 
TERT and Bim, using monoclonal antibodies against anti-STAT3, anti-STAT 3 phospho 
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Y705, anti-STAT3 phospho Y727, anti-telomerase reverse transcriptase (Abcam, USA) and 
anti-Bim (Cell Signaling Technologies, USA). The protein expression was normalized to β-
actin, used as housekeeping control. Antibody-reactive proteins were detected with horseradish 
peroxidase–labeled specific secondary antibodies, and the membrane was developed by 
chemiluminescence (ECL; Amersham) on Kodak Image station. Protein levels were measured 
and quantified using ImageJ Version 1.43 software.  
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CHAPTER 4: RESULTS AND DISCUSSION 
 
mbIL15 And mbIL21 Lead To Differential Expansion Of NK Cells  
  
 We have previously extensively compared the attributes of NK cells expanded on 
K562.mbIL15 and K562.mbIL21 (mbIL15 and mbIL21 respectively), since both expansion 
platforms are based on feeder cells modified to express membrane bound cytokines (Table 1). 
We assessed the cytotoxicity abilities of NK cells expanded for 14 days on either mbIL15 or 
mbIL21 from the same donors by calcein release assay, and reported that NK cells expanded 
on mbIL21 was marginally better than mbIL15 expanded NK cells against K562, a target cell 
line used as a standard of cytotoxicity measure of NK cells (62).  
 
 In the current study however, when we tested expanded NK cells against other targets 
such as AML, we observed that mbIL21 expanded NK cells was significantly better in 
cytotoxicity (Figure 9A & 9B). Next, when we assessed the phenotype and receptor expression 
between mbIL15 and mbIL21 expanded NK cells on the 4 donors used in this study, we 
observed that most of the receptors evaluated were similar in both the percentage and relative 
expression (MFI), with very few differences (Figure 10A). We observed the relative 
expression of CD11a (LFA-1), an adhesion molecule and NKp46, the activating receptor to be 
higher in mbIL21 expanded NK cells, whereas the relative expressions of CD27, a maturation 
marker and NKg2A, an inhibitory receptor were higher in mbIL15 expanded NK cells (Figure 
10B). CD11a/ LFA-1 is essential for strong adhesion and target cell lysis by NK cells, 
deficiency in LFA-1 has been associated with impaired NK cell cytotoxicity. The role of LFA-
1 in NK cell cytotoxicity is particularly essential against leukemia (145). NKp46 is an NCR 
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and is a key activating receptor involved in improved NK cell cytotoxicity. A decrease in 
CD27 indicates the maturation status of NK cells, and increased granular content, thereby 
increased effector cell phenotype (146). 
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Figure 9: mbIL21 expanded NK cells have higher cytotoxicity potential. (A) mbIL15 and 
mbIL21 expanded NK cells from the same donor were analyzed for cytotoxicity against K562. 
As shown, NK cells expanded by both methods yielded high cytotoxic ability, with mbIL21 
expanded cells performing better in a non-significant trend. (B) Assessment of cytotoxicity 
against Molm 13, an AML cell line indicates that mbIL21 has significantly higher cytotoxicity 
compared to mbIL15 expanded NK cells at all E:T ratios (p < 0.05). The 4 NK donors used for 
the global differential expression analysis were used for this study; data shown is 
representative of 4 donors tested. 
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Figure 10: NK cells expanded on mbIL15 and mbIL21 are phenotypically similar. (A) 
Flow cytometry analysis of activating and inhibitory receptors following mbIL15 and mbIL21 
from the same donor shows similarity in the expression of most of the receptors. Only a few of 
the receptors showed differences in their expression levels.  Data shown is representative dot 
plots for one of the 4 donors tested. Significance was assessed by one-way anova. (B) Only the 
phenotypic markers and receptors that showed differential expression (CD11a, CD27, NKp46 
and NKG2A) between mbIL15 and mbIL21 are represented. Data shown is an average of 
expression levels from the 4 donors tested. One way anova was performed on prism to assess 
the significance in differential expression.  
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 The largest and the most significant observable difference between mbIL15 and 
mbIL21 expanded NK cells were in the fold expansion, where mbIL21 outperforms mbIL15 
expansion by several thousand folds consistently (Figure 2). Similar to previously published 
data, we observed an increased expansion of NK cells from all 4 donors on mbIL21 after 2 
weeks (Figure 11). As discussed previously, this difference in fold expansion of NK cells may 
be attributed to factors including maintenance of telomere length in mbIL21 NK cells, and 
STAT3 mediated signaling in mbIL21, as opposed to STAT5 mediated signaling in mbIL15, 
but there may be other factors involved in causing this effect. There are not enough evidences 
in literature to explain the tremendous difference in expansion due to IL-15 and IL-21 
signaling. Hence we focused our efforts on delineating the differentially expressed genes and 
their specific methods of gene regulation. 
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Figure 11: mbIL21 expansion is more robust and superior compared to mbIL15. The 4 
normal donor derived NK cells used for the global profiling of gene, protein and miRNA 
expression were assessed for their rate of expansion on mbIL5 and mbIL21 for 2 weeks. The 
mbIL21 expansion method was consistently more prolific and higher numbers of activated NK 
cells. Statistical analysis for differential expansion was performed using non-parametric 
student t test on Graphpad prism. This difference in expansion potential between mbIL15 and 
mbIL21 expansions, and the robustness of IL-21 signaling in causing this expansion are the 
premise of the study conducted here. 
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NK Expansion On mbIL15 And mbIL21 Differentially Regulate Gene And Protein 
Expression 
 
 NK cells expanded on mbIL15 and mbIL21 differ in expression of hTERT, due to 
which NK cells undergo replicative senescence (70), and expansion with mbIL21 significantly 
increased telomere length compared to mbIL15 expansion (62), as discussed previously. The 
role of telomeres and telomerase reverse transcriptase (hTERT) are well established in the 
context of cellular longevity, replication and senescence. Telomeres are physical end of 
chromosomes that shorten with each replicative cycle. To prevent this, the ribonucleoprotein 
enzyme telomerase along with its catalytic subunit hTERT adds TTAGGG repeats to the end 
of chromosomes (147-149). Aberrant overexpression of hTERT is linked to immortalization of 
cells, enhancement of tumor cell proliferation, as well as increased invasiveness and metastatic 
potential (147, 150-152). However these changes caused due to the increase of hTERT in 
mbIL21 expansion is beneficial to NK cells in that cellular proliferation is increased several 
fold leading to an overall improved expansion as shown, unlike any other platform before. 
This observation concurs with previous studies in normal human cells, where overexpression 
of telomerase stabilized telomeres and extended their replicative life span by at least 20 
doublings (153). Conversely, loss of hTERT has been shown not only to induce telomere loss, 
but non-prevention of stress induced senescence as well as apoptosis (154). Senescence in NK 
cells expanded on mbIL15 has been reported previously, however apoptosis has not been 
linked to mbIL15 expansion thus far. Further, the role of IL21 in (potentially preventing) 
apoptosis has not been shown in literature, and could shed more insight into the possible 
repertoire of cellular mechanisms that happen synchronously in order to cause the observed 
expansion outcome.  
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 As detailed in the introduction, STATs are critical transcription factors that regulate IL-
15 and IL-21 mediated signaling. IL-21 signals predominantly through STAT3 via activation 
of JAK 1, and IL-15 signals predominantly through STAT5 via activation of JAK 3. The 
traditional role of STAT5 and STAT3 in NK cells is to promote survival, maturation and 
proliferation and activation of NK cells (155), however, the extent to which these functions are 
exerted differs greatly between the 2 transcription factors. In the context of activation and 
proliferation of NK cells in vivo, STAT5 acts as a master regulator (156), however depending 
on other cytokine signals STAT5 regulation could act to convert NK cells from cytotoxic 
killers to tumor promoters (156). We recently reported that STAT3 plays a critical role in NK 
cell proliferation, NKG2D expression, and cytotoxicity (157). It is well established that 
dominant negative STAT3 mutations lead to NK cell deficiencies such as Job’s Syndrome or 
hyper-IgE syndrome, characterized by recurrent bacterial skin and lung infections (158-161).  
  
 Given the role of Stats and hTERT in the expansion outcome of NK cells, we sought  
to further understand the role of additional proteins and pathways that could mediate the 
observed differences in expansion between mbIL15 and mbIL21. We focused our efforts on 
understanding additional molecular mechanisms by assessing the global gene expression 
profiles using Affymetrix Human Transcriptome HTA micro array 2.0 and protein expression 
by RPPA. 
 
Gene Expression 
  
 We assessed the differential gene expression between mbIL15 and mbIL21 expanded 
NK cells with 4 samples each. Additionally, we also assessed the differential expression of 
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genes between fresh and expanded NK cells. This data is not used further in this study, but 
future research utilizing this data is under consideration. 
 
 Upon interrogation of gene expression of over 47,000 transcripts, we found that there 
were only a handful of genes that seemed to be differentially expressed. However this seems 
sufficient to drive a significant difference in the observed expansion between the 2 groups. We 
interrogated the gene expression data by looking for the most highly expressed genes in the 
mbIL21 cohort, and conversely genes that were lowest expressed in mbIL21 but very high in 
mbIL15 cohort which are represented in the far extreme spectrum of our analysis (Figure 12). 
A comparison of the highest scoring genes between fresh NK cells, as well as NK cells 
expanded on mbIL15 and mbIL21 is represented in Figure 13, where the heatmap indicates the 
expression levels of our highest scoring genes. Further, we correlated our findings with their 
known functions in NK cells and other lymphocytes (Table 3).   
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Figure 12: Volcano plot of mRNA gene expression analysis. NK cells expanded with 
mbIL15 and mbIl21 were assessed for differential gene expression by microarray. Data 
indicates only a few genes are differentially expressed between the 2 groups. Volcano plot 
indicates fold change of expression plotted against significance. Data analysis was performed 
by specifically interrogating highest expressing genes in mbIL21, thus the left side indicates 
high expression, and the right extreme negative to lower expression for mbIL21 expanded 
cells. Conversely, right extreme indicates high expression and left extreme low expression for 
mbIL15 NK cells. Genes on the very top are high significance, with higher expression in both 
cohorts. A list of genes that are differentially expressed between the groups was derived from 
this data. 
P 
va
lu
e 
(<
0.
02
5)
	
Fold Change	
Fold Change mbIL15 vs mbIL21	
Upregulated 
in mbIL21	
Upregulated 
in mbIL15	
Upregulated 
in mbIL15 
high 
signiﬁcance	
Upregulated 
in mbIL21 
high 
signiﬁcance	
	 57	
 
Figure 13: Differential gene expression between mbIL15 and mbIL21 expanded NK cells. 
Highest expressing genes in both expansion methods were first assessed by comparison of fold 
change and significance (p < 0.025). The differentially expressed gene set was derived from 
this large dataset, where both high and low expressing genes in both set of samples were taken 
into consideration. Heatmap indicates a panel of the most significantly differentially expressed 
geneset between expansion cohorts. Comparisons between fresh and expanded cells were also 
assessed, but are not included here. Future studies evaluating fresh versus expanded cells are 
under consideration. 
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Table 3A: Functional correlation of highly expressed genes in mbIL15 expanded NK 
cells. Several genes related to enhancing cytotoxicity (indicated with blue arrows) and cellular 
proliferation (indicated with green arrow) was differentially highly expressed in mbIL15 and 
mbIL21 expanded NK cells. The mbIL15 expanded NK cells had high expression of 
cytotoxicity related genes. Of the genes that were related to proliferation and apoptosis, 
BCL2L11, the gene encoding pro-apoptotic protein Bim was highly expressed, indicating a 
survival disadvantage to NK cells. 
RSAD2 Activates NFkB activation
BCL2L11 Pro-apoptotic protein, induces apoptosis
ACVR2A TGFb superfamily protein
CCR2 Essential for viral infection mediation
EPB41L4A Cytoskeletal rearrangenent
ITGA1 Subunit of LFA1, an adhesion protein
MYO6 Upregulated in adaptive NK cells
CD44 Lymphocyte activation
CD70 Activation and cytotoxic function of NK cells
TNFSF14 Stimulation/ proliferation of T cells; apoptosis induction in tumor cells
CEACAM1 Mediates suppression of NKG2D mediated NK cell cytotoxicity
TNFSF4 OX40L
LINC00599 LINC RNA
GEM GTP binding reg protein, signal transduction; Ras GTPases
Function
Gene upregulated 
in mbIL15 
Expanded NK 
cells 
Enhances NK cell 
cytotoxicity	
Genes related to 
cell cycle and 
apoptosis	
Enhances	NK	cell	
cytotoxicity	
Genes	related	to	
cell	cycle	and	
apoptosis	
A 
	 59	
 
  
 
Table 3B: Functional correlation of highly expressed genes in mbIL21 expanded NK 
cells. Several genes related to enhancing cytotoxicity (indicated with blue arrows) and cellular 
proliferation (indicated with green arrow) was differentially highly expressed in mbIL15 and 
mbIL21 expanded NK cells. Expansion of NK cells with mbIL21 had an opposite effect on the 
expression of genes. Genes related to increasing cellular proliferation, cell cycle and glycoysis, 
AK4 Activates cell cycle progression
NDC1 Acts as an MTOC anchor
MIR15B Activates BCL2, an anti-apoptotic protein
IGFBP7 Regulates apoptosis, cell growth and angiogenesis
HIST2H2AB Promotes Cellular proliferation
IL7R Blocks apoptosis in T cells
MGST1 Prevents oxidative stress accumulation in cells
GPI Glycolytic enzyme promotes glucose metabolism
SDK2 Promotes synaptic connectivity
RIPK2 Potent NFkB activator in immune cells
KLF10 Transcriptional repressor of TGFb signaling
BNIP3 Interacts with BCL2, an anti-apoptotic protein
ALDOC protein in glycolytic pathway, increases glycolysis
Function
Gene upregulated 
in mbIL21 
Expanded NK 
cells 
E3 ubiquitin-protein ligase complex required for cell cycle control, 
promotes cellular proliferationDTL
Enhances	NK	cell	
cytotoxicity	
Genes	related	to	
cell	cycle	and	
apoptosis	
Enhances	NK	cell	
cytotoxicity	
Genes	related	to	
cell	cycle	and	
apoptosis	
B 
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prevention of oxidative stress and apoptosis were higher, along with genes related to 
increasing cytotoxicity.  
 Amongst the genes highly expressed in mbIL15 expanded NK cells, several of the 
genes are associated with enhancing cytotoxicity functions in lymphocytes. These genes 
include RSAD2, CCR2, ITGA1, CD44 and CD70. There were some genes that are contrasting, 
such as CEACAM1, TNFSF4 and ACVR2A. In the context of expansion of NK cells, there 
were far fewer genes that showed significant differences. It was however interesting to note 
that the gene expression profile correlates well with the observed differential expansion. For 
instance, mbIL15 expanded NK cells showed an overall decreased expression of proliferative 
markers, and an increased expression of apoptotic markers such as TNFSF14 and BCL2L11. 
Additionally, previously uncharacterized genes such as KIAA0825 and LINVC00599 also 
flagged as very highly expressed within the mbIL15 cohort (Table 3A).   
  
 In the mbIL21 expanded NK cells, several more genes were upregulated and the gene 
expression pattern was very different; we observed a reverse trend to that of mbIL15 NK cells. 
Of the most highly expressed genes, there were some that were related to increasing NK cell 
cytotoxicity such as RIPK2, KLF10, NDC1, CD109 and SDK2. No genes involved in 
diminishing cytotoxicity potential were in this group. Several of the genes involved in 
enhancing functions such as cellular proliferation, metabolism, cell cycle progression, 
prevention of apoptosis and oxidative stress were highly expressed. These genes include 
HIST2H2AB, ENO1, AK4, MIR15B, GP1, MGST1, DTL, BNIP3, ALDOC and DPP4 (Table 
3B). A detailed list of the most highly expressed genes and their related functions is included 
in Table 4. It is interesting to note that while IL-21 signaling in vivo is linked more to 
cytotoxicity function rather than proliferation, mbIL21mediated activation and signaling has 
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increased expression of a large cohort of genes that helps promote cell cycle progression, 
proliferation, and prevent apoptosis, thereby enhancing the overall prolific expansion. 
 Of particular interest, genes that are involved in enhanced glucose metabolism and 
reduction of oxidative stress such as MGST1, GP1, DT1 and ALDOC were significantly 
upregulated in mbIL21 expanded NK cells. Considering the active proliferation and cell cycle 
ongoing due to IL-21 mediated expansion, NK cells would be subject to a rapid build up of 
oxidative stress due to increased uptake of glucose and higher metabolic activity, resulting in 
an increase in redox state in cells. Higher expression of genes that are involved in reducing 
oxidative stress in NK cells indicates that the robust activation of glucose metabolism due to 
higher cellular turnover and the resultant redox increase would be nullified by these enzymes, 
thereby promoting favorable cellular environment for unimpeded growth potential, as observe 
with mbIL21 expansion. 
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Table 4: Most highly expressed genes in mbIL15 and mbIL21 expanded NK cells and 
their broad cellular functions. 
 
Genes	upregulated	in	mbIL15 Functional	Group
EPB41L4A,	MYO6,	TNFSF8,	 Cellular	growth
BCL2L11 Growth	inhibition
TNFSF4,	RSAD2,	CR2,	ITGA,	CD44,	CD70,	TNFSF14 Cytotoxicity
CEACAM1,	ACVR2A Cytotoxicity	inhibition
GEM,	PLXDC2,	PLEKHA1,	ARHGEF12,	MYO1D,	CASS4 Cellular	Signaling
LINC00599,	DYNC2H1 Unknown	function
Genes	upregulated	in	mbIL21 Functional	Group
DTL,	HIST2H2AB,	AK4,	CDCA7,	DPP4,	FAM162A,	MIR15B,	
GBE1,	MSMO1,	IGFBP7,	SLC7A11,	IL7R	MYB,	CDCA7L,	RIPK2,	
KLF10,	BNIP3,	MGST1,	ALDOC,	GP1
Cellular	growth
- Growth	inhibition
CD160,	NDC1,	CD109,	HLA-DRA	KLF10,	CD68 Cytotoxicity
- Cytotoxicity	inhibition
PGK1,	SCD,	PDLIM3,	DHCR7,	NUCB2,	SNHG1,	GAS2L3,	AK4P3,	 Cellular	Signaling
LINC00263 Unknown	function
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 Further, given the previously established roles of STATs and TERT in mediating 
proliferation and senescence, respectively, and that BCL2L11 (gene encoding pro-apoptotic 
protein Bim) was highly expressed in mbIL15 expanded NK cells, we specifically interrogated 
the gene expression of Stat 3, Stat 5, TERT and BCL2L11 in expanded NK cells. We found 
that upon expansion, expression of Stat 3 and Stat 5 were similar in both mbIL15 and mbIL21. 
Similarly, TERT yielded no significant difference in expression, with mbIL21 cells showing 
marginally higher expression (Figure 14). It is possible that continual activation and 
expression of Stats and TERT for 2 weeks during expansion may have normalized the 
expression levels, and it is also possible that the differences may be greater during an earlier 
time during expansion, such as 24 to 48 hours. However, due to the presence of contaminating 
feeder cells in the culture early in the expansion phase, it was not experimentally feasible to 
perform analysis. It is however, interesting to note that despite no significant difference in 
expression levels, Stats and TERT are critical to the expansion outcome.  
 
 The largest and the most significant difference between mbIL15 and mbIL21 were 
observed in the expression of both transcripts of BCL2L11, with high expression in mbIL15 
NK cells (Figure 14).  BCL2L11 belongs to the BCL-2 family of pro-apoptotic genes that 
promote cellular death by cytochrome C release upon death signal activation in several cell 
types, including immune cells (162). BCL2L11 expression was also found to be high in fresh 
NK cells, consistent with previous findings, the high expression of BCL2L11 in peripheral 
blood NK cells, and subsequent high Bim expression are essential for the maintenance of 
leukocyte homeostasis and preclude autoimmunity under normal conditions in vivo(163). 
Additionally, this corresponds with our findings that mbIL15 expansion increased NK cell 
susceptibility to apoptosis, as evidenced by increase in Annexin V positive apoptotic cell 
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population only after 7 days (Figure 15). This finding indicates that BCL2L11, and 
corresponding Bim mediated apoptosis in mbIL15 is an active and ongoing process throughout 
the expansion cycle in vitro, lending a certain disadvantage to the overall expansion of NK 
cells using mbIL15.  
 
 The changes observed with the expression of BCL2L11 and other apoptotic, cellular 
proliferation and cell cycle genes prompted us to evaluate their protein expression profiling in 
order to confirm whether the findings with gene expression data could be correlated in the 
protein expression. Hence we performed RPPA for assessment of differentially expressed 
proteins in NK cells.   
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Figure 14: Interrogation of differential expressions of specific genes between mbIL15 and 
mbIL21. Expression levels of Stat 3, Stat 5, TERT  (due to their previously established roles 
in causing the differential expansions) and BCL2L11 were specifically interrogated. Stats and 
TERT (p > 0.05) did not show any difference in their expression levels, although TERT 
showed a marginal difference with higher expression in mbIL21 NK cells. BCL2L11 was 
significantly different between the 2 groups (p < 0.01) very high expression in mbIL15 and 
significantly lower in mbIL21 NK cells, indicating a clear survival advantage in mbIL21 NK 
cells. We focused on this finding for further evaluation, specifically post-transcriptional 
regulation of BCL2L11, as well as Stats and TERT during early phase of expansion. 
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Figure 15: Comparison of apoptosis between mbIL15 and mbIL21 NK cells. NK cells 
from 3 normal donor-derived buffy coats were expanded on either mbIL15 or mbIL21. At the 
end of stim 1 (7 days), CD56+NKp46+ NK cells were assessed for apoptosis by Annexin V 
staining. As shown, mbIL15 expansion increased the rate of apoptosis and decreased live cells, 
whereas mbIL21 expansion indicated higher percentage live cells (p < 0.01) and lower 
percentages of apoptotic and dead cells (p < 0.05). The changes in apoptosis due to IL-15 and 
IL-21 signing and a possible caveat to continual stimulation with IL-15 as opposed to IL-21 
has not been previously reported, and is a new finding from this study.  
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RPPA Protein Expression  
 
 The differential protein expression was assessed in a similar manner to gene expression 
comparing expression of fresh and expanded NK cells, as well as comparison between mbIL15 
and mbIL21 NK cells. The RPPA panel consisted of 280 proteins, and included several genes 
that are critical for cell cycle, proliferation, apoptosis and metabolism. In our comparative 
analysis of protein expression, we scored the proteins in terms of their highest expression, 
followed by the largest differential expression between mbIL15 and mbIL21 cohorts. The 
overall protein expression is represented as a heat map generated by supervised euclidean 
hierarchical clustering; the data represents a snap shot of the initial screening and represents 
the overall differences between fresh and expanded NK cells (Figure 16A). As can be 
observed from the expression pattern, several proteins are differentially expressed between day 
0 fresh NK cells and expanded NK cells, However, as was the pattern with gene expression, 
only a few proteins were differentially expressed between mbIL15 and mbIL21 NK cells. The 
highest scoring proteins amongst the expanded cells were determined from this data and 
further evaluated for their differential expression between mbIL15 and mbIL21 (Figure 16B).  
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Figure 16: Protein expression overview in NK cells, before and after expansion. (A) 
Protein expression in NK cells was assessed by RPPA, and heat map was generated using 
supervised hierarchical clustering. The data shown here represents the most differentially 
expressed proteins between day 0 fresh and expanded NK cells in the panel. It can be observed 
that proteins involved in cell cycle progression, cellular proliferation and apoptosis are 
differentially expressed between fresh and expanded NK cells, and only a few proteins in the 
panel are differentially observed between mbIL15 and mbIL21 NK cells. The focus of further 
study and evaluation is based on this difference in protein expression and its regulation. (B) 
The overall protein expression was also assessed by comparison between individual donors to 
their expanded counterparts. Data from this assessment was pooled for statistical strength, and 
was used in further evaluation. Data shown here represents normalized log fold change for 
each of the samples tested.   
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 We interrogated the protein expression by assessing the most differentially expressed 
between the 3 groups (Figure 17). Several proteins related to function in lymphocytes were 
differentially expressed between the groups. For instance, PDGFRβ, a receptor protein was 
expressed highly in fresh NK cells but was downregulated in both expanded groups. High 
expression of PDGFRβ in NK cells has been shown to inhibit the in vitro lytic activity of NK 
cells (164), suggesting that PDGFRβ expression prevents activation of NK cells under normal 
conditions, and hence is highly expressed in freshly isolated peripheral blood NK cells. It is 
also plausible that expansion causes NK cell activation, and thus PDGFRβ is downregulated in 
both mbIL15 and mbI21 expanded NK cells. Similar downregulation of VEGFR2 was also 
observed in both expansions, increased VEGFR2 is known to prevent activation of 
lymphocytes (165), and thus is another factor highly expressed in fresh peripheral blood NK 
cells, but is downregulated upon activation. Additionally, phosphorylated Src kinases were 
downregulated in expanded NK cells. Src kinases have redundant functions in NK cells and 
participate in activation of inhibitory and activating signals as well as participate in activation 
of MAPK and PI3K pathways (166). Other proteins included p161NK4, a protein associated 
with increased tumorigenesis, and c Kit involved in increased survival, proliferation and 
activation of mouse NK cells (167).  
 
 Additionally, although we did not find significant differences in the gene expression of 
Stats and TERT, we looked at the expression levels of Stats as well as phospho Stats. As 
expected and corresponding to mRNA data, we did not find significant differences in 
expression in either of the Stats or their phosphorylated proteins (Figure 17B). The RPPA 
panel, id not have TERT antibody, and hence expression data for TERT could not be verified. 
 
	 71	
 
Figure 17: Comparison of most differentially expressed proteins by RPPA. (A) Proteins 
that were most differentially expressed (p < 0.01) between fresh and expanded NK cells are 
shown. Proteins involved in regulation of activation such as PDGFRb, VEGFR2, Src kinases 
and c Kit were some of the top scoring proteins. (B) Since IL-15 and IL-21 signal through Stat 
5 and Stat3, respectively, we also compared the protein expression of Stat 3 and Stat5, but we 
did not observe significant differences in their expression (p > 0.05).  
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 Next, we assessed the expression levels of proteins involved in cell cycle progression, 
proliferation and apoptosis between fresh and expanded NK cells (Figure 18A). We observed 
high expression of cell cycle proteins B1 (highest expression in mbIL21) and cyclin D1, 
indicating a positive correlation to increased cell cycle progression in both groups. Cyclin B1 
is required for activation of mitosis and cyclin D1 plays a key role in promoting G1/S 
transition (168). AMP kinase A, a kinase protein involved in cellular activation from resting 
state, activation of glucose uptake and mitochondrial activity was upregulated in both mbIL15 
and mbIL21 NK cells (higher in mbIL21 NK cells), indicating increased cellular activity and 
proliferation. AMP kinase A increase in NK cells has been shown to increase NK cell 
mediated cytotoxicity (169). Additionally, p-Akt expression was also higher in expanded NK 
cells, indicating an overall increase in cellular activation and metabolism.  
  
 Next, we assessed the expression levels of proteins involved in apoptosis, including 
both pro and anti-apoptotic proteins (Figure 18 B and 18C). We observed that most of the 
protein expressions were not different between fresh and expanded, or between the expanded 
groups, except Bim a pro-apoptotic protein encoded by BCL2L11, which was los one of the 
highest differentially expressed gene from mRNA analysis. The expression of Bim was high in 
both fresh and mbIL15 expanded NK cells, however was significantly lower in mbIL21-
expanded cells, in fact Bim was the most highly differentially expressed protein between 
mbIL15 and mbIL21 expanded NK cells. As stated previously, high expression of Bim in 
peripheral blood NK cells is required for preventing NK cell proliferation under normal 
conditions, however, it is essential that Bim expression and corresponding induction of 
apoptosis is prevented in order to successfully expand NK cells.  
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Figure 18: Expression of cell cycle and apoptotic proteins in NK cells before and after 
expansion. (A) Proteins involved in cell cycle progression and cellular proliferation such as 
cyclin D1, cyclin B1, pAKT (p < 0.01) and Amp kinase A (p < 0.05) were upregulated in both 
mbIL15 and mbIL21 expanded NK cells. (B) Comparison of pro-apoptotic proteins in the 
RPPA panel shows marginally lower expression of Bak, Bax and Puma (p > 0.05). As shown, 
the most significant and the highest differential expression between mbIL15 and mbIL21 
amongst all the proteins assessed was observed with Bim (p < 0.001). (C) Analysis of anti-
apoptotic proteins in the panel shows lower marginally higher expression of Bcl-Xl and 
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significantly higher Mcl-1 (p < 0.01) in mbIL15 expanded NK cells, however despite 
increased expression of these anti-apoptotic proteins NK cells expanded on mbIL15 undergo 
high rate of apoptosis, primarily mediated by Bim, thereby leading to an overall decreased 
expansion potential, when compared to mbIL21 expansion.  
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 It is interesting to note that IL-15 signaling in vivo is associated with increased 
activation and proliferation of NK cells, one of the mechanisms through which IL-15 mediates 
this effect is by suppression of apoptosis (35). However, it is noteworthy that cytokine 
signaling in vivo is a tightly regulated process that allows activation or inhibition of cytolytic 
immune cells, only when required, and is not a continual process. This however is a 
remarkable contrast to activation through cytokine signaling ex vivo, where NK cells are 
continually stimulated by the presence of IL-15 or IL-21, in this study. It is also interesting to 
note that even through continual stimulation, whilst IL-21 signaling through Stat 3 caused an 
active downregulation of Bim, as well as maintenance of telomere length, IL-15 through Stat 5 
signaling decreased telomere length, as well as increase BCL2L11 and Bim, leading to 
senescence and apoptotic death, respectively.  
 
 Since the differential expression of Bim due to IL-15 and IL-21 signaling is a new 
discovery, we also explored the mechanisms that cause the observed differences, and focused 
our efforts on understanding the expression profile and role of miRNA in mediating these 
changes.  
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Expansion Platforms Lead To Differences In miRNA Expression Profiles 
 
 MicroRNAs are non-coding RNAs that are highly conserved and regulate numerous 
cellular functions including functions in immune cells. As discussed in the introduction, the 
role of miRNA in the development, survival, and function of T and B cells are well studied 
(170-173). The NK cell miRNA expression as well as the mechanisms of miRNA-regulated 
NK cell development, homeostasis, and functional responses is actively being investigated. 
The mechanisms of activation of miRNA in NK cell development, function and even diseases 
have been reported (131), such as the role of miR-155 in regulating interferon γ (140), miR-
27a in regulation of granzyme and perforin in NK cells (174), miR-183 in regulation of TGFβ 
(135), to name a few. However, there are currently no studies comparing the expression of 
miRNA or evaluating their role in activation and expansion of NK cells or in ex vivo 
expansion of NK cells. Since we developed the mbIL21 platform for the expansion of NK 
cells, we were specifically interested in understanding the miRNA repertoire and their role in 
causing the prolific proliferation due to IL-21 signaling. Further, we wanted to compare the 
miRNA expression to the popular IL-15 cytokine based membrane bound platform, especially 
due to the observed differences in their expansion potential.  
 
 Based on the differential expansion capabilities of NK cells with mbIL21 and mbIL15, 
and the differential expression of BCL2L11, Bim, as well as our previous understanding of 
Stat signaling (IL-15 and IL-21 mediating Stat 5 and Stat 3, respectively), and the role of 
TERT in mbIL15 and mbIL21 NK cells, we hypothesized that these differences could be 
mediated by miRNA. We proposed that IL-15 and IL-21 signaling could potentially cause 
differential miRNA expression, with consequent differential function, phenotype as well as 
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expansion. To evaluate this hypothesis, we assessed miRNA expression in normal donor-
derived peripheral blood NK cells and NK cells expanded on either mbIL15 or mbIL21 (from 
the same donors) by Nanostring n-Counter method. We assessed the expression of 800 
miRNAs in the panel, and as expected, we observed differential expression of miRNAs 
between the 3 groups. Upon background correction and normalization, 117 miRNAs were 
found to be significantly different (p < 0.01) and are represented in a heat map generated by 
supervised hierarchical clustering (Figure 19).  
 
 We further used this data to specifically compare the miRNA expression in 2 ways. We 
first assessed the differential expression of miRNA in fresh NK cells compared to that of 
expanded (both) groups. Secondly, we assessed the most significantly differentially expressed 
miRNA between mbIL15 and mbIL21, and the findings from this comparison were further 
evaluated, as discussed below. Additionally, since the goal of this project is to specifically 
address the differential expansion potential between mbIL15 and mbIL21, this data is not 
utilized further in this specific study. However, future research based on these findings is 
under consideration, some of which are discussed in the future directions. 
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Figure 19: Differential miRNA expression between fresh, mbIL15 and mbIL21 expanded 
NK cells. Nanostring data for miRNA expression was assessed for 800 miRNAs, after 
background correction and normalization, paired student t test was performed on graphpad 
prism. (A) The heat map gives an overview of the number of miRNAs that are differential 
between fresh and expanded NK cells, as well as between mbIL15 and mbIL21. 117 of the 
miRNA were considered significantly differentially expressed with p ≤ 0.05. The dataset from 
this heat map was further stringently assessed for difference in fold expression, and used in 
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subsequent experiments. (B) Volcano plot showing expression of miRNA in mbIL15 and 
mbIL21 expanded NK cells plotted based on significance vs. fold change with high expression 
in mbIL15 on top and low expression in the bottom of the panel, and vice versa for mbIL21 
cells. The miRNAs indicated in red were considered significant, and similar to gene and 
protein expression, only a handful of the miRNAs are significantly differentially expressed 
based on our stringent analysis setting of p ≤ 0.01 and fold change of delta > 4 (log2). 
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 Next, we evaluated the dataset for the most stringent differential expression between 
fresh and expanded NK cells, by looking for miRNA that had a delta value of at least greater 
than 4 (8 fold difference) and our findings include13 miRNAs that fit these criteria: these 
miRNAs are miR 1246, miR 4284, miR 451a, miR 221-3p, miR 124-3p, miR 146a-4p, miR 
1555-5p, miR 181a-5p, miR 210, miR 34a-5p, miR 630, miR 18a-5p and miR 338-5p. 
Interestingly, the expression pattern of these miRNA encompassed a spectrum of high and low 
expressing miRNA in both fresh and expanded NK cells (Figure 20A). We performed detailed 
correlative analyses of the most significantly differential miRNAs through search engines 
including miRwalk, miRbase and targetscan, to identify the significance of the miRNA to that 
of our protein and gene expression data. Our analyses showed that the miRNA expressed in 
expanded NK cells were not only regulating expansion and growth potential of NK cells, but 
also play significant roles in mediating critical functions in lymphocytes including NK cells. 
For instance, miR-1246 has been shown to be involved in B cell activation (175), miR-451a 
plays a role in modulating cytokine secretion in dendritic cells (176), miR 221-3p suppression 
increases CD4 T cell proliferation (177), miR 155-5p in IFN-γ activation (140), and miR 210 
induces CD4 T cells via FOXp3 (178), to name a few validated functions. Based on the 
compiled information of validated and predicted targets of these miRNA as detailed on the 
miRwalk website (along with a comparison of 8 miRNA prediction tools), we observed that 
several other miRNAs in the panel have binding sites and varied functions, specifically in 
immune cell components (Table 5).   
 
 Further, we specifically assessed the differences in expression of miRNA between 
mbIL15 and mbIL21 expanded NK cells by looking for miRNAs that were expressed very 
highly in both mbIL15 and mbIL21 groups. Interestingly, miRNAs related to oxidative stress 
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response such as miR miR 34a-5p, miR 1915-3p, and miR 150-3p were comparatively 
downregulated in mbIL21 expanded NK cell cohort. Further, miRNAs that are involved in 
enhancing NK cell cytolytic functions such as let-7 family of miRs, miR 21, miR 1224 and 
miR 187 were equally distributed between both mbIL15 and mbIL21 expanded NK cells. 
However it was interesting to note that other miRNAs involved in enhancing cellular 
cytotoxicity related functions such as miR 27a (granzyme B and perforin), miR 155 (IFNγ), 
miR 146a (IRAK 1 and TRAF6: Toll like receptors; negative regulator of pro-inflammatory 
cytokines including TNFα), miR 125b (activation of KLF13, a transcription factor essential for 
T lymphocyte activation and inflammation, TNFα activation), miR 142 (IL6 activation), miR 
221 (dendritic cell maturation and development), miR 378  (Granzyme B) and miR 223 
(IKKα, NLRP3, Stat3 activation leading to increased immune cell differentiation, maturation, 
lymphocyte and granulocyte activation and IL6 production) were significantly lower in 
mbIL21 expanded NK cells, suggesting that the observed increased cytolytic function could be 
modulated by these miRNAs.  
 
 Through this study, we identified miR 124-3p to be highly expressed in mbIL15 and 
lower in mbIL21 by 18 fold, and to be the most differentially expressed miRNA in the group 
(Figure 20B). Additionally, miR 124-3p was highly expressed in fresh NK cells as well 
(Figure 20A).  
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Figure 20: Summary of most significantly differential miRNA between fresh, mbIL15 
and mbIL21 expanded NK cells. (A) The data represented here shows the most significantly 
differential miRNAs between fresh and expanded NK cells. As shown, miRNA that are either 
higher or lower in expanded cells compared to fresh NK cells are included. Data analysis was 
performed using paired student t test on graphpad prism, and miRNA with fold difference ≥ 8 
folds were considered for further analysis. Further, we show that miR 124-3p is one of the 
miRNAs that are differential between fresh and expanded NK cells. (B) Differential 
expression between mbIL15 and mbIL21 was analyzed from the most significant dataset. We 
show the miRNA that are expressed highest in mbIL15 (left side of the panel) and highest in 
mbIL21 (right side of the panel), and corresponding expression in the other counterpart of 
expanded NK cells. We identified miR 124-3p to be highly expressed in mbIL1, and to be the 
most differentially expressed miRNA in the panel, with a 18-fold difference in expression 
between mbIL15 and mbIL21. Based on this finding, we further explored the role of miR 124-
3p in regulation of cellular processes including proliferation and apoptosis.  
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miRNA	 Fresh mbIL15 mbIL21 Protein Function	in	lymphocytes/NK	cells
miR	4284 Low Highest High CDK17 Cell	Cycle	Progression
AKT1,	PIK3CA Signaling	activation	of	NKG2D
GATA3 Maturation	of	NK	cells,	IFN-γ	production
JAK2 IFN-γ	signaling	and	activation
CDK1B,	CDK1A,	CDK6 Cell	Cycle	Progression
CCND1 Cellular	proliferation
STAT3 IL-21	signaling,	diffreentiation,	proliferation,	telomere	length
CCND1 Cellular	proliferation
CDK6,	CDKN2D,	CDK4,	CDKN1B Cell	Cycle	Progression
CD28 Co-activating	receptors	for	NK	cells
IL-1 Costimulates	IFN-γ	production
IL-6 NK	cell	production
IL-7 NK	cell	survivsl
IL-8 T	cell	recruitment
STAT1 IL-15	signaling
CDKN2A Cell	Cycle	Progression
IFN-γ,	TNF Cytolytic	function
miR	155-5p Low High High IL-10 Cytotoxicity
ZAP70 Cellular	activation	of	ADCC
DAP12 NKp44	activation,	co-receptor	for	activation
Dicer Increases	survival	and	activation
Notch1 Increases	generation	of	functional	NK	cells
BCL2 Anti-apopttic	protein
TNF-α	 Inflammation	and	immune	system	development
IL-6 NK	cell	production
PTEN Regulation	of	imune	response,	autoimmunity
IL-1 Costimulates	IFN-γ	production
AKT Increases	cellular	activity	ad	metabolism
Dicer Increases	survival	and	activation
Notch1 Increases	generation	of	functional	NK	cells
CDKN1A,	CDK6,	CDKN2A Cell	Cycle	Progression
CCND1 Cellular	proliferation
Notch1 Increases	generation	of	functional	NK	cells
DICER Increases	survival	and	activation
STAT5A IL-15	signaling
CDKN1A,	CDKN2A,	 Cell	Cycle	Progression
CCND1 Cellular	proliferation
miR	144-3p Highest Low Low MTOR Induces	proliferation	and	apoptosis
miR	210 Low High	 Highest
miR	22-3p High High Low
miR	34a-5p Low Highest High
miR	1915-3p Low High Low
miR	4488 Low High Low
miR	146a-5p High Highest Low
miR	181-5p High Low Low
miR	221-3p Low High High
miR	124-3p High Highest Low
Comparitive	expression	levels	in	NK	cells
High	 Low LowestmiR	451a	
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Table 5: Correlation of differentially expressed miRNA to their known regulatory 
functions. The miRNA that were differentially expressed were correlated for their known 
function based on literary evidence for validated targets in various cell types including NK 
cells and other lymphocytes. We identified several miRNA functions related to cell cycle 
progression, cellular proliferation, apoptosis and cytolytic function. The direction of 
correlation in the expression of miRNA to the activation or suppression status of specific 
proteins, in NK cells is not compared in this table. Plans for future studies based on miRNA-
mediated regulation of NK cell activation, proliferation and function is possible from this 
dataset. 
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MiR 124-3p 
 
 MiR 124-3p belongs to the 124 family of miRNAs, and originally characterized in 
neuronal cells where it is expressed abundantly (179). Not much is known about the role of 
miR 124-3p in immune cells, except recent reports in dendritic cell development, regulation of 
M2 macrophage polarization and T(H)1 and T(H)2 helper T cell development (180). However, 
miR 124-3p is extensively studied in tumor cells and has been shown to impact proliferation, 
apoptosis and invasive potential in these cells (181). Under normal conditions, miR 124-3p is 
highly expressed acts as a tumor suppressor, but is deregulated in several tumor types 
including breast cancer, colorectal cancer, nasopharyngeal carcinoma, glioblastoma, MDS and 
prostate cancer and hepatocellular carcinoma (182-186). Downregulation of miR 124-3p in 
these tumors has been shown to increase proliferation and decrease apoptosis. Interestingly, 
miR 124-3p has a 3’UTR binding site for STAT 3, and has been shown to downregulate 
STAT-3 as well as affect phosphorylation of STAT 3, thereby its function in inducing 
proliferation and prevention of apoptosis (187). Additionally, miR 124-3p has a binding site 
for BCL2L11, however, activation of miR 124-3p has also been shown to induce apoptosis in 
cells through several mechanism including suppression of STAT 3, suppression of CCND2, 
MMP2 and inhibition of anti-apoptotic proteins (188). Additionally recent evidences show that 
miRNAs could potentially switch their roles from repression to activation depending on the 
cellular stimuli (112). Furthermore, it is interesting to note that miR 124-3p has a potential 
binding site for TERT, and could also regulate TERT (189), in addition to STAT 3 and 
inducing apoptosis. 
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Correlation Of Key Findings 
  
 In our studies, we observed similar findings with mbIL15 and mbIL21 expansions of 
NK cells. W observed that mbIL15 expanded NK cells showed higher miR 124-3p expression, 
and lower expansion, as well as increased apoptosis, as explained previously. On the other 
hand, we also observed that miR 124-3p levels were comparatively lower in mbIL21 expanded 
NK cells, and expansion potential was higher and apoptosis was lower in these cells. 
Additionally, we reported differential expression of BCL2L11 and Bim through this study, as 
well as the role of STAT 3 and TERT in causing the differential expansion between mbIL15 
and mbIL2 1through our previous findings.  
 
 This kindled our curiosity to study miR 124-3p, Bim, Stat 3 and TERT in the context 
of NK cell expansion, and evaluate the role of miR 124-3p in modulating IL-15 and IL-
21mediated expansion of NK cells. We hypothesized that upregulation of miR 124-3p is 
responsible for diminished expansion of NK cells on membrane bound IL15 compared to 
membrane bound IL21 due to decrease in Stat 3 and increase in Bim (BCL2L11) leading to 
reduced proliferation and increased apoptosis. In order to address this, we proposed that 
knockdown of miR 124-3p, followed by expansion with mbIL15 would increase Stat 3, 
decrease Bim and restore the proliferation potential and reduce apoptosis, thereby increasing 
the overall expansion in these cells, compared to mbIL21 expanded NK cells (Figure 21). 
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Figure 21: Schematic of correlation of key findings miR 124-3p, BCL2L11 and Bim. 
Through the global expression analysis, we identified that miR 124-3p as the most 
differentially expressed miRNA between mbIL15 and mbIL21. Additionally, we identified 
differential expression of BCL2L11 and Bim. Combining this with our previous findings on 
STAT3 and TERT, we proposed to knockdown the expression of miR 124-3p in fresh NK 
cells, prior to expansion, and evaluate its effect on apoptosis, proliferation, TERT expression 
as well as overall expansion with mbIL15. We propose that knockdown of miR 124-3p would 
have beneficial effect of increasing expansion of NK cell by decrease in apoptosis and increase 
in proliferation. Additionally, this validation would render mechanistic insight into one of the 
methods by which IL-15 and IL-21cytokine signaling in NK cells is being modulate by 
miRNA, specifically miR 124-3p, in causing a prolific expansion differential. 
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Mir 124-3p Regulates Proliferation, Apoptosis And Senescence In NK Cells 
 
 To assess the potential of miR 124-3p in regulating proliferation, apoptosis and 
senescence in NK cells and its role in regulating the overall differential expansion of NK cells, 
we performed transient knockdown of miR 124-3p in NK cells. We preferred the transient 
knockdown method for the following reasons: Firstly, the entirety of this work is based on 
primary NK cells, and these cells are not easily amenable to genetic modifications, and hence 
technically challenging to achieve a permanent knockout model. Secondly, we have 
established techniques in our lab to successfully transiently knock down proteins with siRNA 
previously, and have reported that primary NK cells tolerate transient knockdown reasonably 
(190). Based on this, we knocked down miR 124-3p in normal donor-derived and Rosettesep-
purified fresh peripheral blood NK cells. The effect of knock down was assessed for all 
subsequent experiments by measurement of miR 124-3p by qRT-PCR.  
 
 As detailed in the methods section, fresh NK cells were electroporated with anti-miR 
124-3p along with negative controls. Unelectroporated cells were used as baseline. Since we 
used primary samples for all experiments, and electroporated the cells, we worked with 
smaller sample size, and hence we followed the expression of miR 124-3p for 4 days. We 
observed that the peak knockdown effect of miRNA was between 24 and 48 hours, following 
which miR 124-3p increased in NK cells, and was completely normalized by day 4. We also 
observed a 2.4 fold decrease in the expression of miR 124-3p (Figure 22A and 22B). 
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Figure 22: miR 124-3p expression in NK cells following knockdown by electroporation. 
Fresh NK cells were electroporated with 200 nM of anti-miR 124-3p or negative control using 
Amaxa nucleofector (data shown for n=4 electroporation). Electroporated cells were rested 
overnight in complete RPMI media freshly supplemented with IL-2, and miR 124-3p was 
measured by Taqman miRNA q RT-PCR. Statistical analysis was performed on Graphpad 
prism by student t test, * indicates p < 0.05, ** indicates p < 0.01. (A) Comparison of miR 
124-3p between unelectroporated and negative control electroporated NK cells. As shown, 
electroporation with negative control did not alter miR 124-3p expression in NK cells. (B) 
Comparison of anti-miR 124-3p and negative control electroporated NK cells indicate that 
miR 124-3p is significantly reduced after knock down (2.4 folds after 24 hrs). The effect of 
knockdown was normalized by day 4 in culture, and hence subsequent correlative gene and 
protein expressions were measured within this time frame.  
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Mir 124-3p Knockdown Increases Overall Expansion  
 
 Upon confirmation of successful transient knockdown of miR 124-3p in NK cells, we 
assessed the impact of miR 124-3p knockdown on the overall expansion of NK cells. Normal 
donor-derived and Rosettesep purified NK cells were electroporated with anti-miR 124-3p or 
negative control as detailed above. Unelectroporated NK cells served as baseline comparative 
control. All 3 fractions of NK cells were divided into 2 parts, and expansion was set up with 
either K562.mbIL15 or K562.mbIL21, as described previously. After 7 days, NK cells were 
counted by trypan blue exclusion method, as well as assessed by CD56, CD16, NKp46 and 
lack of CD3 expression by flow cytometry. The fold expansion of these NK cells was 
calculated as described in detail in the methods section. The fold expansion comparison 
between the 3 groups (unelectroporated, negative control and anti-miR 124-3p electroporated 
cells) is represented in Figure 23.  
 
 As shown in Figure 23, the overall expansion of NK cells with mbIL15 was improved 
significantly, and was comparable to mbIL21 expanded NK cells. Additionally, the effect of 
knockdown of miR 124-3p was more prominent in mbIL15 than in mbIL21 expansion, 
possibly due to the robustness of mbIL21 expansion due to an existing lower expression of 
miR 124-3p in these cells (data not shown).  
 
 By knocking down miR 124-3p, we were able to demonstrate improved expansion of 
NK cells with mbIL15, although not to the extent of IL-21 mediated expansion, primarily due 
to 2 reasons: firstly, we compared electroporated and mbIL15 expanded NK cells to that of 
unelectroporated and mbIL21 expanded NK cells in order to show the difference in improved 
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expansion. It is possible that anti-miR 124-3p and mbIL15 expanded cells had to overcome 
electroporation-induced stress before expansion potential could be wholly realized. 
Additionally, knockdown of miR 124-3p in this situation is transient, and thus it could be 
argued that a potential knockout (such as CRISPR or lentiviral transduction) would be more 
beneficial, since miR 124-3p expression will be completely eliminated, and thus expansion 
could be unimpeded even with mbIL15. Further this effect on the overall improvement in 
efficacy of mbIL15 mediated expansion lays credence to our hypothesis, and to the potential 
role of miR 124-3p in regulating and driving the overall expansion potential of NK cells. 
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Figure 23: Knockdown of miR 124-3p enhances expansion of mbIL15 NK cells. NK cells 
from 4 normal donors were expanded with mbIL15 (left panel), as shown, cells expanded at an 
average 5-folds in 7 days. NK cells form the same donors were expanded on mbIL21 as well 
(right panel), with an average 17-fold expansion (difference in fold expansion p < 0.01). NK 
cells were also subject to miR 124-3p knockdown by electroporation and expanded on mbIL15 
as shown (middle panel). After 7 days, fold expansion in mbIL15 increased to an average of 
9.75 folds (p < 0.05, compared to mbIL21 expansion). This data substantiates the role of miR 
124-3p in mediating the increase in overall expansion potential of NK cells. 
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Mir 124-3p Knockdown Increases Proliferation 
 
 To further understand the process by which miR 124-3p knockdown causes this 
increase in expansion, we evaluated if proliferation increased in NK cells upon miR 124-3p 
knockdown. Under tumor conditions, decrease in miR 124-3p has been previously shown to 
increase proliferation of tumor cells by activation of STAT 3, cyclin dependent kinase 6, Rb 
gene as well as activation of anti-apoptotic proteins (BCL2, MCL1) (181, 183-185, 187, 191).  
Normal donor-derived and Rosettesep purified fresh NK cells were electroporated with anti-
miR 124-3p and negative control as before. Corresponding unelectroporated NK cells were 
used as baseline comparative control. All 3 fractions of NK cells were pre-loaded with CFSE 
dye, followed by expansion with either mbIL15 or mbIL21. The rate of proliferation was 
measured by flow cytometry on day 1, 4 and 7, by assessing the number of proliferative cycles 
on CD56+NKp46+ NK cells (Figure 24).  
 
 We compared the miR 124-3p knockdown NK cells’ proliferation with that of negative 
control, as well as mbIL21 expanded NK cells, and observed an increase in the number of NK 
cell proliferative cycles as measured by flow cytometry. Further, we observed that the effect of 
knockdown of miR 124-3p was more significant in mbIL15 expansion, compared to that of 
mbIL21 expansion. Additionally, similar to the overall expansion pattern, despite NK cells 
having to overcome the electroporation-induced stress, they nevertheless were able to 
proliferate better when compared to unelectroporated mbIL15 NK cells. This data shows that 
miR 124-3p is involved in mediating the proliferative potential in NK cells and is differential 
between mbIL15 and mbIL21, due their differential expression.  
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Figure 24: Knockdown of miR124-3p enhances proliferation in mbIL15 NK cells. NK 
cells from 6 donors were electroporated with anti-miR 124-3p and pre-loaded with CFSE dye 
to evaluate proliferation. NK cells were then expanded on either mbIL15 or mbIL21 and 
assessed for proliferation by flow cytometry on day 1, day 4 (data not shown) and day 7. 
Although NK cells were pre-loaded with CFSE, CD56+NKp46+ cells were gated to ensure 
accuracy. Data shown here is representative of 6, bar graph shows average and median centric 
analysis of the number of proliferative peaks between the different groups. (A) Comparison of 
CFSE proliferation between unelectroporated, negative control and miR 124-3p knockdown 
NK cells that were expanded on mbIL15. As can be seen, mbIL15 expansion did not promote 
proliferation of NK cells (left panel), however, miR 124-3p knockdown, supports better 
proliferation with mbIL15 (p < 0.05). (B) Comparison of proliferation between 
unelectroporated, negative control and miR 124-3p knockdown cells that were expanded with 
mbIL15 and mbIL21. Data is representative from the same donor. As shown, miR 124-3p 
knockdown enhanced proliferation in mbIL15 NK cells, indicating the role of miR 124-3p in 
promoting proliferation in NK cells (p < 0.01). (C) The number of proliferative peaks for each 
sample was counted and the data shows the average number of proliferative cycles in each 
group. As expected, mbIL21 is more robust in supporting proliferation (left panel), however, 
miR 124-3p knockdown removed the proliferative check due to continual IL-15 signaling, and 
promotes proliferation even in mbIL15 NK cells. P values were calculated by paired student t 
test on graphpad prism, and significance is indicated in the bar graph. 
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Mir 124-3p Knockdown Decreases Apoptosis 
 
Mir 124-3p has been shown to be high under normal conditions, and acts as a tumor 
suppressor, but has been shown to be downregulated in several cancers, and one of the primary 
ways by which miR 124-3p exerts its action is by the inhibition of STAT 3, increased 
proliferation and decreased apoptosis in tumor cells (181, 184, 192). Based on this, we showed 
that knockdown of miR 124-3pand stimulation with mbIL15 increased overall expansion in 
NK cells due to increased proliferation. In addition, we also evaluated the effect on miR 124-
3p knockdown on the overall apoptosis by flow cytometry. Similar to the expansion and 
proliferation analyses, we knocked down miR 124-3p in 3 normal donor-derived and 
Rosettesep purified NK cells, and expanded the cells with mbIL15 or mbIL21. We assessed 
the effect of knockdown by flow cytometry on day 4 and day 7 (day 4 data not shown), by 
staining for Annexin V and PI and gated for NK cells on CD56+NKp46+ population (Figure 
25). Unelectroporated NK cells were also expanded with mbIL15 and mbIL21, and as 
expected mbIL15 NK cells had increased apoptotic and lower live cell populations (Figure 15). 
 
 Based on the flow cytometry data, we observed that knockdown of miR 124-3p had a 
significant effect on lowering the apoptotic rate in mbIL15 expanded NK cells. As before, we 
also observed that the effect was more pronounced in mbIL15 expansion compared to mbIL21. 
This could be because of the fact that the apoptosis was already very low in mbIL21 
expansion. Furthermore, this data shows that miR 124-3p is involved in mediating the 
apoptosis in NK cells and, lowering miR 124-3p has beneficial effects to the overall expansion 
potential of NK cells.  
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Figure 25: Knockdown of miR124-3p reduces apoptosis in mbIL15 NK cells. NK cells 
were tested for the rate of apoptosis before and after knockdown of miR 124-3p. Fresh 
peripheral blood NK cells from 3 donors were electroporated with negative control or anti-miR 
124-3p, followed by expansion with either mbIL15 or mbIL21. Unelectroporated NK cells 
were use as baseline control and the combined data on apoptosis of unelectroporated NK cells 
is shown in Figure 15. Percentage apoptotic, live and dead cells were calculated based on the 
flow cytometry data, and analyzed on graphpad prism by paired student t test, and significance 
are indicated in the bar graph. (A) Representative flow plots are shown. NK cells were 
expanded for 7 days following knockdown of miR 124-3p and apoptosis was assessed by 
Annexin V and PI positive cells gated on CD56 and NKp46. The top panel represents 
comparison between unelectropoareted mbIL15 and mbIL21 NK cells, as shown mbIL15 
shows higher rate of apoptosis. A similar trend is observed in negative control NK cells as 
well. However, expansion following knockdown of miR 124-3p (bottom flow panel) indicates 
that NK cells are able to overcome the continual IL-15 signaling mediated apoptosis. (B) 
Comparison of negative control and miR 124-3p knockdown cells indicates that mbIL15 
expansion of NK cells after miR 124-3p knockdown are able to prevent apoptosis, and 
increase the percent live cells. This effect was not as pronounced in mbIL21 NK cells where 
the rate of apoptosis was lower in both negative control as well as miR 124-3p knockdown 
cells (right panel).  
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Mir 124-3p Knockdown Regulates Expression of STAT 3, TERT And BCL2L11 (Bim)  
 
 Through our experiments, we had validated role of knock down of miR 124-3p in 
increasing proliferation, decreasing apoptosis, and as a result increasing the overall expansion 
potential of NK cells. As stated previously, miR 124-3p has been shown to promote 
tumorigenesis through downregulation of STAT3. We have also shown through our expression 
profile studies that BCL2L11 and Bim were the most significantly differentially regulated 
gene and protein, respectively, when compared between mbIL15 and mbIL21 NK cells, and 
that miR 124-3p is the most significantly differential miRNA between the 2 groups. 
Additionally, we have shown through previous studies that STAT3 (IL-21) signaling in NK 
cells promotes telomere maintenance, whereas STAT 5 (IL-15) signaling prevents TERT 
expression, and by extension, telomere length.  
 
 In order to corroborate our findings in this study, as well as to confirm the role of 
STAT3, TERT and BCL2L11 in NK cells, we proposed to knockdown miR 124-3p in fresh 
NK cells and follow the expression changes in these genes. Additionally, although STAT3, 
STAT5 and TERT were shown to be critical to the expansion with IL-15 and IL-21 in previous 
studies, we did not find the expression levels of these genes to be different through gene 
expression studies (Figure 14). Hence, we wanted to capitulate the effect of knockdown of 
miR 124-3p at the earliest possible timeline, and hence chose to perform the experiments on 
fresh peripheral blood NK cells. We electroporated the NK cells with either negative control or 
anti-miR 124-3p, and followed the gene expression of STAT3, TERT and BCL2L11 on day 1, 
2 and 3 (as much as the sample size permitted) by qPCR. 
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 We observed that the expression levels of STAT3 and TERT increased significantly. 
More interestingly, the expression of BCL2L11 significantly reduced, indicating that although 
miR 124-3p has a 3’ UTR binding site for BCL2L11, suggesting that the activation or 
repression of expression is context dependent based on cellular stimuli (Figure 26). 
Additionally, two co‐expressed mRNA transcripts that are targeted by the same miRNAs are 
functionally coupled to one another as a result of the finite amount of available miRNA. Thus, 
transient changes in the expression levels of one of the genes will have a direct or indirect 
impact on the expression and abundance of the other transcript driven by the amount of 
miRNA availability (112, 120). 
 
 Further, we assessed the effect of IL-15 and IL-21 signaling in modulating the 
expression levels of STAT3, TERT and BCL2L11 after miR 124-3p knock down. We 
electroporated fresh NK cells with negative control or anti-miR 124-3p, and expanded the cells 
for7 days with mbIL15 and mbIL21. The NK cells were FACS sorted on day 7 based on CD56 
and NKp46 expression, and mRNA expression was evaluated by qPCR. We observe that 
despite mbIL15 expansion and IL-15 mediated signaling in NK cells, knockdown of miR 124-
3p increased STAT3 and TERT significantly, and reduced BCL2L11 significantly (Figure 27). 
This data suggests that miR 124-3p mediates its effect on expansion by increasing 
proliferation, decreasing senescence and decreasing apoptosis, specifically by modulating the 
expression of STAT3, TERT and BCL2L11.  
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Figure 26: Knockdown of miR124-3p increases STAT3 and TERT, and decreases 
BCL2L11 in NK cells. Fresh peripheral blood NK cells were electroporated with negative 
control or anti-miR 124-3p, and unelectroporated NK cells were used as baseline comparative 
controls. mRNA was collected from collected from the cells 1 2 and 3 days after 
electroporation and gene expression was evaluated by qRT-PCR for the expression of STAT3, 
TERT and Bim. As shown, ΔΔCt values for the expression levels of STAT3 and TERT 
increased significantly over 3 days, whereas BCL2L11 decreased following knockdown (n=3). 
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Figure 27: Expansion of NK cells with mbI15 after knockdown of miR124-3p increases 
STAT3 and TERT, and decreases BCL2L11 in NK cells. Similar to the experiment above, 
NK cells were electroporated with negative control or anti-miR 124-3p, and NK cells were 
expanded for 1 week with either mbIL15 or mbIL21. The cells were sorted for CD56 and 
NKp46 after 7 days, and the effect of IL-15 signaling on NK cells was measured by the 
expression of STAT3, TERT and BCL2L11 by qRTPCR. As shown, STAT3 and TERT 
expression in NK cells increased, and BCL2L11 expression decreased despite mbIL15 
expansion, corroborating the increased proliferation and decreased apoptosis observed.  
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 The expression level of hTERT is critical and rate limiting to telomerase activity and 
telomere length, and its expression is primarily by transcriptional control (193-195). Thus, in 
order to establish the molecular mechanism of telomerase regulation, it is critical to understand 
the transcriptional and post transcriptional regulation of hTERT. So far, although telomere 
length and TERT expression changes have been observed in NK cells, it has not been 
empirically shown to be due to any contributing factor. This is the first report showing the 
regulation of TERT in expanded NK cells through miRNA. 
 
 Finally, we validated our gene expression findings after miR 124-3p knockdown, by 
measuring the protein expression in NK cells. Similar to gene expression studies, we 
electroporated the NK cells with negative control or anti-miR 124-3p, and assessed the 
expression of Stat3, Tert, Bim and phospho-Stat (Y705 and Y727) by western blot. 
Corresponding with he gene expression data, we observed that Stat3, Tert and phospho-Stats 
expression increased whilst Bim expression decreased (Figure 28). 
 
 Taken together, we have shown through this study that downregulation of miR 124-3p 
in IL-21 mediated expansion of NK cells is responsible for the higher expansion observed. 
Knockdown of miR 124-3p and expansion using IL-15 was able to partially restore 
proliferation, understandably because of the transient nature of knockdown. 
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Figure 28: Knockdown of miR 124-3p Increases Stat 3, p-Stat3 and Tert Protein 
Expression and Decreases Bim Protein Expression. NK cells were electroporated with 
negative control and anti-miR 124-3p, and protein was collected and estimated after 48 hours. 
Western blot analysis was performed to probe for Stat3, Tert, p-Stats and Bim; β-actin was 
used for loading control. As shown, the expression of Stat3, Tert p-Stat3 Y705 and p-Stat3 Y-
727 increased, and Bim expression decreased due to miR 124-3p knockdown, corroborating 
our findings with increased proliferation, and decreased apoptosis in NK cells. 
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CHAPTER 5: SUMMARY AND CONCLUSION 
 
 NK cells are lymphocytes of the innate immune system, and are attractive candidates 
for adoptive immunotherapy. Owing to the small percentage of NK cells in the peripheral 
blood, several expansion methods have been developed including K562 based membrane 
bound IL15 and membrane bound IL21 developed in or lab. K562.mbIL21 far exceeds he 
expansion potential of K562.mbIL15, whilst maintaining phenotype and cytotoxic functions. 
Considering the effectiveness of mbIL21-mediated expansion of functionally potent NK cells, 
it is definitively advantageous to use this system for clinical applications, where permissible.  
 
 The sustained proliferative advantage of IL-21 signaling ex vivo arises from the 
continual activation of Stat3 by IL-21, and promotion of sustained phosphorylation of Stat3. 
The role of Stat3 in increased proliferation and anti-apoptotic signals in tumor cells are well 
established. Contrary to IL-21, Stat5 signaling activated by IL-15. Interestingly, Stat5 has also 
been shown to be activated by IL-21, with more sustained activation by IL-1. This clearly 
indicates an advantage to the IL-21 mediated pro survival signal in NK cells. We and others 
have previously established the role of STAT 3 and STAT 5 in mediating signaling through 
IL-21 and IL-15, respectively, and we have shown that it is possible that STAT 3 signaling and 
possible consequent maintenance of telomere length, promotes robustness of expansion in the 
mbIL21 platform. Through this project we sought to specifically address the observed 
differences and the possible cellular processes that drive these differences due to IL-15 and IL-
21 signaling. We proposed that the differences between mbIL15 and mbIL21 could be due to 
post-transcriptional regulation, particularly through miRNA. To address this, we performed 
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global expression analyses of mRNA, protein and miRNA, and identified key differential 
factors through stringent statistical analyses.  
 
 In addition, Stat3 is involved in driving almost all of the pathways that control NK 
cytolytic activity as well regulatory interactions between NK cells and other components of the 
immune system (196). Stat3 regulates all aspects of NK cell biology, including NK 
development, activation, target cell killing, and fine-tuning of the innate and adaptive immune 
responses, as well as critically regulating the pathways and soluble factors activated in tumor-
associated NK cells, cancer cells, and regulatory myeloid cells, thus collectively determining 
the outcome of cancer immunity. Additionally IL-21 signaling and its resultant Stat3 activation 
has been shown to promote secretion of cytokine and pro-inflammatory mediators including 
IL-6, IFN-γ, IL-17, and CCL5, granzyme B and perforin, thus reiterating the importance of IL-
21 signaling in NK cells. Further, it has also been shown that miRs such as miR 146-3p, miR 
27a, miR 155 which are differentially expressed between mbIL15 and mbIL21 are involved in 
the modulation of 1 or more of these cytokines.  
 
 This data provided us insight into the overall expression pattern, as well as the potential 
for evaluating miRNA in the regulation of other critical aspects of NK cells such as 
cytotoxicity, cytokine production and ADCC. However, since the focus of this project is to 
specifically understand the influence of miRNA in mediating expansion of NK cells through 
IL-15 and IL-21, we intend to use this database and the findings in future studies. We 
discovered BCL2L11, Bim and miR 124-3p to be the most differentially expressed, with 
highest expression in IL-15 expanded NK cells.  
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 Based on literature evidence on miR 124-3p’s role as a tumor suppressor, and its role 
in causing tumorigenesis through increased proliferation and decreased apoptosis, particularly 
via activating STAT3 in various tumor types, and based on the expression pattern in mbIL15 
and mbIL21 NK cells, we hypothesized that knockdown of miR 124-3p followed by expansion 
with mbIL15 would increase Stat3, Tert and reduce Bim, and thus restore the proliferative 
potential of NK cells expanded on IL-15. To accomplish this, we performed transient 
knockdown of miR 124-3p through electroporation, and demonstrated that indeed knockdown 
of miR 124-3p followed by stimulation with mbIL15 increased the overall expansion of NK 
cells. Further we showed that decreasing miR 124-3p modulated the expression levels of key 
functional genes and proteins involved in mediating expansion of NK cells.  
 
 Through this study, we have demonstrated that upregulation of miR 124-3p due to IL-
15 signaling in mbIL15 expansion, drives increased apoptosis and decreased proliferation of 
NK cells mediated by increased BCL2L11 and Bim, and decreased Stat3, Tert and p-Stat3, 
respectively, thereby significantly diminishing the overall expansion potential of these cells 
(Figure 29).  
 
 Furthermore, we have demonstrated through this study that downregulation of miR 
124-3p due to IL-21 signaling in mbIL21 expanded NK cells plays a major role in 
upregulating Stat3 and Tert, and downregulating Bim, thereby driving the prolific expansion 
of NK cells through increased proliferation and decreased apoptosis (Figure 30). 
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Figure 29: Schematic of modified IL-15 mediated signaling in NK cells. Through this 
study, we have discovered the role of miR 124-3p in modulating the expression of Stat3, Bim 
and Tert, thereby driving the differential expansion potential in NK cells. As shown, IL-15 
signaling upregulates miR 124-3p, which in turn activates Bim, and suppresses Tert and Stat3, 
leading to an overall reduced expansion of NK cells due to continual IL-15 signaling.  
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Figure 30: Schematic of modified IL-21 mediated signaling in NK cells. The role IL-21 
signaling in downregulating miR 124-3p, and consequent effect on the overall expansion is 
shown here. IL-21 signaling decreases miR 124-3p, which regulates increased expression of 
Stat3, Bim and Tert, thereby drives the differential expansion potential in NK cells. As shown, 
IL-21 signaling downregulates miR 124-3p, which in turn suppresses Bim, and activates Tert 
and Stat3, leading to an overall prolific increase in expansion of NK cells due to continual IL-
21 signaling.  
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 Finally, through this study, we have demonstrated for the first time that miR 124-3p 
knockdown in mbIL15 NK cells has a significant effect in increasing expression of STAT3 
and TERT, and consequent proliferation of NK cells. We also showed that knockdown of miR 
124-3p in mbIL15 NK cells had a significant effect in decreasing expression of BCL2L11 
(Bim), and consequent apoptosis. We demonstrated that knockdown of miR 124-3p in mbIL15 
NK cells had a significant effect in improving overall expansion of NK cells (Figure 31). 
 
 In conclusion, we have demonstrated the role of miR 124-3p in NK cells for the first 
time in this study. We have also demonstrated the key role that miR 124-3p plays in 
modulating expressions of Tert and Bim in NK cells for the first time through this study. 
Additionally, we have demonstrated the role of miR 124-3p in modulating Stat3 expression in 
NK cells for the first time. We have established that overexpression of miR 124-3p and 
consequent overexpression of Bim (BCL2L11) is responsible for reduced expansion potential 
in mbIL15 NK cells. We also demonstrated that expansion of NK cells on mbIL21 overcomes 
the intrinsic expression of miR 124-3p and consequent Bim (BCL2L11), thus able to support 
robust expansion. We have finally demonstrated that by knockdown of miR 124-3p and 
consequent downregulation of Bim (BCL2L11), as well as increased Stat3 and Tert, we are 
able to support better expansion of mbIL15 NK cells. 
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Figure 31: Schematic of the effect of miR 124-3p knockdown on improving the overall 
expansion potential of mbIL15 NK cells. As shown, knockdown of miR 124-3p, restores the 
proliferative potential and decreases apoptosis due to continual IL-15 signaling, thereby 
improving the expansion of NK cells. Furthermore, the impact of miR 124-3p in modulating 
proliferation and apoptosis through Stat3, Tert and Bim is demonstrated here.  
 
IL15	
JAK	P	
Stat5	P	
Stat5	P	 Stat5	
miR-124-3p	Stat3	
1.  Preven(on	of	Apoptosis		
2.  Preven(on	of	Senescence	
3.  Increased	Survival	
Expansion	
BCL2L11	
(Bim)	 TERT	
	 114	
Impact of Work 
 
 In this study, we performed a global analysis of miRNA, gene and protein expressions 
between freshly isolated NK cells and NK cells expanded on membrane bound IL15 and 
membrane bound IL21. We identified miRNA that differentially regulate several aspects of 
NK cells including cellular proliferation, apoptosis, cytolytic activity, cytokine secretion and 
senescence. Additionally, we identified genes and proteins that are similarly regulating these 
aspects, and correlated them to the miRNA expression. While study and comparison of any of 
these aspects of NK cell biology and function would be relevant and of significance, we 
specifically focused on the most differential quality between NK cells expanded on these 2 
platforms. The	overall	impact	of	this	study	is	twofold:	Firstly	we	have	demonstrated	a	mechanistic	insight	into	the	robustness	of	expansion	of	NK	cells	with	K562.mbIL21,	and	the	role	of	IL-21	mediated-signaling	in	downregulating	miR	124-3p,	thereby,	promoting	proliferation	and	inhibition	of	apoptosis.	Secondly,	we	have	shown	that	knockdown	of	miR	124-3p	overcomes	the	intrinsic	drawback	of	apoptosis	and	reduced	proliferation	seen	with	expansion	of	NK	cells	with	K562.mbIL15,	thereby	promoting	better	expansion	with	mbIL15. 
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CHAPTER 6: FUTURE DIRECTIONS 
 
 In this study, we have defined the role of miR 124-3p in causing the differential 
expansion of NK cells with membrane bound IL-15 and IL-21. We specifically focused on the 
expansion potential of ex vivo expanded NK cells for this project. We have shown that Stat3, 
Tert and Bim expressions are regulated through miR 124-3p, and that miR 124-3p expression 
is mediated by IL-15 and IL-21 signaling differentially. The regulation of Stat3 by miR 124-3p 
has been shown previously to be a direct effect in tumor types. However, the regulation of Tert 
and Bim could be either direct or through indirect mechanisms (through intermediary 
molecules). The list of players in these pathways with regard to IL-15, IL-21 signaling and 
miR 124-3p needs to be further elucidated. 
 
 In this study, we employed a transient knockdown method for studying the effect of 
miR 124-3p in the proliferative and apoptotic outcome in NK cells. It would be interesting to 
see if using lentiviral transduction or CRISPR mediated knockout of miR 124-3p may have a 
different outcome. Additionally, it would be insightful to see if any of the other differentially 
expressed miRNAs act either synergistically or opposite to that of miR 124-3p in his model. 
 
 Based on the differential gene and protein expression in NK cells, we addressed the 
role of miR 124-3p in modulating Bim expression, in addition to Stat 3 and Tert. However, it 
has ben shown that downregulation of miR 124-3p is involved in promoting cell cycle 
progression through upregulation of CDK6 and Rb genes, as well as preventing checkpoint 
inhibition from G0-G1 phase; additionally, downregulation of miR 124-3p has also been 
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shown to enhance the activation of anti-apoptotic proteins. (192, 197). Finding the correlation 
between miR 124-3p and these pathways would add more strength to the proliferation aspect 
of this study.  
 
 Further, it would be interesting to understand how miR 124-3p-mediated Stat3 
regulation affects NK cells functioning. IL-15 signaling is mediated through Stat-1, Stat-3 or 
Stat-5, although there is a preferential signaling through Stat-5. It would be interesting to see if 
increased availability of Stat 3 due to miR 124-3p suppression during the initial phase of NK 
cell expansion could skew the signaling preference for IL-15 from Stat 5 to Stat 3. If this were 
to happen, NK cell expansion with IL-15 would continue more robustly without the impeding 
apoptotic and anti-proliferative signals. 
 
 Finally, with regard to expansion, it would also be interesting to see if miR 124-3p or 
any other miRNA influenced by IL-15 or IL-21 signaling play a role in regulating homeostasis 
in NK cells (ex: miR 142). If such a miRNA could be identified, it would be beneficial for 
modulating NK cell homeostasis not only in this model, but also would be beneficial in 
studying NK cell-related autoimmunity.  
 
 Although we explored the role of miRNA, gene, and protein expression related to 
expansion, our global expression analyses of fresh and expanded NK cells provides a dataset 
with which to address the role of miRNA in regulating various other cellular functions in NK 
cells including differential cytokine secretion due to IL-15 and IL-21 signaling (project design 
and execution under consideration), cytotoxicity, and differential ADCC. Additionally, 
comparison of fresh peripheral blood NK cells’ miRNA and gene expression could be 
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compared with either mbIL15 or mbIL21 expanded NK cells to address the underlying 
mechanisms of cellular activation and increased function in NK cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 118	
Bibliography 
 1.	 Thornthwaite,	J.	T.,	and	Leif,	R.	C.	(1974)	The	plaque	cytogram	assay.	I.	Light	and	scanning	electron	microscopy	of	immunocompetent	cells.	Journal	of	immunology	
113,	1897-1908	2.	 Jondal,	M.,	and	Pross,	H.	(1975)	Surface	markers	on	human	b	and	t	lymphocytes.	VI.	Cytotoxicity	against	cell	lines	as	a	functional	marker	for	lymphocyte	subpopulations.	International	journal	of	cancer.	Journal	international	du	cancer	15,	596-605	3.	 Pross,	H.	F.,	and	Jondal,	M.	(1975)	Cytotoxic	lymphocytes	from	normal	donors.	A	functional	marker	of	human	non-T	lymphocytes.	Clinical	and	experimental	
immunology	21,	226-235	4.	 Herberman,	R.	B.,	Nunn,	M.	E.,	Holden,	H.	T.,	and	Lavrin,	D.	H.	(1975)	Natural	cytotoxic	reactivity	of	mouse	lymphoid	cells	against	syngeneic	and	allogeneic	tumors.	II.	Characterization	of	effector	cells.	International	journal	of	cancer.	
Journal	international	du	cancer	16,	230-239	5.	 Kiessling,	R.,	Klein,	E.,	Pross,	H.,	and	Wigzell,	H.	(1975)	"Natural"	killer	cells	in	the	mouse.	II.	Cytotoxic	cells	with	specificity	for	mouse	Moloney	leukemia	cells.	Characteristics	of	the	killer	cell.	European	journal	of	immunology	5,	117-121	6.	 West,	W.	H.,	Cannon,	G.	B.,	Kay,	H.	D.,	Bonnard,	G.	D.,	and	Herberman,	R.	B.	(1977)	Natural	cytotoxic	reactivity	of	human	lymphocytes	against	a	myeloid	cell	line:	characterization	of	effector	cells.	Journal	of	immunology	118,	355-361	7.	 Lanier,	L.	L.	(2005)	NK	cell	recognition.	Annual	review	of	immunology	23,	225-274	
	 119	
8.	 Caligiuri,	M.	A.	(2008)	Human	natural	killer	cells.	Blood	112,	461-469	9.	 Parham,	P.	(2005)	MHC	class	I	molecules	and	KIRs	in	human	history,	health	and	survival.	Nature	reviews.	Immunology	5,	201-214	10.	 Lanier,	L.	L.,	Testi,	R.,	Bindl,	J.,	and	Phillips,	J.	H.	(1989)	Identity	of	Leu-19	(CD56)	leukocyte	differentiation	antigen	and	neural	cell	adhesion	molecule.	The	Journal	of	
experimental	medicine	169,	2233-2238	11.	 Ritz,	J.,	Schmidt,	R.	E.,	Michon,	J.,	Hercend,	T.,	and	Schlossman,	S.	F.	(1988)	Characterization	of	functional	surface	structures	on	human	natural	killer	cells.	
Advances	in	immunology	42,	181-211	12.	 Lanier,	L.	L.,	Le,	A.	M.,	Civin,	C.	I.,	Loken,	M.	R.,	and	Phillips,	J.	H.	(1986)	The	relationship	of	CD16	(Leu-11)	and	Leu-19	(NKH-1)	antigen	expression	on	human	peripheral	blood	NK	cells	and	cytotoxic	T	lymphocytes.	Journal	of	immunology	
136,	4480-4486	13.	 Sivori,	S.,	Vitale,	M.,	Morelli,	L.,	Sanseverino,	L.,	Augugliaro,	R.,	Bottino,	C.,	Moretta,	L.,	and	Moretta,	A.	(1997)	p46,	a	novel	natural	killer	cell-specific	surface	molecule	that	mediates	cell	activation.	The	Journal	of	experimental	medicine	186,	1129-1136	14.	 Valiante,	N.	M.,	Uhrberg,	M.,	Shilling,	H.	G.,	Lienert-Weidenbach,	K.,	Arnett,	K.	L.,	D'Andrea,	A.,	Phillips,	J.	H.,	Lanier,	L.	L.,	and	Parham,	P.	(1997)	Functionally	and	structurally	distinct	NK	cell	receptor	repertoires	in	the	peripheral	blood	of	two	human	donors.	Immunity	7,	739-751	15.	 Guillerey,	C.,	Huntington,	N.	D.,	and	Smyth,	M.	J.	(2016)	Targeting	natural	killer	cells	in	cancer	immunotherapy.	Nature	immunology	17,	1025-1036	
	 120	
16.	 Cerwenka,	A.,	and	Lanier,	L.	L.	(2001)	Natural	killer	cells,	viruses	and	cancer.	
Nature	reviews.	Immunology	1,	41-49	17.	 Smyth,	M.	J.,	Cretney,	E.,	Kelly,	J.	M.,	Westwood,	J.	A.,	Street,	S.	E.,	Yagita,	H.,	Takeda,	K.,	van	Dommelen,	S.	L.,	Degli-Esposti,	M.	A.,	and	Hayakawa,	Y.	(2005)	Activation	of	NK	cell	cytotoxicity.	Molecular	immunology	42,	501-510	18.	 Kim,	S.,	Iizuka,	K.,	Aguila,	H.	L.,	Weissman,	I.	L.,	and	Yokoyama,	W.	M.	(2000)	In	vivo	natural	killer	cell	activities	revealed	by	natural	killer	cell-deficient	mice.	
Proceedings	of	the	National	Academy	of	Sciences	of	the	United	States	of	America	97,	2731-2736	19.	 Trapani,	J.	A.,	and	Smyth,	M.	J.	(2002)	Functional	significance	of	the	perforin/granzyme	cell	death	pathway.	Nature	reviews.	Immunology	2,	735-747	20.	 Smyth,	M.	J.,	Hayakawa,	Y.,	Takeda,	K.,	and	Yagita,	H.	(2002)	New	aspects	of	natural-killer-cell	surveillance	and	therapy	of	cancer.	Nature	reviews.	Cancer	2,	850-861	21.	 Karre,	K.	(2002)	Immunology.	A	perfect	mismatch.	Science	295,	2029-2031	22.	 Campbell,	K.	S.,	and	Hasegawa,	J.	(2013)	Natural	killer	cell	biology:	an	update	and	future	directions.	The	Journal	of	allergy	and	clinical	immunology	132,	536-544	23.	 Bradley,	M.,	Zeytun,	A.,	Rafi-Janajreh,	A.,	Nagarkatti,	P.	S.,	and	Nagarkatti,	M.	(1998)	Role	of	spontaneous	and	interleukin-2-induced	natural	killer	cell	activity	in	the	cytotoxicity	and	rejection	of	Fas+	and	Fas-	tumor	cells.	Blood	92,	4248-4255	24.	 Cheng,	M.,	Chen,	Y.,	Xiao,	W.,	Sun,	R.,	and	Tian,	Z.	(2013)	NK	cell-based	immunotherapy	for	malignant	diseases.	Cellular	&	molecular	immunology	10,	230-252	
	 121	
25.	 Ruggeri,	L.,	Capanni,	M.,	Urbani,	E.,	Perruccio,	K.,	Shlomchik,	W.	D.,	Tosti,	A.,	Posati,	S.,	Rogaia,	D.,	Frassoni,	F.,	Aversa,	F.,	Martelli,	M.	F.,	and	Velardi,	A.	(2002)	Effectiveness	of	donor	natural	killer	cell	alloreactivity	in	mismatched	hematopoietic	transplants.	Science	295,	2097-2100	26.	 Reefman,	E.,	Kay,	J.	G.,	Wood,	S.	M.,	Offenhauser,	C.,	Brown,	D.	L.,	Roy,	S.,	Stanley,	A.	C.,	Low,	P.	C.,	Manderson,	A.	P.,	and	Stow,	J.	L.	(2010)	Cytokine	secretion	is	distinct	from	secretion	of	cytotoxic	granules	in	NK	cells.	Journal	of	immunology	184,	4852-4862	27.	 Fauriat,	C.,	Long,	E.	O.,	Ljunggren,	H.	G.,	and	Bryceson,	Y.	T.	(2010)	Regulation	of	human	NK-cell	cytokine	and	chemokine	production	by	target	cell	recognition.	
Blood	115,	2167-2176	28.	 Cooper,	M.	A.,	Fehniger,	T.	A.,	Turner,	S.	C.,	Chen,	K.	S.,	Ghaheri,	B.	A.,	Ghayur,	T.,	Carson,	W.	E.,	and	Caligiuri,	M.	A.	(2001)	Human	natural	killer	cells:	a	unique	innate	immunoregulatory	role	for	the	CD56(bright)	subset.	Blood	97,	3146-3151	29.	 Campbell,	J.	J.,	Qin,	S.,	Unutmaz,	D.,	Soler,	D.,	Murphy,	K.	E.,	Hodge,	M.	R.,	Wu,	L.,	and	Butcher,	E.	C.	(2001)	Unique	subpopulations	of	CD56+	NK	and	NK-T	peripheral	blood	lymphocytes	identified	by	chemokine	receptor	expression	repertoire.	
Journal	of	immunology	166,	6477-6482	30.	 De	Maria,	A.,	Bozzano,	F.,	Cantoni,	C.,	and	Moretta,	L.	(2011)	Revisiting	human	natural	killer	cell	subset	function	revealed	cytolytic	CD56(dim)CD16+	NK	cells	as	rapid	producers	of	abundant	IFN-gamma	on	activation.	Proceedings	of	the	
National	Academy	of	Sciences	of	the	United	States	of	America	108,	728-732	
	 122	
31.	 Alter,	G.,	Malenfant,	J.	M.,	Delabre,	R.	M.,	Burgett,	N.	C.,	Yu,	X.	G.,	Lichterfeld,	M.,	Zaunders,	J.,	and	Altfeld,	M.	(2004)	Increased	natural	killer	cell	activity	in	viremic	HIV-1	infection.	Journal	of	immunology	173,	5305-5311	32.	 Montoya,	C.	J.,	Velilla,	P.	A.,	Chougnet,	C.,	Landay,	A.	L.,	and	Rugeles,	M.	T.	(2006)	Increased	IFN-gamma	production	by	NK	and	CD3+/CD56+	cells	in	sexually	HIV-1-exposed	but	uninfected	individuals.	Clinical	immunology	120,	138-146	33.	 Biron,	C.	A.,	Nguyen,	K.	B.,	Pien,	G.	C.,	Cousens,	L.	P.,	and	Salazar-Mather,	T.	P.	(1999)	Natural	killer	cells	in	antiviral	defense:	function	and	regulation	by	innate	cytokines.	Annual	review	of	immunology	17,	189-220	34.	 Vivier,	E.,	Tomasello,	E.,	Baratin,	M.,	Walzer,	T.,	and	Ugolini,	S.	(2008)	Functions	of	natural	killer	cells.	Nature	immunology	9,	503-510	35.	 Ross,	M.	E.,	and	Caligiuri,	M.	A.	(1997)	Cytokine-induced	apoptosis	of	human	natural	killer	cells	identifies	a	novel	mechanism	to	regulate	the	innate	immune	response.	Blood	89,	910-918	36.	 Lanier,	L.	L.	(2014)	Of	snowflakes	and	natural	killer	cell	subsets.	Nature	
biotechnology	32,	140-142	37.	 Cooper,	M.	A.,	Fehniger,	T.	A.,	and	Caligiuri,	M.	A.	(2001)	The	biology	of	human	natural	killer-cell	subsets.	Trends	in	immunology	22,	633-640	38.	 O'Sullivan,	T.	E.,	Sun,	J.	C.,	and	Lanier,	L.	L.	(2015)	Natural	Killer	Cell	Memory.	
Immunity	43,	634-645	39.	 O'Sullivan,	T.	E.,	and	Sun,	J.	C.	(2015)	Generation	of	Natural	Killer	Cell	Memory	during	Viral	Infection.	Journal	of	innate	immunity	7,	557-562	
	 123	
40.	 Becker,	P.	S.,	Suck,	G.,	Nowakowska,	P.,	Ullrich,	E.,	Seifried,	E.,	Bader,	P.,	Tonn,	T.,	and	Seidl,	C.	(2016)	Selection	and	expansion	of	natural	killer	cells	for	NK	cell-based	immunotherapy.	Cancer	immunology,	immunotherapy	:	CII	65,	477-484	41.	 Locatelli,	F.,	Pende,	D.,	Mingari,	M.	C.,	Bertaina,	A.,	Falco,	M.,	Moretta,	A.,	and	Moretta,	L.	(2013)	Cellular	and	molecular	basis	of	haploidentical	hematopoietic	stem	cell	transplantation	in	the	successful	treatment	of	high-risk	leukemias:	role	of	alloreactive	NK	cells.	Frontiers	in	immunology	4,	15	42.	 Aversa,	F.,	Martelli,	M.	F.,	and	Velardi,	A.	(2012)	Haploidentical	hematopoietic	stem	cell	transplantation	with	a	megadose	T-cell-depleted	graft:	harnessing	natural	and	adaptive	immunity.	Seminars	in	oncology	39,	643-652	43.	 Miller,	J.	S.,	Soignier,	Y.,	Panoskaltsis-Mortari,	A.,	McNearney,	S.	A.,	Yun,	G.	H.,	Fautsch,	S.	K.,	McKenna,	D.,	Le,	C.,	Defor,	T.	E.,	Burns,	L.	J.,	Orchard,	P.	J.,	Blazar,	B.	R.,	Wagner,	J.	E.,	Slungaard,	A.,	Weisdorf,	D.	J.,	Okazaki,	I.	J.,	and	McGlave,	P.	B.	(2005)	Successful	adoptive	transfer	and	in	vivo	expansion	of	human	haploidentical	NK	cells	in	patients	with	cancer.	Blood	105,	3051-3057	44.	 Rubnitz,	J.	E.,	Inaba,	H.,	Ribeiro,	R.	C.,	Pounds,	S.,	Rooney,	B.,	Bell,	T.,	Pui,	C.	H.,	and	Leung,	W.	(2010)	NKAML:	a	pilot	study	to	determine	the	safety	and	feasibility	of	haploidentical	natural	killer	cell	transplantation	in	childhood	acute	myeloid	leukemia.	Journal	of	clinical	oncology	:	official	journal	of	the	American	Society	of	
Clinical	Oncology	28,	955-959	45.	 Burns,	L.	J.,	Weisdorf,	D.	J.,	DeFor,	T.	E.,	Vesole,	D.	H.,	Repka,	T.	L.,	Blazar,	B.	R.,	Burger,	S.	R.,	Panoskaltsis-Mortari,	A.,	Keever-Taylor,	C.	A.,	Zhang,	M.	J.,	and	Miller,	J.	S.	(2003)	IL-2-based	immunotherapy	after	autologous	transplantation	for	
	 124	
lymphoma	and	breast	cancer	induces	immune	activation	and	cytokine	release:	a	phase	I/II	trial.	Bone	marrow	transplantation	32,	177-186	46.	 Rosenberg,	S.	A.,	Lotze,	M.	T.,	Yang,	J.	C.,	Aebersold,	P.	M.,	Linehan,	W.	M.,	Seipp,	C.	A.,	and	White,	D.	E.	(1989)	Experience	with	the	use	of	high-dose	interleukin-2	in	the	treatment	of	652	cancer	patients.	Annals	of	surgery	210,	474-484;	discussion	484-475	47.	 Sakamoto,	N.,	Ishikawa,	T.,	Kokura,	S.,	Okayama,	T.,	Oka,	K.,	Ideno,	M.,	Sakai,	F.,	Kato,	A.,	Tanabe,	M.,	Enoki,	T.,	Mineno,	J.,	Naito,	Y.,	Itoh,	Y.,	and	Yoshikawa,	T.	(2015)	Phase	I	clinical	trial	of	autologous	NK	cell	therapy	using	novel	expansion	method	in	patients	with	advanced	digestive	cancer.	Journal	of	translational	
medicine	13,	277	48.	 Koehl,	U.,	Sorensen,	J.,	Esser,	R.,	Zimmermann,	S.,	Gruttner,	H.	P.,	Tonn,	T.,	Seidl,	C.,	Seifried,	E.,	Klingebiel,	T.,	and	Schwabe,	D.	(2004)	IL-2	activated	NK	cell	immunotherapy	of	three	children	after	haploidentical	stem	cell	transplantation.	
Blood	cells,	molecules	&	diseases	33,	261-266	49.	 Koehl,	U.,	Esser,	R.,	Zimmermann,	S.,	Tonn,	T.,	Kotchetkov,	R.,	Bartling,	T.,	Sorensen,	J.,	Gruttner,	H.	P.,	Bader,	P.,	Seifried,	E.,	Martin,	H.,	Lang,	P.,	Passweg,	J.	R.,	Klingebiel,	T.,	and	Schwabe,	D.	(2005)	Ex	vivo	expansion	of	highly	purified	NK	cells	for	immunotherapy	after	haploidentical	stem	cell	transplantation	in	children.	
Klinische	Padiatrie	217,	345-350	50.	 Clausen,	J.,	Petzer,	A.	L.,	Vergeiner,	B.,	Enk,	M.,	Stauder,	R.,	Gastl,	G.,	and	Gunsilius,	E.	(2001)	Optimal	timing	for	the	collection	and	in	vitro	expansion	of	cytotoxic	
	 125	
CD56(+)	lymphocytes	from	patients	undergoing	autologous	peripheral	blood	stem	cell	transplantation.	Journal	of	hematotherapy	&	stem	cell	research	10,	513-521	51.	 Clausen,	J.,	Enk,	M.,	Vergeiner,	B.,	Eisendle,	K.,	Petzer,	A.	L.,	Gastl,	G.,	and	Gunsilius,	E.	(2004)	Suppression	of	natural	killer	cells	in	the	presence	of	CD34+	blood	progenitor	cells	and	peripheral	blood	lymphocytes.	Biology	of	blood	and	marrow	
transplantation	:	journal	of	the	American	Society	for	Blood	and	Marrow	
Transplantation	10,	691-697	52.	 Klingemann,	H.	G.,	and	Martinson,	J.	(2004)	Ex	vivo	expansion	of	natural	killer	cells	for	clinical	applications.	Cytotherapy	6,	15-22	53.	 Suck,	G.,	Oei,	V.	Y.,	Linn,	Y.	C.,	Ho,	S.	H.,	Chu,	S.,	Choong,	A.,	Niam,	M.,	and	Koh,	M.	B.	(2011)	Interleukin-15	supports	generation	of	highly	potent	clinical-grade	natural	killer	cells	in	long-term	cultures	for	targeting	hematological	malignancies.	
Experimental	hematology	39,	904-914	54.	 Brehm,	C.,	Huenecke,	S.,	Quaiser,	A.,	Esser,	R.,	Bremm,	M.,	Kloess,	S.,	Soerensen,	J.,	Kreyenberg,	H.,	Seidl,	C.,	Becker,	P.	S.,	Muhl,	H.,	Klingebiel,	T.,	Bader,	P.,	Passweg,	J.	R.,	Schwabe,	D.,	and	Koehl,	U.	(2011)	IL-2	stimulated	but	not	unstimulated	NK	cells	induce	selective	disappearance	of	peripheral	blood	cells:	concomitant	results	to	a	phase	I/II	study.	PloS	one	6,	e27351	55.	 Suck,	G.,	and	Koh,	M.	B.	(2010)	Emerging	natural	killer	cell	immunotherapies:	large-scale	ex	vivo	production	of	highly	potent	anticancer	effectors.	
Hematology/oncology	and	stem	cell	therapy	3,	135-142	56.	 de	Rham,	C.,	Ferrari-Lacraz,	S.,	Jendly,	S.,	Schneiter,	G.,	Dayer,	J.	M.,	and	Villard,	J.	(2007)	The	proinflammatory	cytokines	IL-2,	IL-15	and	IL-21	modulate	the	
	 126	
repertoire	of	mature	human	natural	killer	cell	receptors.	Arthritis	research	&	
therapy	9,	R125	57.	 Spanholtz,	J.,	Tordoir,	M.,	Eissens,	D.,	Preijers,	F.,	van	der	Meer,	A.,	Joosten,	I.,	Schaap,	N.,	de	Witte,	T.	M.,	and	Dolstra,	H.	(2010)	High	log-scale	expansion	of	functional	human	natural	killer	cells	from	umbilical	cord	blood	CD34-positive	cells	for	adoptive	cancer	immunotherapy.	PloS	one	5,	e9221	58.	 Lapteva,	N.,	Szmania,	S.	M.,	van	Rhee,	F.,	and	Rooney,	C.	M.	(2014)	Clinical	grade	purification	and	expansion	of	natural	killer	cells.	Critical	reviews	in	oncogenesis	
19,	121-132	59.	 Bachanova,	V.,	Burns,	L.	J.,	McKenna,	D.	H.,	Curtsinger,	J.,	Panoskaltsis-Mortari,	A.,	Lindgren,	B.	R.,	Cooley,	S.,	Weisdorf,	D.,	and	Miller,	J.	S.	(2010)	Allogeneic	natural	killer	cells	for	refractory	lymphoma.	Cancer	immunology,	immunotherapy	:	CII	59,	1739-1744	60.	 McKenna,	D.	H.,	Jr.,	Sumstad,	D.,	Bostrom,	N.,	Kadidlo,	D.	M.,	Fautsch,	S.,	McNearney,	S.,	Dewaard,	R.,	McGlave,	P.	B.,	Weisdorf,	D.	J.,	Wagner,	J.	E.,	McCullough,	J.,	and	Miller,	J.	S.	(2007)	Good	manufacturing	practices	production	of	natural	killer	cells	for	immunotherapy:	a	six-year	single-institution	experience.	
Transfusion	47,	520-528	61.	 Pittari,	G.,	Fregni,	G.,	Roguet,	L.,	Garcia,	A.,	Vataire,	A.	L.,	Wittnebel,	S.,	Amsellem,	S.,	Chouaib,	S.,	Bourhis,	J.	H.,	and	Caignard,	A.	(2010)	Early	evaluation	of	natural	killer	activity	in	post-transplant	acute	myeloid	leukemia	patients.	Bone	marrow	
transplantation	45,	862-871	
	 127	
62.	 Denman,	C.	J.,	Senyukov,	V.	V.,	Somanchi,	S.	S.,	Phatarpekar,	P.	V.,	Kopp,	L.	M.,	Johnson,	J.	L.,	Singh,	H.,	Hurton,	L.,	Maiti,	S.	N.,	Huls,	M.	H.,	Champlin,	R.	E.,	Cooper,	L.	J.,	and	Lee,	D.	A.	(2012)	Membrane-bound	IL-21	promotes	sustained	ex	vivo	proliferation	of	human	natural	killer	cells.	PloS	one	7,	e30264	63.	 Shi,	J.,	Tricot,	G.,	Szmania,	S.,	Rosen,	N.,	Garg,	T.	K.,	Malaviarachchi,	P.	A.,	Moreno,	A.,	Dupont,	B.,	Hsu,	K.	C.,	Baxter-Lowe,	L.	A.,	Cottler-Fox,	M.,	Shaughnessy,	J.	D.,	Jr.,	Barlogie,	B.,	and	van	Rhee,	F.	(2008)	Infusion	of	haplo-identical	killer	immunoglobulin-like	receptor	ligand	mismatched	NK	cells	for	relapsed	myeloma	in	the	setting	of	autologous	stem	cell	transplantation.	British	journal	of	
haematology	143,	641-653	64.	 Portevin,	D.,	Poupot,	M.,	Rolland,	O.,	Turrin,	C.	O.,	Fournie,	J.	J.,	Majoral,	J.	P.,	Caminade,	A.	M.,	and	Poupot,	R.	(2009)	Regulatory	activity	of	azabisphosphonate-capped	dendrimers	on	human	CD4+	T	cell	proliferation	enhances	ex-vivo	expansion	of	NK	cells	from	PBMCs	for	immunotherapy.	Journal	of	translational	
medicine	7,	82	65.	 Torelli,	G.	F.,	Guarini,	A.,	Palmieri,	G.,	Breccia,	M.,	Vitale,	A.,	Santoni,	A.,	and	Foa,	R.	(2002)	Expansion	of	cytotoxic	effectors	with	lytic	activity	against	autologous	blasts	from	acute	myeloid	leukaemia	patients	in	complete	haematological	remission.	British	journal	of	haematology	116,	299-307	66.	 Torelli,	G.	F.,	Guarini,	A.,	Maggio,	R.,	Alfieri,	C.,	Vitale,	A.,	and	Foa,	R.	(2005)	Expansion	of	natural	killer	cells	with	lytic	activity	against	autologous	blasts	from	adult	and	pediatric	acute	lymphoid	leukemia	patients	in	complete	hematologic	remission.	Haematologica	90,	785-792	
	 128	
67.	 Berg,	M.,	Lundqvist,	A.,	McCoy,	P.,	Jr.,	Samsel,	L.,	Fan,	Y.,	Tawab,	A.,	and	Childs,	R.	(2009)	Clinical-grade	ex	vivo-expanded	human	natural	killer	cells	up-regulate	activating	receptors	and	death	receptor	ligands	and	have	enhanced	cytolytic	activity	against	tumor	cells.	Cytotherapy	11,	341-355	68.	 Gong,	W.,	Xiao,	W.,	Hu,	M.,	Weng,	X.,	Qian,	L.,	Pan,	X.,	and	Ji,	M.	(2010)	Ex	vivo	expansion	of	natural	killer	cells	with	high	cytotoxicity	by	K562	cells	modified	to	co-express	major	histocompatibility	complex	class	I	chain-related	protein	A,	4-1BB	ligand,	and	interleukin-15.	Tissue	antigens	76,	467-475	69.	 Somanchi,	S.	S.,	and	Lee,	D.	A.	(2016)	Ex	Vivo	Expansion	of	Human	NK	Cells	Using	K562	Engineered	to	Express	Membrane	Bound	IL21.	Methods	in	molecular	biology	
1441,	175-193	70.	 Fujisaki,	H.,	Kakuda,	H.,	Shimasaki,	N.,	Imai,	C.,	Ma,	J.,	Lockey,	T.,	Eldridge,	P.,	Leung,	W.	H.,	and	Campana,	D.	(2009)	Expansion	of	highly	cytotoxic	human	natural	killer	cells	for	cancer	cell	therapy.	Cancer	research	69,	4010-4017	71.	 Zhang,	H.,	Cui,	Y.,	Voong,	N.,	Sabatino,	M.,	Stroncek,	D.	F.,	Morisot,	S.,	Civin,	C.	I.,	Wayne,	A.	S.,	Levine,	B.	L.,	and	Mackall,	C.	L.	(2011)	Activating	signals	dominate	inhibitory	signals	in	CD137L/IL-15	activated	natural	killer	cells.	Journal	of	
immunotherapy	34,	187-195	72.	 Somanchi,	S.	S.,	Senyukov,	V.	V.,	Denman,	C.	J.,	and	Lee,	D.	A.	(2011)	Expansion,	purification,	and	functional	assessment	of	human	peripheral	blood	NK	cells.	
Journal	of	visualized	experiments	:	JoVE		
	 129	
73.	 Kucuk,	C.,	Hu,	X.,	Iqbal,	J.,	Gaulard,	P.,	Klinkebiel,	D.,	Cornish,	A.,	Dave,	B.	J.,	and	Chan,	W.	C.	(2013)	HACE1	is	a	tumor	suppressor	gene	candidate	in	natural	killer	cell	neoplasms.	The	American	journal	of	pathology	182,	49-55	74.	 Kucuk,	C.,	Iqbal,	J.,	Hu,	X.,	Gaulard,	P.,	De	Leval,	L.,	Srivastava,	G.,	Au,	W.	Y.,	McKeithan,	T.	W.,	and	Chan,	W.	C.	(2011)	PRDM1	is	a	tumor	suppressor	gene	in	natural	killer	cell	malignancies.	Proceedings	of	the	National	Academy	of	Sciences	of	
the	United	States	of	America	108,	20119-20124	75.	 Shah,	N.,	Martin-Antonio,	B.,	Yang,	H.,	Ku,	S.,	Lee,	D.	A.,	Cooper,	L.	J.,	Decker,	W.	K.,	Li,	S.,	Robinson,	S.	N.,	Sekine,	T.,	Parmar,	S.,	Gribben,	J.,	Wang,	M.,	Rezvani,	K.,	Yvon,	E.,	Najjar,	A.,	Burks,	J.,	Kaur,	I.,	Champlin,	R.	E.,	Bollard,	C.	M.,	and	Shpall,	E.	J.	(2013)	Antigen	presenting	cell-mediated	expansion	of	human	umbilical	cord	blood	yields	log-scale	expansion	of	natural	killer	cells	with	anti-myeloma	activity.	
PloS	one	8,	e76781	76.	 Knorr,	D.	A.,	Ni,	Z.,	Hermanson,	D.,	Hexum,	M.	K.,	Bendzick,	L.,	Cooper,	L.	J.,	Lee,	D.	A.,	and	Kaufman,	D.	S.	(2013)	Clinical-scale	derivation	of	natural	killer	cells	from	human	pluripotent	stem	cells	for	cancer	therapy.	Stem	cells	translational	medicine	
2,	274-283	77.	 Bock,	A.	M.,	Knorr,	D.,	and	Kaufman,	D.	S.	(2013)	Development,	expansion,	and	in	vivo	monitoring	of	human	NK	cells	from	human	embryonic	stem	cells	(hESCs)	and	and	induced	pluripotent	stem	cells	(iPSCs).	Journal	of	visualized	experiments	:	
JoVE,	e50337	78.	 Liu,	Y.,	Wu,	H.	W.,	Sheard,	M.	A.,	Sposto,	R.,	Somanchi,	S.	S.,	Cooper,	L.	J.,	Lee,	D.	A.,	and	Seeger,	R.	C.	(2013)	Growth	and	activation	of	natural	killer	cells	ex	vivo	from	
	 130	
children	with	neuroblastoma	for	adoptive	cell	therapy.	Clinical	cancer	research	:	
an	official	journal	of	the	American	Association	for	Cancer	Research	19,	2132-2143	79.	 Sheard,	M.	A.,	Asgharzadeh,	S.,	Liu,	Y.,	Lin,	T.	Y.,	Wu,	H.	W.,	Ji,	L.,	Groshen,	S.,	Lee,	D.	A.,	and	Seeger,	R.	C.	(2013)	Membrane-bound	TRAIL	supplements	natural	killer	cell	cytotoxicity	against	neuroblastoma	cells.	Journal	of	immunotherapy	36,	319-329	80.	 Schafer,	J.	L.,	Colantonio,	A.	D.,	Neidermyer,	W.	J.,	Dudley,	D.	M.,	Connole,	M.,	O'Connor,	D.	H.,	and	Evans,	D.	T.	(2014)	KIR3DL01	recognition	of	Bw4	ligands	in	the	rhesus	macaque:	maintenance	of	Bw4	specificity	since	the	divergence	of	apes	and	Old	World	monkeys.	Journal	of	immunology	192,	1907-1917	81.	 Foltz,	J.	A.,	Somanchi,	S.	S.,	Yang,	Y.,	Aquino-Lopez,	A.,	Bishop,	E.	E.,	and	Lee,	D.	A.	(2016)	NCR1	Expression	Identifies	Canine	Natural	Killer	Cell	Subsets	with	Phenotypic	Similarity	to	Human	Natural	Killer	Cells.	Frontiers	in	immunology	7,	521	82.	 Johnston,	J.	A.,	Bacon,	C.	M.,	Finbloom,	D.	S.,	Rees,	R.	C.,	Kaplan,	D.,	Shibuya,	K.,	Ortaldo,	J.	R.,	Gupta,	S.,	Chen,	Y.	Q.,	Giri,	J.	D.,	and	et	al.	(1995)	Tyrosine	phosphorylation	and	activation	of	STAT5,	STAT3,	and	Janus	kinases	by	interleukins	2	and	15.	Proceedings	of	the	National	Academy	of	Sciences	of	the	
United	States	of	America	92,	8705-8709	83.	 Murphy,	W.	J.,	Parham,	P.,	and	Miller,	J.	S.	(2012)	NK	cells--from	bench	to	clinic.	
Biology	of	blood	and	marrow	transplantation	:	journal	of	the	American	Society	for	
Blood	and	Marrow	Transplantation	18,	S2-7	
	 131	
84.	 Mishra,	A.,	Sullivan,	L.,	and	Caligiuri,	M.	A.	(2014)	Molecular	pathways:	interleukin-15	signaling	in	health	and	in	cancer.	Clinical	cancer	research	:	an	
official	journal	of	the	American	Association	for	Cancer	Research	20,	2044-2050	85.	 Lin,	J.	X.,	Migone,	T.	S.,	Tsang,	M.,	Friedmann,	M.,	Weatherbee,	J.	A.,	Zhou,	L.,	Yamauchi,	A.,	Bloom,	E.	T.,	Mietz,	J.,	John,	S.,	and	et	al.	(1995)	The	role	of	shared	receptor	motifs	and	common	Stat	proteins	in	the	generation	of	cytokine	pleiotropy	and	redundancy	by	IL-2,	IL-4,	IL-7,	IL-13,	and	IL-15.	Immunity	2,	331-339	86.	 Waldmann,	T.	A.,	and	Tagaya,	Y.	(1999)	The	multifaceted	regulation	of	interleukin-15	expression	and	the	role	of	this	cytokine	in	NK	cell	differentiation	and	host	response	to	intracellular	pathogens.	Annual	review	of	immunology	17,	19-49	87.	 Shibuya,	H.,	Yoneyama,	M.,	Ninomiya-Tsuji,	J.,	Matsumoto,	K.,	and	Taniguchi,	T.	(1992)	IL-2	and	EGF	receptors	stimulate	the	hematopoietic	cell	cycle	via	different	signaling	pathways:	demonstration	of	a	novel	role	for	c-myc.	Cell	70,	57-67	88.	 Lord,	J.	D.,	McIntosh,	B.	C.,	Greenberg,	P.	D.,	and	Nelson,	B.	H.	(2000)	The	IL-2	receptor	promotes	lymphocyte	proliferation	and	induction	of	the	c-myc,	bcl-2,	and	bcl-x	genes	through	the	trans-activation	domain	of	Stat5.	Journal	of	immunology	
164,	2533-2541	89.	 Asao,	H.,	Okuyama,	C.,	Kumaki,	S.,	Ishii,	N.,	Tsuchiya,	S.,	Foster,	D.,	and	Sugamura,	K.	(2001)	Cutting	edge:	the	common	gamma-chain	is	an	indispensable	subunit	of	the	IL-21	receptor	complex.	Journal	of	immunology	167,	1-5	90.	 Wendt,	K.,	Wilk,	E.,	Buyny,	S.,	Schmidt,	R.	E.,	and	Jacobs,	R.	(2007)	Interleukin-21	differentially	affects	human	natural	killer	cell	subsets.	Immunology	122,	486-495	
	 132	
91.	 Parrish-Novak,	J.,	Dillon,	S.	R.,	Nelson,	A.,	Hammond,	A.,	Sprecher,	C.,	Gross,	J.	A.,	Johnston,	J.,	Madden,	K.,	Xu,	W.,	West,	J.,	Schrader,	S.,	Burkhead,	S.,	Heipel,	M.,	Brandt,	C.,	Kuijper,	J.	L.,	Kramer,	J.,	Conklin,	D.,	Presnell,	S.	R.,	Berry,	J.,	Shiota,	F.,	Bort,	S.,	Hambly,	K.,	Mudri,	S.,	Clegg,	C.,	Moore,	M.,	Grant,	F.	J.,	Lofton-Day,	C.,	Gilbert,	T.,	Rayond,	F.,	Ching,	A.,	Yao,	L.,	Smith,	D.,	Webster,	P.,	Whitmore,	T.,	Maurer,	M.,	Kaushansky,	K.,	Holly,	R.	D.,	and	Foster,	D.	(2000)	Interleukin	21	and	its	receptor	are	involved	in	NK	cell	expansion	and	regulation	of	lymphocyte	function.	Nature	408,	57-63	92.	 Strengell,	M.,	Matikainen,	S.,	Siren,	J.,	Lehtonen,	A.,	Foster,	D.,	Julkunen,	I.,	and	Sareneva,	T.	(2003)	IL-21	in	synergy	with	IL-15	or	IL-18	enhances	IFN-gamma	production	in	human	NK	and	T	cells.	Journal	of	immunology	170,	5464-5469	93.	 Frederiksen,	K.	S.,	Lundsgaard,	D.,	Freeman,	J.	A.,	Hughes,	S.	D.,	Holm,	T.	L.,	Skrumsager,	B.	K.,	Petri,	A.,	Hansen,	L.	T.,	McArthur,	G.	A.,	Davis,	I.	D.,	and	Skak,	K.	(2008)	IL-21	induces	in	vivo	immune	activation	of	NK	cells	and	CD8(+)	T	cells	in	patients	with	metastatic	melanoma	and	renal	cell	carcinoma.	Cancer	immunology,	
immunotherapy	:	CII	57,	1439-1449	94.	 Sarosiek,	K.	A.,	Malumbres,	R.,	Nechushtan,	H.,	Gentles,	A.	J.,	Avisar,	E.,	and	Lossos,	I.	S.	(2010)	Novel	IL-21	signaling	pathway	up-regulates	c-Myc	and	induces	apoptosis	of	diffuse	large	B-cell	lymphomas.	Blood	115,	570-580	95.	 Bhatt,	S.,	Matthews,	J.,	Parvin,	S.,	Sarosiek,	K.	A.,	Zhao,	D.,	Jiang,	X.,	Isik,	E.,	Letai,	A.,	and	Lossos,	I.	S.	(2015)	Direct	and	immune-mediated	cytotoxicity	of	interleukin-21	contributes	to	antitumor	effects	in	mantle	cell	lymphoma.	Blood	126,	1555-1564	
	 133	
96.	 de	Totero,	D.,	Meazza,	R.,	Zupo,	S.,	Cutrona,	G.,	Matis,	S.,	Colombo,	M.,	Balleari,	E.,	Pierri,	I.,	Fabbi,	M.,	Capaia,	M.,	Azzarone,	B.,	Gobbi,	M.,	Ferrarini,	M.,	and	Ferrini,	S.	(2006)	Interleukin-21	receptor	(IL-21R)	is	up-regulated	by	CD40	triggering	and	mediates	proapoptotic	signals	in	chronic	lymphocytic	leukemia	B	cells.	Blood	107,	3708-3715	97.	 Gowda,	A.,	Roda,	J.,	Hussain,	S.	R.,	Ramanunni,	A.,	Joshi,	T.,	Schmidt,	S.,	Zhang,	X.,	Lehman,	A.,	Jarjoura,	D.,	Carson,	W.	E.,	Kindsvogel,	W.,	Cheney,	C.,	Caligiuri,	M.	A.,	Tridandapani,	S.,	Muthusamy,	N.,	and	Byrd,	J.	C.	(2008)	IL-21	mediates	apoptosis	through	up-regulation	of	the	BH3	family	member	BIM	and	enhances	both	direct	and	antibody-dependent	cellular	cytotoxicity	in	primary	chronic	lymphocytic	leukemia	cells	in	vitro.	Blood	111,	4723-4730	98.	 Konnikova,	L.,	Simeone,	M.	C.,	Kruger,	M.	M.,	Kotecki,	M.,	and	Cochran,	B.	H.	(2005)	Signal	transducer	and	activator	of	transcription	3	(STAT3)	regulates	human	telomerase	reverse	transcriptase	(hTERT)	expression	in	human	cancer	and	primary	cells.	Cancer	research	65,	6516-6520	99.	 Lee,	R.	C.,	Feinbaum,	R.	L.,	and	Ambros,	V.	(1993)	The	C.	elegans	heterochronic	gene	lin-4	encodes	small	RNAs	with	antisense	complementarity	to	lin-14.	Cell	75,	843-854	100.	 Carthew,	R.	W.,	and	Sontheimer,	E.	J.	(2009)	Origins	and	Mechanisms	of	miRNAs	and	siRNAs.	Cell	136,	642-655	101.	 Lewis,	B.	P.,	Shih,	I.	H.,	Jones-Rhoades,	M.	W.,	Bartel,	D.	P.,	and	Burge,	C.	B.	(2003)	Prediction	of	mammalian	microRNA	targets.	Cell	115,	787-798	
	 134	
102.	 Johnston,	R.	J.,	and	Hobert,	O.	(2003)	A	microRNA	controlling	left/right	neuronal	asymmetry	in	Caenorhabditis	elegans.	Nature	426,	845-849	103.	 Cheng,	A.	M.,	Byrom,	M.	W.,	Shelton,	J.,	and	Ford,	L.	P.	(2005)	Antisense	inhibition	of	human	miRNAs	and	indications	for	an	involvement	of	miRNA	in	cell	growth	and	apoptosis.	Nucleic	acids	research	33,	1290-1297	104.	 Chen,	J.	F.,	Mandel,	E.	M.,	Thomson,	J.	M.,	Wu,	Q.,	Callis,	T.	E.,	Hammond,	S.	M.,	Conlon,	F.	L.,	and	Wang,	D.	Z.	(2006)	The	role	of	microRNA-1	and	microRNA-133	in	skeletal	muscle	proliferation	and	differentiation.	Nature	genetics	38,	228-233	105.	 Hatfield,	S.	D.,	Shcherbata,	H.	R.,	Fischer,	K.	A.,	Nakahara,	K.,	Carthew,	R.	W.,	and	Ruohola-Baker,	H.	(2005)	Stem	cell	division	is	regulated	by	the	microRNA	pathway.	Nature	435,	974-978	106.	 Croce,	C.	M.,	and	Calin,	G.	A.	(2005)	miRNAs,	cancer,	and	stem	cell	division.	Cell	
122,	6-7	107.	 Naguibneva,	I.,	Ameyar-Zazoua,	M.,	Polesskaya,	A.,	Ait-Si-Ali,	S.,	Groisman,	R.,	Souidi,	M.,	Cuvellier,	S.,	and	Harel-Bellan,	A.	(2006)	The	microRNA	miR-181	targets	the	homeobox	protein	Hox-A11	during	mammalian	myoblast	differentiation.	Nature	cell	biology	8,	278-284	108.	 Bartel,	D.	P.	(2004)	MicroRNAs:	genomics,	biogenesis,	mechanism,	and	function.	
Cell	116,	281-297	109.	 Filipowicz,	W.	(2005)	RNAi:	the	nuts	and	bolts	of	the	RISC	machine.	Cell	122,	17-20	110.	 Matsushima,	K.,	Isomoto,	H.,	Yamaguchi,	N.,	Inoue,	N.,	Machida,	H.,	Nakayama,	T.,	Hayashi,	T.,	Kunizaki,	M.,	Hidaka,	S.,	Nagayasu,	T.,	Nakashima,	M.,	Ujifuku,	K.,	
	 135	
Mitsutake,	N.,	Ohtsuru,	A.,	Yamashita,	S.,	Korpal,	M.,	Kang,	Y.,	Gregory,	P.	A.,	Goodall,	G.	J.,	Kohno,	S.,	and	Nakao,	K.	(2011)	MiRNA-205	modulates	cellular	invasion	and	migration	via	regulating	zinc	finger	E-box	binding	homeobox	2	expression	in	esophageal	squamous	cell	carcinoma	cells.	Journal	of	translational	
medicine	9,	30	111.	 Ling,	H.,	Fabbri,	M.,	and	Calin,	G.	A.	(2013)	MicroRNAs	and	other	non-coding	RNAs	as	targets	for	anticancer	drug	development.	Nature	reviews.	Drug	discovery	12,	847-865	112.	 Calin,	G.	A.,	and	Croce,	C.	M.	(2006)	MicroRNA	signatures	in	human	cancers.	
Nature	reviews.	Cancer	6,	857-866	113.	 Mitchell,	P.	S.,	Parkin,	R.	K.,	Kroh,	E.	M.,	Fritz,	B.	R.,	Wyman,	S.	K.,	Pogosova-Agadjanyan,	E.	L.,	Peterson,	A.,	Noteboom,	J.,	O'Briant,	K.	C.,	Allen,	A.,	Lin,	D.	W.,	Urban,	N.,	Drescher,	C.	W.,	Knudsen,	B.	S.,	Stirewalt,	D.	L.,	Gentleman,	R.,	Vessella,	R.	L.,	Nelson,	P.	S.,	Martin,	D.	B.,	and	Tewari,	M.	(2008)	Circulating	microRNAs	as	stable	blood-based	markers	for	cancer	detection.	Proceedings	of	the	National	
Academy	of	Sciences	of	the	United	States	of	America	105,	10513-10518	114.	 Calin,	G.	A.,	Cimmino,	A.,	Fabbri,	M.,	Ferracin,	M.,	Wojcik,	S.	E.,	Shimizu,	M.,	Taccioli,	C.,	Zanesi,	N.,	Garzon,	R.,	Aqeilan,	R.	I.,	Alder,	H.,	Volinia,	S.,	Rassenti,	L.,	Liu,	X.,	Liu,	C.	G.,	Kipps,	T.	J.,	Negrini,	M.,	and	Croce,	C.	M.	(2008)	MiR-15a	and	miR-16-1	cluster	functions	in	human	leukemia.	Proceedings	of	the	National	Academy	of	
Sciences	of	the	United	States	of	America	105,	5166-5171	115.	 Ha,	M.,	and	Kim,	V.	N.	(2014)	Regulation	of	microRNA	biogenesis.	Nature	reviews.	
Molecular	cell	biology	15,	509-524	
	 136	
116.	 Rodriguez,	A.,	Griffiths-Jones,	S.,	Ashurst,	J.	L.,	and	Bradley,	A.	(2004)	Identification	of	mammalian	microRNA	host	genes	and	transcription	units.	Genome	research	14,	1902-1910	117.	 Denli,	A.	M.,	Tops,	B.	B.,	Plasterk,	R.	H.,	Ketting,	R.	F.,	and	Hannon,	G.	J.	(2004)	Processing	of	primary	microRNAs	by	the	Microprocessor	complex.	Nature	432,	231-235	118.	 Steitz,	J.	A.,	and	Vasudevan,	S.	(2009)	miRNPs:	versatile	regulators	of	gene	expression	in	vertebrate	cells.	Biochemical	Society	transactions	37,	931-935	119.	 Brummer,	A.,	and	Hausser,	J.	(2014)	MicroRNA	binding	sites	in	the	coding	region	of	mRNAs:	extending	the	repertoire	of	post-transcriptional	gene	regulation.	
BioEssays	:	news	and	reviews	in	molecular,	cellular	and	developmental	biology	36,	617-626	120.	 Vasudevan,	S.,	Tong,	Y.,	and	Steitz,	J.	A.	(2007)	Switching	from	repression	to	activation:	microRNAs	can	up-regulate	translation.	Science	318,	1931-1934	121.	 Eiring,	A.	M.,	Harb,	J.	G.,	Neviani,	P.,	Garton,	C.,	Oaks,	J.	J.,	Spizzo,	R.,	Liu,	S.,	Schwind,	S.,	Santhanam,	R.,	Hickey,	C.	J.,	Becker,	H.,	Chandler,	J.	C.,	Andino,	R.,	Cortes,	J.,	Hokland,	P.,	Huettner,	C.	S.,	Bhatia,	R.,	Roy,	D.	C.,	Liebhaber,	S.	A.,	Caligiuri,	M.	A.,	Marcucci,	G.,	Garzon,	R.,	Croce,	C.	M.,	Calin,	G.	A.,	and	Perrotti,	D.	(2010)	miR-328	functions	as	an	RNA	decoy	to	modulate	hnRNP	E2	regulation	of	mRNA	translation	in	leukemic	blasts.	Cell	140,	652-665	122.	 Orom,	U.	A.,	Nielsen,	F.	C.,	and	Lund,	A.	H.	(2008)	MicroRNA-10a	binds	the	5'UTR	of	ribosomal	protein	mRNAs	and	enhances	their	translation.	Molecular	cell	30,	460-471	
	 137	
123.	 Cai,	Y.,	Yu,	X.,	Hu,	S.,	and	Yu,	J.	(2009)	A	brief	review	on	the	mechanisms	of	miRNA	regulation.	Genomics,	proteomics	&	bioinformatics	7,	147-154	124.	 Lewis,	B.	P.,	Burge,	C.	B.,	and	Bartel,	D.	P.	(2005)	Conserved	seed	pairing,	often	flanked	by	adenosines,	indicates	that	thousands	of	human	genes	are	microRNA	targets.	Cell	120,	15-20	125.	 He,	L.,	and	Hannon,	G.	J.	(2004)	MicroRNAs:	small	RNAs	with	a	big	role	in	gene	regulation.	Nature	reviews.	Genetics	5,	522-531	126.	 Lee,	S.,	and	Vasudevan,	S.	(2013)	Post-transcriptional	stimulation	of	gene	expression	by	microRNAs.	Advances	in	experimental	medicine	and	biology	768,	97-126	127.	 Vasudevan,	S.,	and	Steitz,	J.	A.	(2007)	AU-rich-element-mediated	upregulation	of	translation	by	FXR1	and	Argonaute	2.	Cell	128,	1105-1118	128.	 Li,	L.	C.,	Okino,	S.	T.,	Zhao,	H.,	Pookot,	D.,	Place,	R.	F.,	Urakami,	S.,	Enokida,	H.,	and	Dahiya,	R.	(2006)	Small	dsRNAs	induce	transcriptional	activation	in	human	cells.	
Proceedings	of	the	National	Academy	of	Sciences	of	the	United	States	of	America	
103,	17337-17342	129.	 Saraiya,	A.	A.,	Li,	W.,	and	Wang,	C.	C.	(2013)	Transition	of	a	microRNA	from	repressing	to	activating	translation	depending	on	the	extent	of	base	pairing	with	the	target.	PloS	one	8,	e55672	130.	 Turchinovich,	A.,	and	Burwinkel,	B.	(2012)	Distinct	AGO1	and	AGO2	associated	miRNA	profiles	in	human	cells	and	blood	plasma.	RNA	biology	9,	1066-1075	131.	 Sullivan,	R.	P.,	Leong,	J.	W.,	and	Fehniger,	T.	A.	(2013)	MicroRNA	regulation	of	natural	killer	cells.	Frontiers	in	immunology	4,	44	
	 138	
132.	 Leong,	J.	W.,	Sullivan,	R.	P.,	and	Fehniger,	T.	A.	(2014)	microRNA	management	of	NK-cell	developmental	and	functional	programs.	European	journal	of	immunology	
44,	2862-2868	133.	 Beaulieu,	A.	M.,	Bezman,	N.	A.,	Lee,	J.	E.,	Matloubian,	M.,	Sun,	J.	C.,	and	Lanier,	L.	L.	(2013)	MicroRNA	function	in	NK-cell	biology.	Immunological	reviews	253,	40-52	134.	 Presnell,	S.	R.,	Al-Attar,	A.,	Cichocki,	F.,	Miller,	J.	S.,	and	Lutz,	C.	T.	(2015)	Human	natural	killer	cell	microRNA:	differential	expression	of	MIR181A1B1	and	MIR181A2B2	genes	encoding	identical	mature	microRNAs.	Genes	and	immunity	
16,	89-98	135.	 Donatelli,	S.	S.,	Zhou,	J.	M.,	Gilvary,	D.	L.,	Eksioglu,	E.	A.,	Chen,	X.,	Cress,	W.	D.,	Haura,	E.	B.,	Schabath,	M.	B.,	Coppola,	D.,	Wei,	S.,	and	Djeu,	J.	Y.	(2014)	TGF-beta-inducible	microRNA-183	silences	tumor-associated	natural	killer	cells.	
Proceedings	of	the	National	Academy	of	Sciences	of	the	United	States	of	America	
111,	4203-4208	136.	 Liu,	X.,	Wang,	Y.,	Sun,	Q.,	Yan,	J.,	Huang,	J.,	Zhu,	S.,	and	Yu,	J.	(2012)	Identification	of	microRNA	transcriptome	involved	in	human	natural	killer	cell	activation.	
Immunology	letters	143,	208-217	137.	 Sullivan,	R.	P.,	Leong,	J.	W.,	Schneider,	S.	E.,	Keppel,	C.	R.,	Germino,	E.,	French,	A.	R.,	and	Fehniger,	T.	A.	(2012)	MicroRNA-deficient	NK	cells	exhibit	decreased	survival	but	enhanced	function.	Journal	of	immunology	188,	3019-3030	138.	 Bezman,	N.	A.,	Cedars,	E.,	Steiner,	D.	F.,	Blelloch,	R.,	Hesslein,	D.	G.,	and	Lanier,	L.	L.	(2010)	Distinct	requirements	of	microRNAs	in	NK	cell	activation,	survival,	and	function.	Journal	of	immunology	185,	3835-3846	
	 139	
139.	 Bezman,	N.	A.,	Chakraborty,	T.,	Bender,	T.,	and	Lanier,	L.	L.	(2011)	miR-150	regulates	the	development	of	NK	and	iNKT	cells.	The	Journal	of	experimental	
medicine	208,	2717-2731	140.	 Trotta,	R.,	Chen,	L.,	Ciarlariello,	D.,	Josyula,	S.,	Mao,	C.,	Costinean,	S.,	Yu,	L.,	Butchar,	J.	P.,	Tridandapani,	S.,	Croce,	C.	M.,	and	Caligiuri,	M.	A.	(2012)	miR-155	regulates	IFN-gamma	production	in	natural	killer	cells.	Blood	119,	3478-3485	141.	 Ma,	F.,	Xu,	S.,	Liu,	X.,	Zhang,	Q.,	Xu,	X.,	Liu,	M.,	Hua,	M.,	Li,	N.,	Yao,	H.,	and	Cao,	X.	(2011)	The	microRNA	miR-29	controls	innate	and	adaptive	immune	responses	to	intracellular	bacterial	infection	by	targeting	interferon-gamma.	Nature	
immunology	12,	861-869	142.	 Somanchi,	S.	S.,	McCulley,	K.	J.,	Somanchi,	A.,	Chan,	L.	L.,	and	Lee,	D.	A.	(2015)	A	Novel	Method	for	Assessment	of	Natural	Killer	Cell	Cytotoxicity	Using	Image	Cytometry.	PloS	one	10,	e0141074	143.	 Geiss,	G.	K.,	Bumgarner,	R.	E.,	Birditt,	B.,	Dahl,	T.,	Dowidar,	N.,	Dunaway,	D.	L.,	Fell,	H.	P.,	Ferree,	S.,	George,	R.	D.,	Grogan,	T.,	James,	J.	J.,	Maysuria,	M.,	Mitton,	J.	D.,	Oliveri,	P.,	Osborn,	J.	L.,	Peng,	T.,	Ratcliffe,	A.	L.,	Webster,	P.	J.,	Davidson,	E.	H.,	Hood,	L.,	and	Dimitrov,	K.	(2008)	Direct	multiplexed	measurement	of	gene	expression	with	color-coded	probe	pairs.	Nature	biotechnology	26,	317-325	144.	 M'Boutchou,	M.	N.,	and	van	Kempen,	L.	C.	(2016)	Analysis	of	the	Tumor	Microenvironment	Transcriptome	via	NanoString	mRNA	and	miRNA	Expression	Profiling.	Methods	in	molecular	biology	1458,	291-310	145.	 Barber,	D.	F.,	Faure,	M.,	and	Long,	E.	O.	(2004)	LFA-1	contributes	an	early	signal	for	NK	cell	cytotoxicity.	Journal	of	immunology	173,	3653-3659	
	 140	
146.	 Vossen,	M.	T.,	Matmati,	M.,	Hertoghs,	K.	M.,	Baars,	P.	A.,	Gent,	M.	R.,	Leclercq,	G.,	Hamann,	J.,	Kuijpers,	T.	W.,	and	van	Lier,	R.	A.	(2008)	CD27	defines	phenotypically	and	functionally	different	human	NK	cell	subsets.	Journal	of	immunology	180,	3739-3745	147.	 Lu,	M.	H.,	Liao,	Z.	L.,	Zhao,	X.	Y.,	Fan,	Y.	H.,	Lin,	X.	L.,	Fang,	D.	C.,	Guo,	H.,	and	Yang,	S.	M.	(2012)	hTERT-based	therapy:	a	universal	anticancer	approach	(Review).	
Oncology	reports	28,	1945-1952	148.	 Cohen,	S.	B.,	Graham,	M.	E.,	Lovrecz,	G.	O.,	Bache,	N.,	Robinson,	P.	J.,	and	Reddel,	R.	R.	(2007)	Protein	composition	of	catalytically	active	human	telomerase	from	immortal	cells.	Science	315,	1850-1853	149.	 Zvereva,	M.	I.,	Shcherbakova,	D.	M.,	and	Dontsova,	O.	A.	(2010)	Telomerase:	structure,	functions,	and	activity	regulation.	Biochemistry.	Biokhimiia	75,	1563-1583	150.	 Blasco,	M.	A.,	and	Hahn,	W.	C.	(2003)	Evolving	views	of	telomerase	and	cancer.	
Trends	in	cell	biology	13,	289-294	151.	 Kim,	N.	W.,	Piatyszek,	M.	A.,	Prowse,	K.	R.,	Harley,	C.	B.,	West,	M.	D.,	Ho,	P.	L.,	Coviello,	G.	M.,	Wright,	W.	E.,	Weinrich,	S.	L.,	and	Shay,	J.	W.	(1994)	Specific	association	of	human	telomerase	activity	with	immortal	cells	and	cancer.	Science	
266,	2011-2015	152.	 Liu,	H.,	Liu,	Q.,	Ge,	Y.,	Zhao,	Q.,	Zheng,	X.,	and	Zhao,	Y.	(2016)	hTERT	promotes	cell	adhesion	and	migration	independent	of	telomerase	activity.	Scientific	reports	6,	22886	
	 141	
153.	 Bodnar,	A.	G.,	Ouellette,	M.,	Frolkis,	M.,	Holt,	S.	E.,	Chiu,	C.	P.,	Morin,	G.	B.,	Harley,	C.	B.,	Shay,	J.	W.,	Lichtsteiner,	S.,	and	Wright,	W.	E.	(1998)	Extension	of	life-span	by	introduction	of	telomerase	into	normal	human	cells.	Science	279,	349-352	154.	 Hahn,	W.	C.,	Stewart,	S.	A.,	Brooks,	M.	W.,	York,	S.	G.,	Eaton,	E.,	Kurachi,	A.,	Beijersbergen,	R.	L.,	Knoll,	J.	H.,	Meyerson,	M.,	and	Weinberg,	R.	A.	(1999)	Inhibition	of	telomerase	limits	the	growth	of	human	cancer	cells.	Nature	medicine	
5,	1164-1170	155.	 Gotthardt,	D.,	and	Sexl,	V.	(2016)	STATs	in	NK-Cells:	The	Good,	the	Bad,	and	the	Ugly.	Frontiers	in	immunology	7,	694	156.	 Gotthardt,	D.,	Putz,	E.	M.,	Grundschober,	E.,	Prchal-Murphy,	M.,	Straka,	E.,	Kudweis,	P.,	Heller,	G.,	Bago-Horvath,	Z.,	Witalisz-Siepracka,	A.,	Cumaraswamy,	A.	A.,	Gunning,	P.	T.,	Strobl,	B.,	Muller,	M.,	Moriggl,	R.,	Stockmann,	C.,	and	Sexl,	V.	(2016)	STAT5	Is	a	Key	Regulator	in	NK	Cells	and	Acts	as	a	Molecular	Switch	from	Tumor	Surveillance	to	Tumor	Promotion.	Cancer	discovery	6,	414-429	157.	 Zhu,	S.,	Phatarpekar,	P.	V.,	Denman,	C.	J.,	Senyukov,	V.	V.,	Somanchi,	S.	S.,	Nguyen-Jackson,	H.	T.,	Mace,	E.	M.,	Freeman,	A.	F.,	Watowich,	S.	S.,	Orange,	J.	S.,	Holland,	S.	M.,	and	Lee,	D.	A.	(2014)	Transcription	of	the	activating	receptor	NKG2D	in	natural	killer	cells	is	regulated	by	STAT3	tyrosine	phosphorylation.	Blood	124,	403-411	158.	 He,	J.,	Shi,	J.,	Xu,	X.,	Zhang,	W.,	Wang,	Y.,	Chen,	X.,	Du,	Y.,	Zhu,	N.,	Zhang,	J.,	Wang,	Q.,	and	Yang,	J.	(2012)	STAT3	mutations	correlated	with	hyper-IgE	syndrome	lead	to	blockage	of	IL-6/STAT3	signalling	pathway.	Journal	of	biosciences	37,	243-257	
	 142	
159.	 Holland,	S.	M.,	DeLeo,	F.	R.,	Elloumi,	H.	Z.,	Hsu,	A.	P.,	Uzel,	G.,	Brodsky,	N.,	Freeman,	A.	F.,	Demidowich,	A.,	Davis,	J.,	Turner,	M.	L.,	Anderson,	V.	L.,	Darnell,	D.	N.,	Welch,	P.	A.,	Kuhns,	D.	B.,	Frucht,	D.	M.,	Malech,	H.	L.,	Gallin,	J.	I.,	Kobayashi,	S.	D.,	Whitney,	A.	R.,	Voyich,	J.	M.,	Musser,	J.	M.,	Woellner,	C.,	Schaffer,	A.	A.,	Puck,	J.	M.,	and	Grimbacher,	B.	(2007)	STAT3	mutations	in	the	hyper-IgE	syndrome.	The	New	
England	journal	of	medicine	357,	1608-1619	160.	 Ives,	M.	L.,	Ma,	C.	S.,	Palendira,	U.,	Chan,	A.,	Bustamante,	J.,	Boisson-Dupuis,	S.,	Arkwright,	P.	D.,	Engelhard,	D.,	Averbuch,	D.,	Magdorf,	K.,	Roesler,	J.,	Peake,	J.,	Wong,	M.,	Adelstein,	S.,	Choo,	S.,	Smart,	J.	M.,	French,	M.	A.,	Fulcher,	D.	A.,	Cook,	M.	C.,	Picard,	C.,	Durandy,	A.,	Tsumura,	M.,	Kobayashi,	M.,	Uzel,	G.,	Casanova,	J.	L.,	Tangye,	S.	G.,	and	Deenick,	E.	K.	(2013)	Signal	transducer	and	activator	of	transcription	3	(STAT3)	mutations	underlying	autosomal	dominant	hyper-IgE	syndrome	impair	human	CD8(+)	T-cell	memory	formation	and	function.	The	
Journal	of	allergy	and	clinical	immunology	132,	400-411	e409	161.	 Minegishi,	Y.,	Saito,	M.,	Tsuchiya,	S.,	Tsuge,	I.,	Takada,	H.,	Hara,	T.,	Kawamura,	N.,	Ariga,	T.,	Pasic,	S.,	Stojkovic,	O.,	Metin,	A.,	and	Karasuyama,	H.	(2007)	Dominant-negative	mutations	in	the	DNA-binding	domain	of	STAT3	cause	hyper-IgE	syndrome.	Nature	448,	1058-1062	162.	 O'Connor,	L.,	Strasser,	A.,	O'Reilly,	L.	A.,	Hausmann,	G.,	Adams,	J.	M.,	Cory,	S.,	and	Huang,	D.	C.	(1998)	Bim:	a	novel	member	of	the	Bcl-2	family	that	promotes	apoptosis.	The	EMBO	journal	17,	384-395	163.	 Bouillet,	P.,	Metcalf,	D.,	Huang,	D.	C.,	Tarlinton,	D.	M.,	Kay,	T.	W.,	Kontgen,	F.,	Adams,	J.	M.,	and	Strasser,	A.	(1999)	Proapoptotic	Bcl-2	relative	Bim	required	for	
	 143	
certain	apoptotic	responses,	leukocyte	homeostasis,	and	to	preclude	autoimmunity.	Science	286,	1735-1738	164.	 Gersuk,	G.	M.,	Chang,	W.	C.,	and	Pattengale,	P.	K.	(1988)	Inhibition	of	human	natural	killer	cell	activity	by	platelet-derived	growth	factor.	II.	Membrane	binding	studies,	effects	of	recombinant	IFN-alpha	and	IL-2,	and	lack	of	effect	on	T	cell	and	antibody-dependent	cellular	cytotoxicity.	Journal	of	immunology	141,	4031-4038	165.	 Gavalas,	N.	G.,	Tsiatas,	M.,	Tsitsilonis,	O.,	Politi,	E.,	Ioannou,	K.,	Ziogas,	A.	C.,	Rodolakis,	A.,	Vlahos,	G.,	Thomakos,	N.,	Haidopoulos,	D.,	Terpos,	E.,	Antsaklis,	A.,	Dimopoulos,	M.	A.,	and	Bamias,	A.	(2012)	VEGF	directly	suppresses	activation	of	T	cells	from	ascites	secondary	to	ovarian	cancer	via	VEGF	receptor	type	2.	British	
journal	of	cancer	107,	1869-1875	166.	 Lanier,	L.	L.	(2008)	Up	on	the	tightrope:	natural	killer	cell	activation	and	inhibition.	Nature	immunology	9,	495-502	167.	 Colucci,	F.,	and	Di	Santo,	J.	P.	(2000)	The	receptor	tyrosine	kinase	c-kit	provides	a	critical	signal	for	survival,	expansion,	and	maturation	of	mouse	natural	killer	cells.	
Blood	95,	984-991	168.	 Palazon,	L.	S.,	Davies,	T.	J.,	and	Gardner,	R.	L.	(1998)	Translational	inhibition	of	cyclin	B1	and	appearance	of	cyclin	D1	very	early	in	the	differentiation	of	mouse	trophoblast	giant	cells.	Molecular	human	reproduction	4,	1013-1020	169.	 Whalen,	M.	M.,	and	Odman-Ghazi,	S.	O.	(2006)	Effects	of	adenylyl	cyclase	and	protein	kinase	A	inhibition	on	signaling	enzymes	in	natural	killer	cells:	comparison	to	tributyltin.	Human	&	experimental	toxicology	25,	333-340	
	 144	
170.	 Podshivalova,	K.,	and	Salomon,	D.	R.	(2013)	MicroRNA	regulation	of	T-lymphocyte	immunity:	modulation	of	molecular	networks	responsible	for	T-cell	activation,	differentiation,	and	development.	Critical	reviews	in	immunology	33,	435-476	171.	 Dooley,	J.,	Linterman,	M.	A.,	and	Liston,	A.	(2013)	MicroRNA	regulation	of	T-cell	development.	Immunological	reviews	253,	53-64	172.	 Mao,	T.	K.,	and	Chen,	C.	Z.	(2007)	Dissecting	microRNA-mediated	gene	regulation	and	function	in	T-cell	development.	Methods	in	enzymology	427,	171-189	173.	 Danger,	R.,	Braza,	F.,	Giral,	M.,	Soulillou,	J.	P.,	and	Brouard,	S.	(2014)	MicroRNAs,	Major	Players	in	B	Cells	Homeostasis	and	Function.	Frontiers	in	immunology	5,	98	174.	 Kim,	T.	D.,	Lee,	S.	U.,	Yun,	S.,	Sun,	H.	N.,	Lee,	S.	H.,	Kim,	J.	W.,	Kim,	H.	M.,	Park,	S.	K.,	Lee,	C.	W.,	Yoon,	S.	R.,	Greenberg,	P.	D.,	and	Choi,	I.	(2011)	Human	microRNA-27a*	targets	Prf1	and	GzmB	expression	to	regulate	NK-cell	cytotoxicity.	Blood	118,	5476-5486	175.	 Luo,	S.,	Liu,	Y.,	Liang,	G.,	Zhao,	M.,	Wu,	H.,	Liang,	Y.,	Qiu,	X.,	Tan,	Y.,	Dai,	Y.,	Yung,	S.,	Chan,	T.	M.,	and	Lu,	Q.	(2015)	The	role	of	microRNA-1246	in	the	regulation	of	B	cell	activation	and	the	pathogenesis	of	systemic	lupus	erythematosus.	Clinical	
epigenetics	7,	24	176.	 Rosenberger,	C.	M.,	Podyminogin,	R.	L.,	Navarro,	G.,	Zhao,	G.	W.,	Askovich,	P.	S.,	Weiss,	M.	J.,	and	Aderem,	A.	(2012)	miR-451	regulates	dendritic	cell	cytokine	responses	to	influenza	infection.	Journal	of	immunology	189,	5965-5975	177.	 Grigoryev,	Y.	A.,	Kurian,	S.	M.,	Hart,	T.,	Nakorchevsky,	A.	A.,	Chen,	C.,	Campbell,	D.,	Head,	S.	R.,	Yates,	J.	R.,	3rd,	and	Salomon,	D.	R.	(2011)	MicroRNA	regulation	of	
	 145	
molecular	networks	mapped	by	global	microRNA,	mRNA,	and	protein	expression	in	activated	T	lymphocytes.	Journal	of	immunology	187,	2233-2243	178.	 Zhao,	M.,	Wang,	L.	T.,	Liang,	G.	P.,	Zhang,	P.,	Deng,	X.	J.,	Tang,	Q.,	Zhai,	H.	Y.,	Chang,	C.	C.,	Su,	Y.	W.,	and	Lu,	Q.	J.	(2014)	Up-regulation	of	microRNA-210	induces	immune	dysfunction	via	targeting	FOXP3	in	CD4(+)	T	cells	of	psoriasis	vulgaris.	
Clinical	immunology	150,	22-30	179.	 Visvanathan,	J.,	Lee,	S.,	Lee,	B.,	Lee,	J.	W.,	and	Lee,	S.	K.	(2007)	The	microRNA	miR-124	antagonizes	the	anti-neural	REST/SCP1	pathway	during	embryonic	CNS	development.	Genes	&	development	21,	744-749	180.	 Qin,	Z.,	Wang,	P.	Y.,	Su,	D.	F.,	and	Liu,	X.	(2016)	miRNA-124	in	Immune	System	and	Immune	Disorders.	Frontiers	in	immunology	7,	406	181.	 Cao,	Q.,	Li,	Y.	Y.,	He,	W.	F.,	Zhang,	Z.	Z.,	Zhou,	Q.,	Liu,	X.,	Shen,	Y.,	and	Huang,	T.	T.	(2013)	Interplay	between	microRNAs	and	the	STAT3	signaling	pathway	in	human	cancers.	Physiological	genomics	45,	1206-1214	182.	 Xia,	Q.,	Hu,	J.,	and	Meng,	Y.	S.	(2012)	[Abnormal	expression	of	microRNA-124	in	patients	with	leukemia	or	myelodysplastic	syndrome	and	its	significance].	
Zhongguo	shi	yan	xue	ye	xue	za	zhi	20,	358-361	183.	 Shi,	X.	B.,	Xue,	L.,	Ma,	A.	H.,	Tepper,	C.	G.,	Gandour-Edwards,	R.,	Kung,	H.	J.,	and	deVere	White,	R.	W.	(2013)	Tumor	suppressive	miR-124	targets	androgen	receptor	and	inhibits	proliferation	of	prostate	cancer	cells.	Oncogene	32,	4130-4138	
	 146	
184.	 Zhang,	J.,	Lu,	Y.,	Yue,	X.,	Li,	H.,	Luo,	X.,	Wang,	Y.,	Wang,	K.,	and	Wan,	J.	(2013)	MiR-124	suppresses	growth	of	human	colorectal	cancer	by	inhibiting	STAT3.	PloS	one	
8,	e70300	185.	 Xu,	S.,	Zhao,	N.,	Hui,	L.,	Song,	M.,	Miao,	Z.	W.,	and	Jiang,	X.	J.	(2016)	MicroRNA-124-3p	inhibits	the	growth	and	metastasis	of	nasopharyngeal	carcinoma	cells	by	targeting	STAT3.	Oncology	reports	35,	1385-1394	186.	 Hatziapostolou,	M.,	Polytarchou,	C.,	Aggelidou,	E.,	Drakaki,	A.,	Poultsides,	G.	A.,	Jaeger,	S.	A.,	Ogata,	H.,	Karin,	M.,	Struhl,	K.,	Hadzopoulou-Cladaras,	M.,	and	Iliopoulos,	D.	(2011)	An	HNF4alpha-miRNA	inflammatory	feedback	circuit	regulates	hepatocellular	oncogenesis.	Cell	147,	1233-1247	187.	 Koukos,	G.,	Polytarchou,	C.,	Kaplan,	J.	L.,	Morley-Fletcher,	A.,	Gras-Miralles,	B.,	Kokkotou,	E.,	Baril-Dore,	M.,	Pothoulakis,	C.,	Winter,	H.	S.,	and	Iliopoulos,	D.	(2013)	MicroRNA-124	regulates	STAT3	expression	and	is	down-regulated	in	colon	tissues	of	pediatric	patients	with	ulcerative	colitis.	Gastroenterology	145,	842-852	e842	188.	 You,	L.,	Wang,	Z.,	Li,	H.,	Shou,	J.,	Jing,	Z.,	Xie,	J.,	Sui,	X.,	Pan,	H.,	and	Han,	W.	(2015)	The	role	of	STAT3	in	autophagy.	Autophagy	11,	729-739	189.	 Qin,	Y.	Z.,	Xie,	X.	C.,	Liu,	H.	Z.,	Lai,	H.,	Qiu,	H.,	and	Ge,	L.	Y.	(2015)	Screening	and	preliminary	validation	of	miRNAs	with	the	regulation	of	hTERT	in	colorectal	cancer.	Oncology	reports	33,	2728-2736	190.	 Phatarpekar,	P.	V.,	Lee,	D.	A.,	and	Somanchi,	S.	S.	(2016)	Electroporation	of	siRNA	to	Silence	Gene	Expression	in	Primary	NK	Cells.	Methods	in	molecular	biology	
1441,	267-276	
	 147	
191.	 Silber,	J.,	Lim,	D.	A.,	Petritsch,	C.,	Persson,	A.	I.,	Maunakea,	A.	K.,	Yu,	M.,	Vandenberg,	S.	R.,	Ginzinger,	D.	G.,	James,	C.	D.,	Costello,	J.	F.,	Bergers,	G.,	Weiss,	W.	A.,	Alvarez-Buylla,	A.,	and	Hodgson,	J.	G.	(2008)	miR-124	and	miR-137	inhibit	proliferation	of	glioblastoma	multiforme	cells	and	induce	differentiation	of	brain	tumor	stem	cells.	BMC	medicine	6,	14	192.	 Deng,	D.,	Wang,	L.,	Chen,	Y.,	Li,	B.,	Xue,	L.,	Shao,	N.,	Wang,	Q.,	Xia,	X.,	Yang,	Y.,	and	Zhi,	F.	(2016)	MicroRNA-124-3p	regulates	cell	proliferation,	invasion,	apoptosis,	and	bioenergetics	by	targeting	PIM1	in	astrocytoma.	Cancer	science	107,	899-907	193.	 Kyo,	S.,	Kanaya,	T.,	Takakura,	M.,	Tanaka,	M.,	and	Inoue,	M.	(1999)	Human	telomerase	reverse	transcriptase	as	a	critical	determinant	of	telomerase	activity	in	normal	and	malignant	endometrial	tissues.	International	journal	of	cancer.	
Journal	international	du	cancer	80,	60-63	194.	 Meyerson,	M.,	Counter,	C.	M.,	Eaton,	E.	N.,	Ellisen,	L.	W.,	Steiner,	P.,	Caddle,	S.	D.,	Ziaugra,	L.,	Beijersbergen,	R.	L.,	Davidoff,	M.	J.,	Liu,	Q.,	Bacchetti,	S.,	Haber,	D.	A.,	and	Weinberg,	R.	A.	(1997)	hEST2,	the	putative	human	telomerase	catalytic	subunit	gene,	is	up-regulated	in	tumor	cells	and	during	immortalization.	Cell	90,	785-795	195.	 Zhang,	Y.,	Toh,	L.,	Lau,	P.,	and	Wang,	X.	(2012)	Human	telomerase	reverse	transcriptase	(hTERT)	is	a	novel	target	of	the	Wnt/beta-catenin	pathway	in	human	cancer.	The	Journal	of	biological	chemistry	287,	32494-32511	196.	 Cacalano,	N.	A.	(2016)	Regulation	of	Natural	Killer	Cell	Function	by	STAT3.	
Frontiers	in	immunology	7,	128	
	 148	
197.	 Xu,	X.,	Li,	S.,	Lin,	Y.,	Chen,	H.,	Hu,	Z.,	Mao,	Y.,	Xu,	X.,	Wu,	J.,	Zhu,	Y.,	Zheng,	X.,	Luo,	J.,	and	Xie,	L.	(2013)	MicroRNA-124-3p	inhibits	cell	migration	and	invasion	in	bladder	cancer	cells	by	targeting	ROCK1.	Journal	of	translational	medicine	11,	276		
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 149	
VITA 
 
Anitha Somanchi was born in Coimbatore, in the southern state of Tamil Nadu, India to Mrs. 
Vasumathy and Mr. Gururajan. Anitha completed her high school education at Lady 
Sivaswami Iyer Girls’ Higher Secondary School, Mylapore, Chennai. Anitha received her 
Bachelor’s and Master’s degrees in Biochemistry from the University of Madras, India. 
Following her education, Anitha moved to the United States, where she worked as a Research 
technician at Childrens Hospital Los Angeles and U.T. M.D. Anderson Cancer Center. Anitha 
joined the Ph.D program at the Graduate School of Biomedical Sciences, The University of 
Texas MD Anderson Cancer Center, Houston in August 2012, to pursue her passion in 
immunotherapy for cancer and worked under the mentorship of Drs. Eugenie Kleinerman and 
Dean Lee. Her project specialization is on Natural Killer (NK) cells for immunotherapy 
applications, and understanding the microRNA profiles in NK cells and their manipulation for 
better expansion of NK cells.  
 
 
 
 
